id	sid	tid	token	lemma	pos
bjos-8666637	1	1	1	1	NUM
bjos-8666637	1	2	volume	volume	NOUN
bjos-8666637	1	3	22	22	NUM
bjos-8666637	1	4	2023	2023	NUM
bjos-8666637	1	5	e236637	e236637	ADJ
bjos-8666637	1	6	original	original	ADJ
bjos-8666637	1	7	article	article	NOUN
bjos-8666637	1	8	braz	braz	PROPN
bjos-8666637	1	9	j	j	PROPN
bjos-8666637	1	10	oral	oral	PROPN
bjos-8666637	1	11	sci	sci	PROPN
bjos-8666637	1	12	.	.	PUNCT
bjos-8666637	2	1	2023;22	2023;22	NUM
bjos-8666637	2	2	:	:	PUNCT
bjos-8666637	2	3	e236637http://dx.doi.org/10.20396	e236637http://dx.doi.org/10.20396	ADV
bjos-8666637	2	4	/	/	SYM
bjos-8666637	2	5	bjos.v22i00.8666637	bjos.v22i00.8666637	NOUN
bjos-8666637	2	6	1	1	NUM
bjos-8666637	2	7	department	department	NOUN
bjos-8666637	2	8	of	of	ADP
bjos-8666637	2	9	dentistry	dentistry	NOUN
bjos-8666637	2	10	,	,	PUNCT
bjos-8666637	2	11	faculty	faculty	NOUN
bjos-8666637	2	12	of	of	ADP
bjos-8666637	2	13	health	health	NOUN
bjos-8666637	2	14	sciences	sciences	PROPN
bjos-8666637	2	15	,	,	PUNCT
bjos-8666637	2	16	university	university	NOUN
bjos-8666637	2	17	of	of	ADP
bjos-8666637	2	18	brasília	brasília	PROPN
bjos-8666637	2	19	.	.	PROPN
bjos-8666637	3	1	2	2	NUM
bjos-8666637	3	2	post	post	ADJ
bjos-8666637	3	3	-	-	ADJ
bjos-8666637	3	4	graduate	graduate	ADJ
bjos-8666637	3	5	program	program	NOUN
bjos-8666637	3	6	in	in	ADP
bjos-8666637	3	7	dentistry	dentistry	NOUN
bjos-8666637	3	8	,	,	PUNCT
bjos-8666637	3	9	university	university	NOUN
bjos-8666637	3	10	of	of	ADP
bjos-8666637	3	11	brasília	brasília	PROPN
bjos-8666637	3	12	.	.	PROPN
bjos-8666637	4	1	3	3	NUM
bjos-8666637	4	2	department	department	NOUN
bjos-8666637	4	3	of	of	ADP
bjos-8666637	4	4	cell	cell	NOUN
bjos-8666637	4	5	biology	biology	NOUN
bjos-8666637	4	6	,	,	PUNCT
bjos-8666637	4	7	institute	institute	NOUN
bjos-8666637	4	8	of	of	ADP
bjos-8666637	4	9	biological	biological	ADJ
bjos-8666637	4	10	sciences	sciences	PROPN
bjos-8666637	4	11	,	,	PUNCT
bjos-8666637	4	12	university	university	NOUN
bjos-8666637	4	13	of	of	ADP
bjos-8666637	4	14	brasília	brasília	PROPN
bjos-8666637	4	15	.	.	PROPN
bjos-8666637	4	16	4	4	NUM
bjos-8666637	4	17	department	department	NOUN
bjos-8666637	4	18	of	of	ADP
bjos-8666637	4	19	medicine	medicine	NOUN
bjos-8666637	4	20	,	,	PUNCT
bjos-8666637	4	21	faculty	faculty	NOUN
bjos-8666637	4	22	of	of	ADP
bjos-8666637	4	23	medicine	medicine	NOUN
bjos-8666637	4	24	of	of	ADP
bjos-8666637	4	25	ribeirão	ribeirão	PROPN
bjos-8666637	4	26	preto	preto	PROPN
bjos-8666637	4	27	,	,	PUNCT
bjos-8666637	4	28	university	university	PROPN
bjos-8666637	4	29	of	of	ADP
bjos-8666637	4	30	são	são	PROPN
bjos-8666637	4	31	paulo	paulo	PROPN
bjos-8666637	4	32	.	.	PUNCT
bjos-8666637	5	1	5	5	NUM
bjos-8666637	5	2	department	department	NOUN
bjos-8666637	5	3	of	of	ADP
bjos-8666637	5	4	pharmacy	pharmacy	NOUN
bjos-8666637	5	5	,	,	PUNCT
bjos-8666637	5	6	faculty	faculty	NOUN
bjos-8666637	5	7	of	of	ADP
bjos-8666637	5	8	health	health	NOUN
bjos-8666637	5	9	sciences	sciences	PROPN
bjos-8666637	5	10	,	,	PUNCT
bjos-8666637	5	11	university	university	NOUN
bjos-8666637	5	12	of	of	ADP
bjos-8666637	5	13	brasília	brasília	PROPN
bjos-8666637	5	14	.	.	PUNCT
bjos-8666637	6	1	corresponding	correspond	VERB
bjos-8666637	6	2	author	author	NOUN
bjos-8666637	6	3	:	:	PUNCT
bjos-8666637	6	4	danielly	danielly	ADV
bjos-8666637	6	5	de	de	X
bjos-8666637	6	6	mendonça	mendonça	ADJ
bjos-8666637	6	7	guimarães	guimarães	PROPN
bjos-8666637	6	8	cnd	cnd	PROPN
bjos-8666637	6	9	4	4	NUM
bjos-8666637	6	10	,	,	PUNCT
bjos-8666637	6	11	lote	lote	PROPN
bjos-8666637	6	12	06	06	NUM
bjos-8666637	6	13	,	,	PUNCT
bjos-8666637	6	14	loja	loja	PROPN
bjos-8666637	6	15	01/02	01/02	NUM
bjos-8666637	6	16	,	,	PUNCT
bjos-8666637	6	17	taguatinga	taguatinga	VERB
bjos-8666637	6	18	norte	norte	PROPN
bjos-8666637	6	19	brasília	brasília	PROPN
bjos-8666637	6	20	/	/	SYM
bjos-8666637	6	21	distrito	distrito	PROPN
bjos-8666637	6	22	federal	federal	PROPN
bjos-8666637	6	23	72120045	72120045	NUM
bjos-8666637	6	24	e	e	NOUN
bjos-8666637	6	25	-	-	NOUN
bjos-8666637	6	26	mail	mail	NOUN
bjos-8666637	6	27	:	:	PUNCT
bjos-8666637	6	28	daniellymendoncaguimaraes@	daniellymendoncaguimaraes@	PROPN
bjos-8666637	6	29	gmail.com	gmail.com	X
bjos-8666637	6	30	editor	editor	NOUN
bjos-8666637	6	31	:	:	PUNCT
bjos-8666637	6	32	dr	dr	PROPN
bjos-8666637	6	33	.	.	PROPN
bjos-8666637	6	34	altair	altair	PROPN
bjos-8666637	6	35	a.	a.	PROPN
bjos-8666637	6	36	del	del	PROPN
bjos-8666637	6	37	bel	bel	PROPN
bjos-8666637	6	38	cury	cury	PROPN
bjos-8666637	6	39	received	receive	VERB
bjos-8666637	6	40	:	:	PUNCT
bjos-8666637	6	41	august	august	PROPN
bjos-8666637	6	42	8	8	NUM
bjos-8666637	6	43	,	,	PUNCT
bjos-8666637	6	44	2021	2021	NUM
bjos-8666637	6	45	accepted	accept	VERB
bjos-8666637	6	46	:	:	PUNCT
bjos-8666637	6	47	april	april	PROPN
bjos-8666637	6	48	9	9	NUM
bjos-8666637	6	49	,	,	PUNCT
bjos-8666637	6	50	2022	2022	NUM
bjos-8666637	6	51	xerostomia	xerostomia	NOUN
bjos-8666637	6	52	and	and	CCONJ
bjos-8666637	6	53	dysgeusia	dysgeusia	NOUN
bjos-8666637	6	54	in	in	ADP
bjos-8666637	6	55	the	the	DET
bjos-8666637	6	56	elderly	elderly	ADJ
bjos-8666637	6	57	:	:	PUNCT
bjos-8666637	6	58	prevalence	prevalence	NOUN
bjos-8666637	6	59	of	of	ADP
bjos-8666637	6	60	and	and	CCONJ
bjos-8666637	6	61	association	association	NOUN
bjos-8666637	6	62	with	with	ADP
bjos-8666637	6	63	polypharmacy	polypharmacy	NOUN
bjos-8666637	6	64	danielly	danielly	ADV
bjos-8666637	6	65	de	de	ADP
bjos-8666637	6	66	mendonça	mendonça	X
bjos-8666637	6	67	guimarães*1	guimarães*1	PROPN
bjos-8666637	6	68	,	,	PUNCT
bjos-8666637	6	69	yeda	yeda	PROPN
bjos-8666637	6	70	maria	maria	PROPN
bjos-8666637	6	71	parro2	parro2	NOUN
bjos-8666637	6	72	,	,	PUNCT
bjos-8666637	6	73	herick	herick	PROPN
bjos-8666637	6	74	sampaio	sampaio	PROPN
bjos-8666637	6	75	muller3	muller3	PROPN
bjos-8666637	6	76	,	,	PUNCT
bjos-8666637	6	77	eduardo	eduardo	PROPN
bjos-8666637	6	78	barbosa	barbosa	PROPN
bjos-8666637	6	79	coelho4	coelho4	PROPN
bjos-8666637	6	80	,	,	PUNCT
bjos-8666637	6	81	vicente	vicente	PROPN
bjos-8666637	6	82	de	de	PROPN
bjos-8666637	6	83	paulo	paulo	PROPN
bjos-8666637	6	84	martins3	martins3	PROPN
bjos-8666637	6	85	,	,	PUNCT
bjos-8666637	6	86	rafael	rafael	PROPN
bjos-8666637	6	87	santana5	santana5	PROPN
bjos-8666637	6	88	,	,	PUNCT
bjos-8666637	6	89	érica	érica	PROPN
bjos-8666637	6	90	negrini	negrini	PROPN
bjos-8666637	7	1	lia1,2	lia1,2	ADJ
bjos-8666637	7	2	xerostomia	xerostomia	NOUN
bjos-8666637	7	3	is	be	AUX
bjos-8666637	7	4	defined	define	VERB
bjos-8666637	7	5	as	as	ADP
bjos-8666637	7	6	the	the	DET
bjos-8666637	7	7	perception	perception	NOUN
bjos-8666637	7	8	of	of	ADP
bjos-8666637	7	9	dry	dry	ADJ
bjos-8666637	7	10	mouth	mouth	NOUN
bjos-8666637	7	11	,	,	PUNCT
bjos-8666637	7	12	and	and	CCONJ
bjos-8666637	7	13	dysgeusia	dysgeusia	PROPN
bjos-8666637	7	14	,	,	PUNCT
bjos-8666637	7	15	as	as	ADP
bjos-8666637	7	16	a	a	DET
bjos-8666637	7	17	change	change	NOUN
bjos-8666637	7	18	in	in	ADP
bjos-8666637	7	19	taste	taste	NOUN
bjos-8666637	7	20	.	.	PUNCT
bjos-8666637	8	1	both	both	PRON
bjos-8666637	8	2	are	be	AUX
bjos-8666637	8	3	common	common	ADJ
bjos-8666637	8	4	complaints	complaint	NOUN
bjos-8666637	8	5	in	in	ADP
bjos-8666637	8	6	the	the	DET
bjos-8666637	8	7	elderly	elderly	ADJ
bjos-8666637	8	8	,	,	PUNCT
bjos-8666637	8	9	especially	especially	ADV
bjos-8666637	8	10	among	among	ADP
bjos-8666637	8	11	those	those	PRON
bjos-8666637	8	12	making	make	VERB
bjos-8666637	8	13	use	use	NOUN
bjos-8666637	8	14	of	of	ADP
bjos-8666637	8	15	polypharmacy	polypharmacy	NOUN
bjos-8666637	8	16	drug	drug	NOUN
bjos-8666637	8	17	combinations	combination	NOUN
bjos-8666637	8	18	.	.	PUNCT
bjos-8666637	9	1	aim	aim	VERB
bjos-8666637	9	2	:	:	PUNCT
bjos-8666637	10	1	this	this	DET
bjos-8666637	10	2	study	study	NOUN
bjos-8666637	10	3	aimed	aim	VERB
bjos-8666637	10	4	to	to	PART
bjos-8666637	10	5	determine	determine	VERB
bjos-8666637	10	6	the	the	DET
bjos-8666637	10	7	prevalence	prevalence	NOUN
bjos-8666637	10	8	of	of	ADP
bjos-8666637	10	9	xerostomia	xerostomia	PROPN
bjos-8666637	10	10	and	and	CCONJ
bjos-8666637	10	11	dysgeusia	dysgeusia	NOUN
bjos-8666637	10	12	and	and	CCONJ
bjos-8666637	10	13	to	to	PART
bjos-8666637	10	14	investigate	investigate	VERB
bjos-8666637	10	15	their	their	PRON
bjos-8666637	10	16	association	association	NOUN
bjos-8666637	10	17	with	with	ADP
bjos-8666637	10	18	polypharmacy	polypharmacy	NOUN
bjos-8666637	10	19	in	in	ADP
bjos-8666637	10	20	the	the	DET
bjos-8666637	10	21	elderly	elderly	ADJ
bjos-8666637	10	22	.	.	PUNCT
bjos-8666637	11	1	methods	method	NOUN
bjos-8666637	11	2	:	:	PUNCT
bjos-8666637	11	3	older	old	ADJ
bjos-8666637	11	4	people	people	NOUN
bjos-8666637	11	5	under	under	ADP
bjos-8666637	11	6	follow	follow	NOUN
bjos-8666637	11	7	-	-	PUNCT
bjos-8666637	11	8	up	up	NOUN
bjos-8666637	11	9	at	at	ADP
bjos-8666637	11	10	the	the	DET
bjos-8666637	11	11	multidisciplinary	multidisciplinary	ADJ
bjos-8666637	11	12	elderly	elderly	ADJ
bjos-8666637	11	13	center	center	NOUN
bjos-8666637	11	14	of	of	ADP
bjos-8666637	11	15	the	the	DET
bjos-8666637	11	16	university	university	NOUN
bjos-8666637	11	17	hospital	hospital	NOUN
bjos-8666637	11	18	of	of	ADP
bjos-8666637	11	19	brasília	brasília	PROPN
bjos-8666637	11	20	were	be	AUX
bjos-8666637	11	21	interviewed	interview	VERB
bjos-8666637	11	22	and	and	CCONJ
bjos-8666637	11	23	asked	ask	VERB
bjos-8666637	11	24	about	about	ADP
bjos-8666637	11	25	health	health	NOUN
bjos-8666637	11	26	problems	problem	NOUN
bjos-8666637	11	27	,	,	PUNCT
bjos-8666637	11	28	medications	medication	NOUN
bjos-8666637	11	29	used	use	VERB
bjos-8666637	11	30	,	,	PUNCT
bjos-8666637	11	31	presence	presence	NOUN
bjos-8666637	11	32	of	of	ADP
bjos-8666637	11	33	xerostomia	xerostomia	PROPN
bjos-8666637	11	34	and	and	CCONJ
bjos-8666637	11	35	dysgeusia	dysgeusia	PROPN
bjos-8666637	11	36	.	.	PUNCT
bjos-8666637	12	1	descriptive	descriptive	ADJ
bjos-8666637	12	2	statistics	statistic	NOUN
bjos-8666637	12	3	were	be	AUX
bjos-8666637	12	4	used	use	VERB
bjos-8666637	12	5	to	to	PART
bjos-8666637	12	6	determine	determine	VERB
bjos-8666637	12	7	the	the	DET
bjos-8666637	12	8	prevalence	prevalence	NOUN
bjos-8666637	12	9	of	of	ADP
bjos-8666637	12	10	the	the	DET
bjos-8666637	12	11	symptoms	symptom	NOUN
bjos-8666637	12	12	surveyed	survey	VERB
bjos-8666637	12	13	.	.	PUNCT
bjos-8666637	13	1	the	the	DET
bjos-8666637	13	2	chi	chi	ADJ
bjos-8666637	13	3	-	-	PUNCT
bjos-8666637	13	4	square	square	ADJ
bjos-8666637	13	5	test	test	NOUN
bjos-8666637	13	6	was	be	AUX
bjos-8666637	13	7	used	use	VERB
bjos-8666637	13	8	to	to	PART
bjos-8666637	13	9	investigate	investigate	VERB
bjos-8666637	13	10	the	the	DET
bjos-8666637	13	11	relationship	relationship	NOUN
bjos-8666637	13	12	between	between	ADP
bjos-8666637	13	13	xerostomia	xerostomia	PROPN
bjos-8666637	13	14	and	and	CCONJ
bjos-8666637	13	15	dysgeusia	dysgeusia	NOUN
bjos-8666637	13	16	and	and	CCONJ
bjos-8666637	13	17	polypharmacy	polypharmacy	NOUN
bjos-8666637	13	18	.	.	PUNCT
bjos-8666637	14	1	secondary	secondary	ADJ
bjos-8666637	14	2	associations	association	NOUN
bjos-8666637	14	3	were	be	AUX
bjos-8666637	14	4	performed	perform	VERB
bjos-8666637	14	5	using	use	VERB
bjos-8666637	14	6	binomial	binomial	ADJ
bjos-8666637	14	7	logistic	logistic	ADJ
bjos-8666637	14	8	regression	regression	NOUN
bjos-8666637	14	9	.	.	PUNCT
bjos-8666637	15	1	results	result	NOUN
bjos-8666637	15	2	:	:	PUNCT
bjos-8666637	15	3	ninety	ninety	NUM
bjos-8666637	15	4	-	-	PUNCT
bjos-8666637	15	5	six	six	NUM
bjos-8666637	15	6	older	old	ADJ
bjos-8666637	15	7	people	people	NOUN
bjos-8666637	15	8	were	be	AUX
bjos-8666637	15	9	evaluated	evaluate	VERB
bjos-8666637	15	10	and	and	CCONJ
bjos-8666637	15	11	of	of	ADP
bjos-8666637	15	12	these	these	PRON
bjos-8666637	15	13	,	,	PUNCT
bjos-8666637	15	14	62.5	62.5	NUM
bjos-8666637	15	15	%	%	NOUN
bjos-8666637	15	16	had	have	VERB
bjos-8666637	15	17	xerostomia	xerostomia	NOUN
bjos-8666637	15	18	and	and	CCONJ
bjos-8666637	15	19	21.1	21.1	NUM
bjos-8666637	15	20	%	%	NOUN
bjos-8666637	15	21	,	,	PUNCT
bjos-8666637	15	22	had	have	VERB
bjos-8666637	15	23	dysgeusia	dysgeusia	NOUN
bjos-8666637	15	24	.	.	PUNCT
bjos-8666637	16	1	the	the	DET
bjos-8666637	16	2	average	average	ADJ
bjos-8666637	16	3	number	number	NOUN
bjos-8666637	16	4	of	of	ADP
bjos-8666637	16	5	medications	medication	NOUN
bjos-8666637	16	6	used	use	VERB
bjos-8666637	16	7	was	be	AUX
bjos-8666637	16	8	4±3	4±3	NUM
bjos-8666637	16	9	medications	medication	NOUN
bjos-8666637	16	10	per	per	ADP
bjos-8666637	16	11	individual	individual	NOUN
bjos-8666637	16	12	.	.	PUNCT
bjos-8666637	17	1	polypharmacy	polypharmacy	NOUN
bjos-8666637	17	2	was	be	AUX
bjos-8666637	17	3	associated	associate	VERB
bjos-8666637	17	4	with	with	ADP
bjos-8666637	17	5	xerostomia	xerostomia	NOUN
bjos-8666637	17	6	but	but	CCONJ
bjos-8666637	17	7	not	not	PART
bjos-8666637	17	8	dysgeusia	dysgeusia	PROPN
bjos-8666637	17	9	.	.	PUNCT
bjos-8666637	18	1	it	it	PRON
bjos-8666637	18	2	was	be	AUX
bjos-8666637	18	3	possible	possible	ADJ
bjos-8666637	18	4	to	to	PART
bjos-8666637	18	5	associate	associate	VERB
bjos-8666637	18	6	xerostomia	xerostomia	NOUN
bjos-8666637	18	7	with	with	ADP
bjos-8666637	18	8	the	the	DET
bjos-8666637	18	9	use	use	NOUN
bjos-8666637	18	10	of	of	ADP
bjos-8666637	18	11	antihypertensive	antihypertensive	ADJ
bjos-8666637	18	12	drugs	drug	NOUN
bjos-8666637	18	13	.	.	PUNCT
bjos-8666637	19	1	conclusion	conclusion	NOUN
bjos-8666637	19	2	:	:	PUNCT
bjos-8666637	19	3	xerostomia	xerostomia	PROPN
bjos-8666637	19	4	was	be	AUX
bjos-8666637	19	5	a	a	DET
bjos-8666637	19	6	frequent	frequent	ADJ
bjos-8666637	19	7	complaint	complaint	NOUN
bjos-8666637	19	8	among	among	ADP
bjos-8666637	19	9	elderly	elderly	ADJ
bjos-8666637	19	10	people	people	NOUN
bjos-8666637	19	11	making	make	VERB
bjos-8666637	19	12	use	use	NOUN
bjos-8666637	19	13	of	of	ADP
bjos-8666637	19	14	polypharmacy	polypharmacy	NOUN
bjos-8666637	19	15	,	,	PUNCT
bjos-8666637	19	16	especially	especially	ADV
bjos-8666637	19	17	those	those	PRON
bjos-8666637	19	18	using	use	VERB
bjos-8666637	19	19	antihypertensives	antihypertensive	NOUN
bjos-8666637	19	20	.	.	PUNCT
bjos-8666637	20	1	antihypertensives	antihypertensive	NOUN
bjos-8666637	20	2	and	and	CCONJ
bjos-8666637	20	3	antidepressants	antidepressant	NOUN
bjos-8666637	20	4	were	be	AUX
bjos-8666637	20	5	used	use	VERB
bjos-8666637	20	6	most	most	ADJ
bjos-8666637	20	7	drugs	drug	NOUN
bjos-8666637	20	8	by	by	ADP
bjos-8666637	20	9	the	the	DET
bjos-8666637	20	10	elderly	elderly	ADJ
bjos-8666637	20	11	and	and	CCONJ
bjos-8666637	20	12	exhibited	exhibit	VERB
bjos-8666637	20	13	interactions	interaction	NOUN
bjos-8666637	20	14	with	with	ADP
bjos-8666637	20	15	drugs	drug	NOUN
bjos-8666637	20	16	most	most	ADV
bjos-8666637	20	17	prescribed	prescribe	VERB
bjos-8666637	20	18	in	in	ADP
bjos-8666637	20	19	dentistry	dentistry	NOUN
bjos-8666637	20	20	.	.	PUNCT
bjos-8666637	21	1	two	two	NUM
bjos-8666637	21	2	contraindications	contraindication	NOUN
bjos-8666637	21	3	were	be	AUX
bjos-8666637	21	4	found	find	VERB
bjos-8666637	21	5	between	between	ADP
bjos-8666637	21	6	fluconazole	fluconazole	NOUN
bjos-8666637	21	7	and	and	CCONJ
bjos-8666637	21	8	mirtazapine	mirtazapine	NOUN
bjos-8666637	21	9	;	;	PUNCT
bjos-8666637	21	10	and	and	CCONJ
bjos-8666637	21	11	between	between	ADP
bjos-8666637	21	12	erythromycin	erythromycin	NOUN
bjos-8666637	21	13	and	and	CCONJ
bjos-8666637	21	14	simvastatin	simvastatin	NOUN
bjos-8666637	21	15	.	.	PUNCT
bjos-8666637	22	1	keywords	keyword	NOUN
bjos-8666637	22	2	:	:	PUNCT
bjos-8666637	22	3	xerostomia	xerostomia	NOUN
bjos-8666637	22	4	.	.	PUNCT
bjos-8666637	23	1	dysgeusia	dysgeusia	PROPN
bjos-8666637	23	2	.	.	PUNCT
bjos-8666637	24	1	drug	drug	NOUN
bjos-8666637	24	2	interactions	interaction	NOUN
bjos-8666637	24	3	.	.	PUNCT
bjos-8666637	25	1	dental	dental	ADJ
bjos-8666637	25	2	care	care	NOUN
bjos-8666637	25	3	for	for	ADP
bjos-8666637	25	4	aged	aged	ADJ
bjos-8666637	25	5	.	.	PUNCT
bjos-8666637	26	1	https://orcid.org/0000-0002-9385-5184	https://orcid.org/0000-0002-9385-5184	NOUN
bjos-8666637	26	2	https://orcid.org/0000-0001-8428-6226	https://orcid.org/0000-0001-8428-6226	PRON
bjos-8666637	26	3	https://orcid.org/0000-0003-2474-8294	https://orcid.org/0000-0003-2474-8294	NOUN
bjos-8666637	26	4	https://orcid.org/0000-0003-3491-3396	https://orcid.org/0000-0003-3491-3396	VERB
bjos-8666637	26	5	https://orcid.org/0000-0001-7611-861x	https://orcid.org/0000-0001-7611-861x	ADJ
bjos-8666637	26	6	https://orcid.org/0000-0003-4481-210x	https://orcid.org/0000-0003-4481-210x	PROPN
bjos-8666637	27	1	https://orcid.org/0000-0001-5691-415x	https://orcid.org/0000-0001-5691-415x	PROPN
bjos-8666637	27	2	2	2	NUM
bjos-8666637	27	3	guimarães	guimarães	NOUN
bjos-8666637	27	4	et	et	PROPN
bjos-8666637	27	5	al	al	PROPN
bjos-8666637	27	6	.	.	PROPN
bjos-8666637	27	7	braz	braz	PROPN
bjos-8666637	27	8	j	j	PROPN
bjos-8666637	27	9	oral	oral	PROPN
bjos-8666637	27	10	sci	sci	PROPN
bjos-8666637	27	11	.	.	PUNCT
bjos-8666637	28	1	2023;22	2023;22	NUM
bjos-8666637	28	2	:	:	PUNCT
bjos-8666637	28	3	e236637	e236637	ADJ
bjos-8666637	28	4	introduction	introduction	NOUN
bjos-8666637	28	5	elderly	elderly	ADJ
bjos-8666637	28	6	brazilians	brazilian	NOUN
bjos-8666637	28	7	represent	represent	VERB
bjos-8666637	28	8	about	about	ADV
bjos-8666637	28	9	15	15	NUM
bjos-8666637	28	10	%	%	NOUN
bjos-8666637	28	11	of	of	ADP
bjos-8666637	28	12	the	the	DET
bjos-8666637	28	13	country	country	NOUN
bjos-8666637	28	14	’s	’s	PART
bjos-8666637	28	15	population1	population1	NOUN
bjos-8666637	28	16	,	,	PUNCT
bjos-8666637	28	17	and	and	CCONJ
bjos-8666637	28	18	the	the	DET
bjos-8666637	28	19	number	number	NOUN
bjos-8666637	28	20	is	be	AUX
bjos-8666637	28	21	expected	expect	VERB
bjos-8666637	28	22	to	to	PART
bjos-8666637	28	23	increase	increase	VERB
bjos-8666637	28	24	due	due	ADP
bjos-8666637	28	25	to	to	ADP
bjos-8666637	28	26	the	the	DET
bjos-8666637	28	27	demographic	demographic	ADJ
bjos-8666637	28	28	transition2	transition2	NOUN
bjos-8666637	28	29	.	.	PUNCT
bjos-8666637	29	1	in	in	ADP
bjos-8666637	29	2	view	view	NOUN
bjos-8666637	29	3	of	of	ADP
bjos-8666637	29	4	this	this	DET
bjos-8666637	29	5	reality	reality	NOUN
bjos-8666637	29	6	,	,	PUNCT
bjos-8666637	29	7	the	the	DET
bjos-8666637	29	8	aging	age	VERB
bjos-8666637	29	9	process	process	NOUN
bjos-8666637	29	10	requires	require	VERB
bjos-8666637	29	11	multidisciplinary	multidisciplinary	ADJ
bjos-8666637	29	12	attention	attention	NOUN
bjos-8666637	29	13	,	,	PUNCT
bjos-8666637	29	14	especially	especially	ADV
bjos-8666637	29	15	from	from	ADP
bjos-8666637	29	16	health	health	NOUN
bjos-8666637	29	17	professionals	professional	NOUN
bjos-8666637	29	18	.	.	PUNCT
bjos-8666637	30	1	older	old	ADJ
bjos-8666637	30	2	people	people	NOUN
bjos-8666637	30	3	are	be	AUX
bjos-8666637	30	4	often	often	ADV
bjos-8666637	30	5	affected	affect	VERB
bjos-8666637	30	6	by	by	ADP
bjos-8666637	30	7	mutimorbidies	mutimorbidie	NOUN
bjos-8666637	30	8	and	and	CCONJ
bjos-8666637	30	9	are	be	AUX
bjos-8666637	30	10	exposed	expose	VERB
bjos-8666637	30	11	to	to	ADP
bjos-8666637	30	12	polypharmacy3	polypharmacy3	NOUN
bjos-8666637	30	13	,	,	PUNCT
bjos-8666637	30	14	predisposing	predispose	VERB
bjos-8666637	30	15	to	to	ADP
bjos-8666637	30	16	drug	drug	NOUN
bjos-8666637	30	17	interactions	interaction	NOUN
bjos-8666637	30	18	and	and	CCONJ
bjos-8666637	30	19	adverse	adverse	ADJ
bjos-8666637	30	20	reactions4	reactions4	NOUN
bjos-8666637	30	21	.	.	PUNCT
bjos-8666637	31	1	the	the	DET
bjos-8666637	31	2	concept	concept	NOUN
bjos-8666637	31	3	of	of	ADP
bjos-8666637	31	4	polypharmacy	polypharmacy	NOUN
bjos-8666637	31	5	is	be	AUX
bjos-8666637	31	6	variable	variable	ADJ
bjos-8666637	31	7	in	in	ADP
bjos-8666637	31	8	the	the	DET
bjos-8666637	31	9	literature	literature	NOUN
bjos-8666637	31	10	,	,	PUNCT
bjos-8666637	31	11	and	and	CCONJ
bjos-8666637	31	12	it	it	PRON
bjos-8666637	31	13	can	can	AUX
bjos-8666637	31	14	be	be	AUX
bjos-8666637	31	15	considered	consider	VERB
bjos-8666637	31	16	to	to	PART
bjos-8666637	31	17	be	be	AUX
bjos-8666637	31	18	the	the	DET
bjos-8666637	31	19	simultaneous	simultaneous	ADJ
bjos-8666637	31	20	continuous	continuous	ADJ
bjos-8666637	31	21	long	long	ADJ
bjos-8666637	31	22	-	-	PUNCT
bjos-8666637	31	23	term	term	NOUN
bjos-8666637	31	24	use	use	NOUN
bjos-8666637	31	25	of	of	ADP
bjos-8666637	31	26	3	3	NUM
bjos-8666637	31	27	or	or	CCONJ
bjos-8666637	31	28	more	more	ADV
bjos-8666637	31	29	different	different	ADJ
bjos-8666637	31	30	drugs	drug	NOUN
bjos-8666637	31	31	,	,	PUNCT
bjos-8666637	31	32	in	in	ADP
bjos-8666637	31	33	addition	addition	NOUN
bjos-8666637	31	34	to	to	ADP
bjos-8666637	31	35	those	those	PRON
bjos-8666637	31	36	inappropriate	inappropriate	ADJ
bjos-8666637	31	37	for	for	ADP
bjos-8666637	31	38	the	the	DET
bjos-8666637	31	39	clinical	clinical	ADJ
bjos-8666637	31	40	conditions5	conditions5	NOUN
bjos-8666637	31	41	,	,	PUNCT
bjos-8666637	31	42	such	such	ADJ
bjos-8666637	31	43	as	as	ADP
bjos-8666637	31	44	medications	medication	NOUN
bjos-8666637	31	45	that	that	PRON
bjos-8666637	31	46	meet	meet	VERB
bjos-8666637	31	47	the	the	DET
bjos-8666637	31	48	beers	beer	NOUN
bjos-8666637	31	49	criteria	criterion	NOUN
bjos-8666637	31	50	,	,	PUNCT
bjos-8666637	31	51	in	in	ADP
bjos-8666637	31	52	the	the	DET
bjos-8666637	31	53	case	case	NOUN
bjos-8666637	31	54	of	of	ADP
bjos-8666637	31	55	the	the	DET
bjos-8666637	31	56	elderly5	elderly5	NOUN
bjos-8666637	31	57	.	.	PUNCT
bjos-8666637	32	1	among	among	ADP
bjos-8666637	32	2	the	the	DET
bjos-8666637	32	3	common	common	ADJ
bjos-8666637	32	4	adverse	adverse	ADJ
bjos-8666637	32	5	effects	effect	NOUN
bjos-8666637	32	6	of	of	ADP
bjos-8666637	32	7	polypharmacy	polypharmacy	NOUN
bjos-8666637	32	8	,	,	PUNCT
bjos-8666637	32	9	xerostomia	xerostomia	PROPN
bjos-8666637	32	10	and	and	CCONJ
bjos-8666637	32	11	dysgeusia	dysgeusia	PROPN
bjos-8666637	32	12	have	have	AUX
bjos-8666637	32	13	been	be	AUX
bjos-8666637	32	14	found4,6	found4,6	PROPN
bjos-8666637	32	15	.	.	PUNCT
bjos-8666637	33	1	xerostomia	xerostomia	PROPN
bjos-8666637	33	2	is	be	AUX
bjos-8666637	33	3	a	a	DET
bjos-8666637	33	4	symptom	symptom	NOUN
bjos-8666637	33	5	defined	define	VERB
bjos-8666637	33	6	as	as	ADP
bjos-8666637	33	7	a	a	DET
bjos-8666637	33	8	perception	perception	NOUN
bjos-8666637	33	9	of	of	ADP
bjos-8666637	33	10	dry	dry	ADJ
bjos-8666637	33	11	mouth7	mouth7	NOUN
bjos-8666637	33	12	and	and	CCONJ
bjos-8666637	33	13	may	may	AUX
bjos-8666637	33	14	or	or	CCONJ
bjos-8666637	33	15	may	may	AUX
bjos-8666637	33	16	not	not	PART
bjos-8666637	33	17	be	be	AUX
bjos-8666637	33	18	associated	associate	VERB
bjos-8666637	33	19	with	with	ADP
bjos-8666637	33	20	hyposalivation	hyposalivation	NOUN
bjos-8666637	33	21	,	,	PUNCT
bjos-8666637	33	22	characterized	characterize	VERB
bjos-8666637	33	23	by	by	ADP
bjos-8666637	33	24	decreased	decrease	VERB
bjos-8666637	33	25	salivary	salivary	ADJ
bjos-8666637	33	26	flow8	flow8	PROPN
bjos-8666637	33	27	.	.	PUNCT
bjos-8666637	34	1	the	the	DET
bjos-8666637	34	2	sensation	sensation	NOUN
bjos-8666637	34	3	of	of	ADP
bjos-8666637	34	4	dry	dry	ADJ
bjos-8666637	34	5	mouth	mouth	NOUN
bjos-8666637	34	6	affects	affect	VERB
bjos-8666637	34	7	about	about	ADV
bjos-8666637	34	8	50	50	NUM
bjos-8666637	34	9	%	%	NOUN
bjos-8666637	34	10	of	of	ADP
bjos-8666637	34	11	the	the	DET
bjos-8666637	34	12	elderly	elderly	ADJ
bjos-8666637	34	13	over	over	ADP
bjos-8666637	34	14	60	60	NUM
bjos-8666637	34	15	years9	years9	NOUN
bjos-8666637	34	16	,	,	PUNCT
bjos-8666637	34	17	and	and	CCONJ
bjos-8666637	34	18	it	it	PRON
bjos-8666637	34	19	can	can	AUX
bjos-8666637	34	20	occur	occur	VERB
bjos-8666637	34	21	due	due	ADJ
bjos-8666637	34	22	to	to	ADP
bjos-8666637	34	23	salivary	salivary	VERB
bjos-8666637	34	24	gland	gland	NOUN
bjos-8666637	34	25	agenesis7	agenesis7	PROPN
bjos-8666637	34	26	,	,	PUNCT
bjos-8666637	34	27	in	in	ADP
bjos-8666637	34	28	patients	patient	NOUN
bjos-8666637	34	29	undergoing	undergo	VERB
bjos-8666637	34	30	radiotherapy	radiotherapy	ADJ
bjos-8666637	34	31	treatment	treatment	NOUN
bjos-8666637	34	32	of	of	ADP
bjos-8666637	34	33	the	the	DET
bjos-8666637	34	34	head	head	NOUN
bjos-8666637	34	35	and	and	CCONJ
bjos-8666637	34	36	neck	neck	NOUN
bjos-8666637	34	37	region	region	NOUN
bjos-8666637	34	38	,	,	PUNCT
bjos-8666637	34	39	those	those	PRON
bjos-8666637	34	40	with	with	ADP
bjos-8666637	34	41	sjogren	sjogren	PROPN
bjos-8666637	34	42	’s	’s	PART
bjos-8666637	34	43	syndrome	syndrome	NOUN
bjos-8666637	34	44	,	,	PUNCT
bjos-8666637	34	45	and	and	CCONJ
bjos-8666637	34	46	metabolic	metabolic	NOUN
bjos-8666637	34	47	disorders	disorder	NOUN
bjos-8666637	34	48	such	such	ADJ
bjos-8666637	34	49	as	as	ADP
bjos-8666637	34	50	diabetes	diabetes	NOUN
bjos-8666637	34	51	mellitus	mellitus	NOUN
bjos-8666637	34	52	and	and	CCONJ
bjos-8666637	34	53	rheumatoid	rheumatoid	VERB
bjos-8666637	34	54	arthritis10	arthritis10	NOUN
bjos-8666637	34	55	.	.	PUNCT
bjos-8666637	35	1	in	in	ADP
bjos-8666637	35	2	addition	addition	NOUN
bjos-8666637	35	3	,	,	PUNCT
bjos-8666637	35	4	certain	certain	ADJ
bjos-8666637	35	5	classes	class	NOUN
bjos-8666637	35	6	of	of	ADP
bjos-8666637	35	7	drugs	drug	NOUN
bjos-8666637	35	8	have	have	AUX
bjos-8666637	35	9	been	be	AUX
bjos-8666637	35	10	related	relate	VERB
bjos-8666637	35	11	to	to	ADP
bjos-8666637	35	12	xerostomia	xerostomia	NOUN
bjos-8666637	35	13	,	,	PUNCT
bjos-8666637	35	14	such	such	ADJ
bjos-8666637	35	15	as	as	ADP
bjos-8666637	35	16	antidepressant	antidepressant	ADJ
bjos-8666637	35	17	,	,	PUNCT
bjos-8666637	35	18	anxiolytic	anxiolytic	ADJ
bjos-8666637	35	19	,	,	PUNCT
bjos-8666637	35	20	opioid	opioid	ADJ
bjos-8666637	35	21	,	,	PUNCT
bjos-8666637	35	22	antihypertensive	antihypertensive	ADJ
bjos-8666637	35	23	,	,	PUNCT
bjos-8666637	35	24	diuretic	diuretic	ADJ
bjos-8666637	35	25	,	,	PUNCT
bjos-8666637	35	26	and	and	CCONJ
bjos-8666637	35	27	antihistamine	antihistamine	PROPN
bjos-8666637	35	28	drugs11	drugs11	PROPN
bjos-8666637	35	29	.	.	PUNCT
bjos-8666637	36	1	dysgeusia	dysgeusia	PROPN
bjos-8666637	36	2	is	be	AUX
bjos-8666637	36	3	characterized	characterize	VERB
bjos-8666637	36	4	as	as	ADP
bjos-8666637	36	5	a	a	DET
bjos-8666637	36	6	change	change	NOUN
bjos-8666637	36	7	in	in	ADP
bjos-8666637	36	8	the	the	DET
bjos-8666637	36	9	sense	sense	NOUN
bjos-8666637	36	10	of	of	ADP
bjos-8666637	36	11	taste	taste	NOUN
bjos-8666637	36	12	.	.	PUNCT
bjos-8666637	37	1	it	it	PRON
bjos-8666637	37	2	can	can	AUX
bjos-8666637	37	3	be	be	AUX
bjos-8666637	37	4	qualitative	qualitative	VERB
bjos-8666637	37	5	when	when	SCONJ
bjos-8666637	37	6	the	the	DET
bjos-8666637	37	7	change	change	NOUN
bjos-8666637	37	8	occurs	occur	VERB
bjos-8666637	37	9	in	in	ADP
bjos-8666637	37	10	the	the	DET
bjos-8666637	37	11	altered	altered	ADJ
bjos-8666637	37	12	perception	perception	NOUN
bjos-8666637	37	13	of	of	ADP
bjos-8666637	37	14	the	the	DET
bjos-8666637	37	15	taste	taste	NOUN
bjos-8666637	37	16	of	of	ADP
bjos-8666637	37	17	food	food	NOUN
bjos-8666637	37	18	or	or	CCONJ
bjos-8666637	37	19	quantitative	quantitative	ADJ
bjos-8666637	37	20	when	when	SCONJ
bjos-8666637	37	21	the	the	DET
bjos-8666637	37	22	change	change	NOUN
bjos-8666637	37	23	refers	refer	VERB
bjos-8666637	37	24	to	to	ADP
bjos-8666637	37	25	the	the	DET
bjos-8666637	37	26	lack	lack	NOUN
bjos-8666637	37	27	of	of	ADP
bjos-8666637	37	28	taste	taste	NOUN
bjos-8666637	37	29	in	in	ADP
bjos-8666637	37	30	the	the	DET
bjos-8666637	37	31	food4	food4	PROPN
bjos-8666637	37	32	.	.	PUNCT
bjos-8666637	38	1	this	this	DET
bjos-8666637	38	2	condition	condition	NOUN
bjos-8666637	38	3	can	can	AUX
bjos-8666637	38	4	be	be	AUX
bjos-8666637	38	5	caused	cause	VERB
bjos-8666637	38	6	by	by	ADP
bjos-8666637	38	7	using	use	VERB
bjos-8666637	38	8	some	some	DET
bjos-8666637	38	9	groups	group	NOUN
bjos-8666637	38	10	of	of	ADP
bjos-8666637	38	11	drugs	drug	NOUN
bjos-8666637	38	12	,	,	PUNCT
bjos-8666637	38	13	such	such	ADJ
bjos-8666637	38	14	as	as	ADP
bjos-8666637	38	15	antineoplastic	antineoplastic	ADJ
bjos-8666637	38	16	agents	agent	NOUN
bjos-8666637	38	17	,	,	PUNCT
bjos-8666637	38	18	systemic	systemic	ADJ
bjos-8666637	38	19	antibiotics	antibiotic	NOUN
bjos-8666637	38	20	,	,	PUNCT
bjos-8666637	38	21	and	and	CCONJ
bjos-8666637	38	22	drugs	drug	NOUN
bjos-8666637	38	23	indicated	indicate	VERB
bjos-8666637	38	24	for	for	ADP
bjos-8666637	38	25	the	the	DET
bjos-8666637	38	26	treatment	treatment	NOUN
bjos-8666637	38	27	of	of	ADP
bjos-8666637	38	28	nervous	nervous	ADJ
bjos-8666637	38	29	system	system	NOUN
bjos-8666637	38	30	diseases	disease	NOUN
bjos-8666637	38	31	and	and	CCONJ
bjos-8666637	38	32	the	the	DET
bjos-8666637	38	33	result	result	NOUN
bjos-8666637	38	34	of	of	ADP
bjos-8666637	38	35	drug	drug	NOUN
bjos-8666637	38	36	interactions12	interactions12	PROPN
bjos-8666637	38	37	.	.	PUNCT
bjos-8666637	39	1	infection	infection	NOUN
bjos-8666637	39	2	with	with	ADP
bjos-8666637	39	3	the	the	DET
bjos-8666637	39	4	new	new	ADJ
bjos-8666637	39	5	coronavirus	coronavirus	NOUN
bjos-8666637	39	6	(	(	PUNCT
bjos-8666637	39	7	sars	sar	NOUN
bjos-8666637	39	8	-	-	PUNCT
bjos-8666637	39	9	cov-2	cov-2	NOUN
bjos-8666637	39	10	)	)	PUNCT
bjos-8666637	39	11	also	also	ADV
bjos-8666637	39	12	drew	draw	VERB
bjos-8666637	39	13	attention	attention	NOUN
bjos-8666637	39	14	to	to	ADP
bjos-8666637	39	15	dysgeusia	dysgeusia	NOUN
bjos-8666637	39	16	,	,	PUNCT
bjos-8666637	39	17	as	as	SCONJ
bjos-8666637	39	18	it	it	PRON
bjos-8666637	39	19	has	have	AUX
bjos-8666637	39	20	been	be	AUX
bjos-8666637	39	21	reported	report	VERB
bjos-8666637	39	22	by	by	ADP
bjos-8666637	39	23	approximately	approximately	ADV
bjos-8666637	39	24	43	43	NUM
bjos-8666637	39	25	%	%	NOUN
bjos-8666637	39	26	of	of	ADP
bjos-8666637	39	27	patients	patient	NOUN
bjos-8666637	39	28	affected	affect	VERB
bjos-8666637	39	29	by	by	ADP
bjos-8666637	39	30	covid-1913	covid-1913	NOUN
bjos-8666637	39	31	.	.	PUNCT
bjos-8666637	40	1	both	both	DET
bjos-8666637	40	2	xerostomia	xerostomia	PROPN
bjos-8666637	40	3	and	and	CCONJ
bjos-8666637	40	4	dysgeusia	dysgeusia	PROPN
bjos-8666637	40	5	significantly	significantly	ADV
bjos-8666637	40	6	impact	impact	VERB
bjos-8666637	40	7	the	the	DET
bjos-8666637	40	8	quality	quality	NOUN
bjos-8666637	40	9	of	of	ADP
bjos-8666637	40	10	life12,14	life12,14	NOUN
bjos-8666637	40	11	.	.	PUNCT
bjos-8666637	41	1	xerostomia	xerostomia	PROPN
bjos-8666637	41	2	affects	affect	VERB
bjos-8666637	41	3	the	the	DET
bjos-8666637	41	4	perception	perception	NOUN
bjos-8666637	41	5	of	of	ADP
bjos-8666637	41	6	oral	oral	ADJ
bjos-8666637	41	7	health	health	NOUN
bjos-8666637	41	8	and	and	CCONJ
bjos-8666637	41	9	is	be	AUX
bjos-8666637	41	10	related	relate	VERB
bjos-8666637	41	11	to	to	ADP
bjos-8666637	41	12	a	a	DET
bjos-8666637	41	13	burning	burn	VERB
bjos-8666637	41	14	sensation	sensation	NOUN
bjos-8666637	41	15	in	in	ADP
bjos-8666637	41	16	the	the	DET
bjos-8666637	41	17	mouth	mouth	NOUN
bjos-8666637	41	18	and	and	CCONJ
bjos-8666637	41	19	halitosis15	halitosis15	NOUN
bjos-8666637	41	20	.	.	PUNCT
bjos-8666637	42	1	it	it	PRON
bjos-8666637	42	2	can	can	AUX
bjos-8666637	42	3	also	also	ADV
bjos-8666637	42	4	induce	induce	VERB
bjos-8666637	42	5	caries	carie	NOUN
bjos-8666637	42	6	lesions	lesion	NOUN
bjos-8666637	42	7	and	and	CCONJ
bjos-8666637	42	8	periodontal	periodontal	ADJ
bjos-8666637	42	9	disease	disease	NOUN
bjos-8666637	42	10	,	,	PUNCT
bjos-8666637	42	11	taste	taste	NOUN
bjos-8666637	42	12	disorders	disorder	NOUN
bjos-8666637	42	13	,	,	PUNCT
bjos-8666637	42	14	candidiasis	candidiasis	NOUN
bjos-8666637	42	15	,	,	PUNCT
bjos-8666637	42	16	dysphagia	dysphagia	NOUN
bjos-8666637	42	17	,	,	PUNCT
bjos-8666637	42	18	and	and	CCONJ
bjos-8666637	42	19	speech	speech	NOUN
bjos-8666637	42	20	difficulties14	difficulties14	NOUN
bjos-8666637	42	21	.	.	PUNCT
bjos-8666637	43	1	dysgeusia	dysgeusia	PROPN
bjos-8666637	43	2	can	can	AUX
bjos-8666637	43	3	cause	cause	VERB
bjos-8666637	43	4	feeding	feeding	NOUN
bjos-8666637	43	5	difficulties	difficulty	NOUN
bjos-8666637	43	6	,	,	PUNCT
bjos-8666637	43	7	leading	lead	VERB
bjos-8666637	43	8	to	to	ADP
bjos-8666637	43	9	malnutrition	malnutrition	NOUN
bjos-8666637	43	10	and	and	CCONJ
bjos-8666637	43	11	sarcopenia	sarcopenia	NOUN
bjos-8666637	43	12	in	in	ADP
bjos-8666637	43	13	the	the	DET
bjos-8666637	43	14	elderly12	elderly12	NOUN
bjos-8666637	43	15	.	.	PUNCT
bjos-8666637	44	1	in	in	ADP
bjos-8666637	44	2	addition	addition	NOUN
bjos-8666637	44	3	,	,	PUNCT
bjos-8666637	44	4	it	it	PRON
bjos-8666637	44	5	reduces	reduce	VERB
bjos-8666637	44	6	the	the	DET
bjos-8666637	44	7	ability	ability	NOUN
bjos-8666637	44	8	to	to	PART
bjos-8666637	44	9	differentiate	differentiate	VERB
bjos-8666637	44	10	excessive	excessive	ADJ
bjos-8666637	44	11	concentrations	concentration	NOUN
bjos-8666637	44	12	of	of	ADP
bjos-8666637	44	13	salt	salt	NOUN
bjos-8666637	44	14	and	and	CCONJ
bjos-8666637	44	15	sugar	sugar	NOUN
bjos-8666637	44	16	,	,	PUNCT
bjos-8666637	44	17	which	which	PRON
bjos-8666637	44	18	can	can	AUX
bjos-8666637	44	19	worsen	worsen	VERB
bjos-8666637	44	20	the	the	DET
bjos-8666637	44	21	clinical	clinical	ADJ
bjos-8666637	44	22	condition	condition	NOUN
bjos-8666637	44	23	associated	associate	VERB
bjos-8666637	44	24	with	with	ADP
bjos-8666637	44	25	chronic	chronic	ADJ
bjos-8666637	44	26	diseases	disease	NOUN
bjos-8666637	44	27	such	such	ADJ
bjos-8666637	44	28	as	as	ADP
bjos-8666637	44	29	diabetes	diabetes	NOUN
bjos-8666637	44	30	and	and	CCONJ
bjos-8666637	44	31	high	high	ADJ
bjos-8666637	44	32	blood	blood	NOUN
bjos-8666637	44	33	pressure12	pressure12	NOUN
bjos-8666637	44	34	.	.	PUNCT
bjos-8666637	45	1	given	give	VERB
bjos-8666637	45	2	the	the	DET
bjos-8666637	45	3	above	above	ADJ
bjos-8666637	45	4	,	,	PUNCT
bjos-8666637	45	5	this	this	DET
bjos-8666637	45	6	study	study	NOUN
bjos-8666637	45	7	aimed	aim	VERB
bjos-8666637	45	8	to	to	PART
bjos-8666637	45	9	determine	determine	VERB
bjos-8666637	45	10	the	the	DET
bjos-8666637	45	11	prevalence	prevalence	NOUN
bjos-8666637	45	12	of	of	ADP
bjos-8666637	45	13	xerostomia	xerostomia	PROPN
bjos-8666637	45	14	and	and	CCONJ
bjos-8666637	45	15	dysgeusia	dysgeusia	NOUN
bjos-8666637	45	16	in	in	ADP
bjos-8666637	45	17	the	the	DET
bjos-8666637	45	18	elderly	elderly	ADJ
bjos-8666637	45	19	and	and	CCONJ
bjos-8666637	45	20	to	to	PART
bjos-8666637	45	21	associate	associate	VERB
bjos-8666637	45	22	it	it	PRON
bjos-8666637	45	23	with	with	ADP
bjos-8666637	45	24	polypharmacy	polypharmacy	NOUN
bjos-8666637	45	25	.	.	PUNCT
bjos-8666637	46	1	an	an	DET
bjos-8666637	46	2	additional	additional	ADJ
bjos-8666637	46	3	purpose	purpose	NOUN
bjos-8666637	46	4	was	be	AUX
bjos-8666637	46	5	to	to	PART
bjos-8666637	46	6	determine	determine	VERB
bjos-8666637	46	7	the	the	DET
bjos-8666637	46	8	prevalence	prevalence	NOUN
bjos-8666637	46	9	of	of	ADP
bjos-8666637	46	10	medications	medication	NOUN
bjos-8666637	46	11	used	use	VERB
bjos-8666637	46	12	by	by	ADP
bjos-8666637	46	13	the	the	DET
bjos-8666637	46	14	participants	participant	NOUN
bjos-8666637	46	15	and	and	CCONJ
bjos-8666637	46	16	map	map	VERB
bjos-8666637	46	17	possible	possible	ADJ
bjos-8666637	46	18	interactions	interaction	NOUN
bjos-8666637	46	19	between	between	ADP
bjos-8666637	46	20	the	the	DET
bjos-8666637	46	21	medications	medication	NOUN
bjos-8666637	46	22	used	use	VERB
bjos-8666637	46	23	with	with	ADP
bjos-8666637	46	24	those	those	PRON
bjos-8666637	46	25	most	most	ADV
bjos-8666637	46	26	prescribed	prescribe	VERB
bjos-8666637	46	27	in	in	ADP
bjos-8666637	46	28	dentistry	dentistry	NOUN
bjos-8666637	46	29	.	.	PUNCT
bjos-8666637	47	1	material	material	NOUN
bjos-8666637	47	2	and	and	CCONJ
bjos-8666637	47	3	methods	method	NOUN
bjos-8666637	47	4	study	study	NOUN
bjos-8666637	47	5	design	design	NOUN
bjos-8666637	47	6	and	and	CCONJ
bjos-8666637	47	7	location	location	NOUN
bjos-8666637	47	8	a	a	DET
bjos-8666637	47	9	cross	cross	ADJ
bjos-8666637	47	10	-	-	ADJ
bjos-8666637	47	11	sectional	sectional	ADJ
bjos-8666637	47	12	study	study	NOUN
bjos-8666637	47	13	was	be	AUX
bjos-8666637	47	14	conducted	conduct	VERB
bjos-8666637	47	15	at	at	ADP
bjos-8666637	47	16	the	the	DET
bjos-8666637	47	17	geriatric	geriatric	ADJ
bjos-8666637	47	18	outpatient	outpatient	NOUN
bjos-8666637	47	19	clinic	clinic	NOUN
bjos-8666637	47	20	of	of	ADP
bjos-8666637	47	21	the	the	DET
bjos-8666637	47	22	multidisciplinary	multidisciplinary	ADJ
bjos-8666637	47	23	center	center	NOUN
bjos-8666637	47	24	of	of	ADP
bjos-8666637	47	25	the	the	DET
bjos-8666637	47	26	elderly	elderly	ADJ
bjos-8666637	47	27	hospital	hospital	NOUN
bjos-8666637	47	28	universitário	universitário	PROPN
bjos-8666637	47	29	de	de	X
bjos-8666637	47	30	brasília	brasília	PROPN
bjos-8666637	47	31	,	,	PUNCT
bjos-8666637	47	32	from	from	ADP
bjos-8666637	47	33	july	july	PROPN
bjos-8666637	47	34	to	to	ADP
bjos-8666637	47	35	3	3	NUM
bjos-8666637	47	36	guimarães	guimarães	NOUN
bjos-8666637	48	1	et	et	PROPN
bjos-8666637	48	2	al	al	PROPN
bjos-8666637	48	3	.	.	PROPN
bjos-8666637	48	4	braz	braz	PROPN
bjos-8666637	48	5	j	j	PROPN
bjos-8666637	48	6	oral	oral	PROPN
bjos-8666637	48	7	sci	sci	PROPN
bjos-8666637	48	8	.	.	PUNCT
bjos-8666637	49	1	2023;22	2023;22	NUM
bjos-8666637	49	2	:	:	PUNCT
bjos-8666637	49	3	e236637	e236637	ADJ
bjos-8666637	49	4	august	august	PROPN
bjos-8666637	49	5	2018	2018	NUM
bjos-8666637	49	6	.	.	PUNCT
bjos-8666637	50	1	the	the	DET
bjos-8666637	50	2	ethics	ethic	NOUN
bjos-8666637	50	3	committee	committee	PROPN
bjos-8666637	50	4	approved	approve	VERB
bjos-8666637	50	5	the	the	DET
bjos-8666637	50	6	study	study	NOUN
bjos-8666637	50	7	for	for	ADP
bjos-8666637	50	8	research	research	NOUN
bjos-8666637	50	9	with	with	ADP
bjos-8666637	50	10	human	human	ADJ
bjos-8666637	50	11	beings	being	NOUN
bjos-8666637	50	12	of	of	ADP
bjos-8666637	50	13	the	the	DET
bjos-8666637	50	14	faculty	faculty	NOUN
bjos-8666637	50	15	of	of	ADP
bjos-8666637	50	16	sciences	science	NOUN
bjos-8666637	50	17	of	of	ADP
bjos-8666637	50	18	the	the	DET
bjos-8666637	50	19	health	health	NOUN
bjos-8666637	50	20	of	of	ADP
bjos-8666637	50	21	the	the	DET
bjos-8666637	50	22	university	university	NOUN
bjos-8666637	50	23	of	of	ADP
bjos-8666637	50	24	brasília	brasília	PROPN
bjos-8666637	50	25	(	(	PUNCT
bjos-8666637	50	26	opinion	opinion	NOUN
bjos-8666637	50	27	no	no	INTJ
bjos-8666637	50	28	.	.	PROPN
bjos-8666637	50	29	3,033,121	3,033,121	NUM
bjos-8666637	50	30	;	;	PUNCT
bjos-8666637	50	31	caae	caae	PROPN
bjos-8666637	50	32	818897177.7.0000.0030	818897177.7.0000.0030	NUM
bjos-8666637	50	33	)	)	PUNCT
bjos-8666637	50	34	.	.	PUNCT
bjos-8666637	51	1	participants	participant	NOUN
bjos-8666637	51	2	all	all	DET
bjos-8666637	51	3	the	the	DET
bjos-8666637	51	4	participants	participant	NOUN
bjos-8666637	51	5	who	who	PRON
bjos-8666637	51	6	attended	attend	VERB
bjos-8666637	51	7	the	the	DET
bjos-8666637	51	8	“	"	PUNCT
bjos-8666637	51	9	centro	centro	X
bjos-8666637	51	10	multidisciplinar	multidisciplinar	NOUN
bjos-8666637	51	11	do	do	AUX
bjos-8666637	51	12	idoso	idoso	NOUN
bjos-8666637	51	13	”	"	PUNCT
bjos-8666637	51	14	(	(	PUNCT
bjos-8666637	51	15	multidisciplinary	multidisciplinary	ADJ
bjos-8666637	51	16	center	center	NOUN
bjos-8666637	51	17	for	for	ADP
bjos-8666637	51	18	the	the	DET
bjos-8666637	51	19	elderly	elderly	ADJ
bjos-8666637	51	20	)	)	PUNCT
bjos-8666637	51	21	aged	aged	ADJ
bjos-8666637	51	22	60	60	NUM
bjos-8666637	51	23	years	year	NOUN
bjos-8666637	51	24	or	or	CCONJ
bjos-8666637	51	25	over	over	ADV
bjos-8666637	51	26	,	,	PUNCT
bjos-8666637	51	27	between	between	ADP
bjos-8666637	51	28	july	july	PROPN
bjos-8666637	51	29	and	and	CCONJ
bjos-8666637	51	30	august	august	PROPN
bjos-8666637	51	31	2018	2018	NUM
bjos-8666637	51	32	were	be	AUX
bjos-8666637	51	33	interviewed	interview	VERB
bjos-8666637	51	34	.	.	PUNCT
bjos-8666637	52	1	the	the	DET
bjos-8666637	52	2	exclusion	exclusion	NOUN
bjos-8666637	52	3	criterion	criterion	NOUN
bjos-8666637	52	4	was	be	AUX
bjos-8666637	52	5	patients	patient	NOUN
bjos-8666637	52	6	with	with	ADP
bjos-8666637	52	7	cognitive	cognitive	ADJ
bjos-8666637	52	8	deficit	deficit	NOUN
bjos-8666637	52	9	or	or	CCONJ
bjos-8666637	52	10	dementia	dementia	NOUN
bjos-8666637	52	11	.	.	PUNCT
bjos-8666637	53	1	the	the	DET
bjos-8666637	53	2	interview	interview	NOUN
bjos-8666637	53	3	was	be	AUX
bjos-8666637	53	4	conducted	conduct	VERB
bjos-8666637	53	5	after	after	SCONJ
bjos-8666637	53	6	the	the	DET
bjos-8666637	53	7	objective	objective	NOUN
bjos-8666637	53	8	of	of	ADP
bjos-8666637	53	9	the	the	DET
bjos-8666637	53	10	research	research	NOUN
bjos-8666637	53	11	had	have	AUX
bjos-8666637	53	12	been	be	AUX
bjos-8666637	53	13	explained	explain	VERB
bjos-8666637	53	14	to	to	ADP
bjos-8666637	53	15	the	the	DET
bjos-8666637	53	16	participants	participant	NOUN
bjos-8666637	53	17	and	and	CCONJ
bjos-8666637	53	18	they	they	PRON
bjos-8666637	53	19	had	have	AUX
bjos-8666637	53	20	signed	sign	VERB
bjos-8666637	53	21	the	the	DET
bjos-8666637	53	22	term	term	NOUN
bjos-8666637	53	23	of	of	ADP
bjos-8666637	53	24	free	free	ADJ
bjos-8666637	53	25	and	and	CCONJ
bjos-8666637	53	26	informed	informed	ADJ
bjos-8666637	53	27	consent	consent	NOUN
bjos-8666637	53	28	(	(	PUNCT
bjos-8666637	53	29	tfic	tfic	NOUN
bjos-8666637	53	30	)	)	PUNCT
bjos-8666637	53	31	.	.	PUNCT
bjos-8666637	54	1	the	the	DET
bjos-8666637	54	2	sample	sample	NOUN
bjos-8666637	54	3	calculation	calculation	NOUN
bjos-8666637	54	4	was	be	AUX
bjos-8666637	54	5	based	base	VERB
bjos-8666637	54	6	on	on	ADP
bjos-8666637	54	7	the	the	DET
bjos-8666637	54	8	elderly	elderly	ADJ
bjos-8666637	54	9	population	population	NOUN
bjos-8666637	54	10	in	in	ADP
bjos-8666637	54	11	brazil	brazil	PROPN
bjos-8666637	54	12	in	in	ADP
bjos-8666637	54	13	2017	2017	NUM
bjos-8666637	54	14	,	,	PUNCT
bjos-8666637	54	15	with	with	ADP
bjos-8666637	54	16	a	a	DET
bjos-8666637	54	17	95	95	NUM
bjos-8666637	54	18	%	%	NOUN
bjos-8666637	54	19	confidence	confidence	NOUN
bjos-8666637	54	20	level	level	NOUN
bjos-8666637	54	21	and	and	CCONJ
bjos-8666637	54	22	a	a	DET
bjos-8666637	54	23	10	10	NUM
bjos-8666637	54	24	%	%	NOUN
bjos-8666637	54	25	margin	margin	NOUN
bjos-8666637	54	26	of	of	ADP
bjos-8666637	54	27	error	error	NOUN
bjos-8666637	54	28	.	.	PUNCT
bjos-8666637	55	1	assessment	assessment	NOUN
bjos-8666637	55	2	the	the	DET
bjos-8666637	55	3	assessment	assessment	NOUN
bjos-8666637	55	4	consisted	consist	VERB
bjos-8666637	55	5	of	of	ADP
bjos-8666637	55	6	data	datum	NOUN
bjos-8666637	55	7	collection	collection	NOUN
bjos-8666637	55	8	from	from	ADP
bjos-8666637	55	9	the	the	DET
bjos-8666637	55	10	personal	personal	ADJ
bjos-8666637	55	11	interview	interview	NOUN
bjos-8666637	55	12	,	,	PUNCT
bjos-8666637	55	13	such	such	ADJ
bjos-8666637	55	14	as	as	ADP
bjos-8666637	55	15	age	age	NOUN
bjos-8666637	55	16	and	and	CCONJ
bjos-8666637	55	17	gender	gender	NOUN
bjos-8666637	55	18	,	,	PUNCT
bjos-8666637	55	19	clinical	clinical	ADJ
bjos-8666637	55	20	history	history	NOUN
bjos-8666637	55	21	(	(	PUNCT
bjos-8666637	55	22	comorbidities	comorbiditie	NOUN
bjos-8666637	55	23	and	and	CCONJ
bjos-8666637	55	24	continuous	continuous	ADJ
bjos-8666637	55	25	use	use	NOUN
bjos-8666637	55	26	of	of	ADP
bjos-8666637	55	27	medications	medication	NOUN
bjos-8666637	55	28	)	)	PUNCT
bjos-8666637	55	29	,	,	PUNCT
bjos-8666637	55	30	and	and	CCONJ
bjos-8666637	55	31	evaluation	evaluation	NOUN
bjos-8666637	55	32	of	of	ADP
bjos-8666637	55	33	the	the	DET
bjos-8666637	55	34	participants	participant	NOUN
bjos-8666637	55	35	’	'	PUNCT
bjos-8666637	55	36	clinical	clinical	ADJ
bjos-8666637	55	37	records	record	NOUN
bjos-8666637	55	38	.	.	PUNCT
bjos-8666637	56	1	participants	participant	NOUN
bjos-8666637	56	2	were	be	AUX
bjos-8666637	56	3	asked	ask	VERB
bjos-8666637	56	4	about	about	ADP
bjos-8666637	56	5	the	the	DET
bjos-8666637	56	6	number	number	NOUN
bjos-8666637	56	7	of	of	ADP
bjos-8666637	56	8	drugs	drug	NOUN
bjos-8666637	56	9	they	they	PRON
bjos-8666637	56	10	used	use	VERB
bjos-8666637	56	11	continuously	continuously	ADV
bjos-8666637	56	12	,	,	PUNCT
bjos-8666637	56	13	and	and	CCONJ
bjos-8666637	56	14	their	their	PRON
bjos-8666637	56	15	generic	generic	ADJ
bjos-8666637	56	16	or	or	CCONJ
bjos-8666637	56	17	trade	trade	NOUN
bjos-8666637	56	18	names	name	NOUN
bjos-8666637	56	19	.	.	PUNCT
bjos-8666637	57	1	in	in	ADP
bjos-8666637	57	2	case	case	NOUN
bjos-8666637	57	3	the	the	DET
bjos-8666637	57	4	elderly	elderly	ADJ
bjos-8666637	57	5	had	have	VERB
bjos-8666637	57	6	difficulty	difficulty	NOUN
bjos-8666637	57	7	in	in	ADP
bjos-8666637	57	8	providing	provide	VERB
bjos-8666637	57	9	this	this	DET
bjos-8666637	57	10	information	information	NOUN
bjos-8666637	57	11	,	,	PUNCT
bjos-8666637	57	12	the	the	DET
bjos-8666637	57	13	medical	medical	ADJ
bjos-8666637	57	14	record	record	NOUN
bjos-8666637	57	15	was	be	AUX
bjos-8666637	57	16	consulted	consult	VERB
bjos-8666637	57	17	.	.	PUNCT
bjos-8666637	58	1	in	in	ADP
bjos-8666637	58	2	addition	addition	NOUN
bjos-8666637	58	3	,	,	PUNCT
bjos-8666637	58	4	the	the	DET
bjos-8666637	58	5	participants	participant	NOUN
bjos-8666637	58	6	were	be	AUX
bjos-8666637	58	7	asked	ask	VERB
bjos-8666637	58	8	about	about	ADP
bjos-8666637	58	9	their	their	PRON
bjos-8666637	58	10	self	self	NOUN
bjos-8666637	58	11	-	-	PUNCT
bjos-8666637	58	12	perception	perception	NOUN
bjos-8666637	58	13	of	of	ADP
bjos-8666637	58	14	dry	dry	ADJ
bjos-8666637	58	15	mouth	mouth	NOUN
bjos-8666637	58	16	(	(	PUNCT
bjos-8666637	58	17	xerostomia	xerostomia	NOUN
bjos-8666637	58	18	)	)	PUNCT
bjos-8666637	58	19	and	and	CCONJ
bjos-8666637	58	20	taste	taste	NOUN
bjos-8666637	58	21	alteration	alteration	NOUN
bjos-8666637	58	22	(	(	PUNCT
bjos-8666637	58	23	dysgeusia	dysgeusia	NOUN
bjos-8666637	58	24	)	)	PUNCT
bjos-8666637	58	25	.	.	PUNCT
bjos-8666637	59	1	mapping	mapping	NOUN
bjos-8666637	59	2	of	of	ADP
bjos-8666637	59	3	drug	drug	NOUN
bjos-8666637	59	4	interactions	interaction	NOUN
bjos-8666637	59	5	the	the	DET
bjos-8666637	59	6	drugs	drug	NOUN
bjos-8666637	59	7	listed	list	VERB
bjos-8666637	59	8	by	by	ADP
bjos-8666637	59	9	the	the	DET
bjos-8666637	59	10	participants	participant	NOUN
bjos-8666637	59	11	were	be	AUX
bjos-8666637	59	12	grouped	group	VERB
bjos-8666637	59	13	according	accord	VERB
bjos-8666637	59	14	to	to	ADP
bjos-8666637	59	15	their	their	PRON
bjos-8666637	59	16	drug	drug	NOUN
bjos-8666637	59	17	class	class	NOUN
bjos-8666637	59	18	into	into	ADP
bjos-8666637	59	19	hypoglycemic	hypoglycemic	ADJ
bjos-8666637	59	20	,	,	PUNCT
bjos-8666637	59	21	antihypertensive	antihypertensive	ADJ
bjos-8666637	59	22	,	,	PUNCT
bjos-8666637	59	23	antiplatelet	antiplatelet	NOUN
bjos-8666637	59	24	and	and	CCONJ
bjos-8666637	59	25	anticoagulant	anticoagulant	NOUN
bjos-8666637	59	26	,	,	PUNCT
bjos-8666637	59	27	antilipidemic	antilipidemic	ADJ
bjos-8666637	59	28	,	,	PUNCT
bjos-8666637	59	29	analgesic	analgesic	ADJ
bjos-8666637	59	30	,	,	PUNCT
bjos-8666637	59	31	and	and	CCONJ
bjos-8666637	59	32	non	non	ADJ
bjos-8666637	59	33	-	-	ADJ
bjos-8666637	59	34	steroidal	steroidal	ADJ
bjos-8666637	59	35	anti	anti	ADJ
bjos-8666637	59	36	-	-	ADJ
bjos-8666637	59	37	inflammatory	inflammatory	ADJ
bjos-8666637	59	38	(	(	PUNCT
bjos-8666637	59	39	nsaid	nsaid	PROPN
bjos-8666637	59	40	)	)	PUNCT
bjos-8666637	59	41	,	,	PUNCT
bjos-8666637	59	42	muscle	muscle	NOUN
bjos-8666637	59	43	relaxant	relaxant	NOUN
bjos-8666637	59	44	,	,	PUNCT
bjos-8666637	59	45	benzodiazepine	benzodiazepine	NOUN
bjos-8666637	59	46	,	,	PUNCT
bjos-8666637	59	47	and	and	CCONJ
bjos-8666637	59	48	others	other	NOUN
bjos-8666637	59	49	.	.	PUNCT
bjos-8666637	60	1	the	the	DET
bjos-8666637	60	2	medications	medication	NOUN
bjos-8666637	60	3	most	most	ADV
bjos-8666637	60	4	used	use	VERB
bjos-8666637	60	5	by	by	ADP
bjos-8666637	60	6	the	the	DET
bjos-8666637	60	7	participants	participant	NOUN
bjos-8666637	60	8	(	(	PUNCT
bjos-8666637	60	9	those	those	PRON
bjos-8666637	60	10	mentioned	mention	VERB
bjos-8666637	60	11	more	more	ADJ
bjos-8666637	60	12	than	than	ADP
bjos-8666637	60	13	five	five	NUM
bjos-8666637	60	14	times	time	NOUN
bjos-8666637	60	15	in	in	ADP
bjos-8666637	60	16	the	the	DET
bjos-8666637	60	17	formatted	format	VERB
bjos-8666637	60	18	form	form	NOUN
bjos-8666637	60	19	)	)	PUNCT
bjos-8666637	60	20	were	be	AUX
bjos-8666637	60	21	selected	select	VERB
bjos-8666637	60	22	,	,	PUNCT
bjos-8666637	60	23	and	and	CCONJ
bjos-8666637	60	24	their	their	PRON
bjos-8666637	60	25	possible	possible	ADJ
bjos-8666637	60	26	association	association	NOUN
bjos-8666637	60	27	with	with	ADP
bjos-8666637	60	28	xerostomia	xerostomia	PROPN
bjos-8666637	60	29	and	and	CCONJ
bjos-8666637	60	30	dysgeusia	dysgeusia	PROPN
bjos-8666637	60	31	was	be	AUX
bjos-8666637	60	32	verified	verify	VERB
bjos-8666637	60	33	.	.	PUNCT
bjos-8666637	61	1	the	the	DET
bjos-8666637	61	2	micromedex	micromedex	PROPN
bjos-8666637	61	3	drug	drug	NOUN
bjos-8666637	61	4	interactions	interaction	NOUN
bjos-8666637	61	5	®	®	NOUN
bjos-8666637	61	6	and	and	CCONJ
bjos-8666637	61	7	dynamed	dyname	VERB
bjos-8666637	61	8	®	®	NOUN
bjos-8666637	61	9	database	database	NOUN
bjos-8666637	61	10	was	be	AUX
bjos-8666637	61	11	used	use	VERB
bjos-8666637	61	12	to	to	PART
bjos-8666637	61	13	verify	verify	VERB
bjos-8666637	61	14	the	the	DET
bjos-8666637	61	15	possibility	possibility	NOUN
bjos-8666637	61	16	of	of	ADP
bjos-8666637	61	17	interaction	interaction	NOUN
bjos-8666637	61	18	with	with	ADP
bjos-8666637	61	19	the	the	DET
bjos-8666637	61	20	drugs	drug	NOUN
bjos-8666637	61	21	most	most	ADV
bjos-8666637	61	22	frequently	frequently	ADV
bjos-8666637	61	23	prescribed	prescribe	VERB
bjos-8666637	61	24	in	in	ADP
bjos-8666637	61	25	dentistry	dentistry	NOUN
bjos-8666637	61	26	,	,	PUNCT
bjos-8666637	61	27	such	such	ADJ
bjos-8666637	61	28	as	as	ADP
bjos-8666637	61	29	non	non	ADJ
bjos-8666637	61	30	-	-	ADJ
bjos-8666637	61	31	opioid	opioid	ADJ
bjos-8666637	61	32	analgesics	analgesic	NOUN
bjos-8666637	61	33	and	and	CCONJ
bjos-8666637	61	34	non	non	ADJ
bjos-8666637	61	35	-	-	ADJ
bjos-8666637	61	36	steroidal	steroidal	ADJ
bjos-8666637	61	37	anti	anti	ADJ
bjos-8666637	61	38	-	-	ADJ
bjos-8666637	61	39	inflammatory	inflammatory	ADJ
bjos-8666637	61	40	drugs	drug	NOUN
bjos-8666637	61	41	(	(	PUNCT
bjos-8666637	61	42	nsaids	nsaid	NOUN
bjos-8666637	61	43	)	)	PUNCT
bjos-8666637	61	44	,	,	PUNCT
bjos-8666637	61	45	antibiotics	antibiotic	NOUN
bjos-8666637	61	46	,	,	PUNCT
bjos-8666637	61	47	steroidal	steroidal	NOUN
bjos-8666637	61	48	anti	anti	ADJ
bjos-8666637	61	49	-	-	ADJ
bjos-8666637	61	50	inflammatory	inflammatory	ADJ
bjos-8666637	61	51	drugs	drug	NOUN
bjos-8666637	61	52	(	(	PUNCT
bjos-8666637	61	53	aies	aie	NOUN
bjos-8666637	61	54	)	)	PUNCT
bjos-8666637	61	55	,	,	PUNCT
bjos-8666637	61	56	anxiolytic	anxiolytic	ADJ
bjos-8666637	61	57	and	and	CCONJ
bjos-8666637	61	58	antifungal	antifungal	ADJ
bjos-8666637	61	59	agents	agent	NOUN
bjos-8666637	61	60	,	,	PUNCT
bjos-8666637	61	61	and	and	CCONJ
bjos-8666637	61	62	local	local	ADJ
bjos-8666637	61	63	anesthetics16	anesthetics16	NOUN
bjos-8666637	61	64	.	.	PUNCT
bjos-8666637	62	1	drug	drug	NOUN
bjos-8666637	62	2	interaction	interaction	NOUN
bjos-8666637	62	3	was	be	AUX
bjos-8666637	62	4	selected	select	VERB
bjos-8666637	62	5	and	and	CCONJ
bjos-8666637	62	6	classified	classify	VERB
bjos-8666637	62	7	according	accord	VERB
bjos-8666637	62	8	to	to	ADP
bjos-8666637	62	9	its	its	PRON
bjos-8666637	62	10	severity	severity	NOUN
bjos-8666637	62	11	in	in	ADP
bjos-8666637	62	12	minor	minor	ADJ
bjos-8666637	62	13	,	,	PUNCT
bjos-8666637	62	14	moderate	moderate	ADJ
bjos-8666637	62	15	,	,	PUNCT
bjos-8666637	62	16	major	major	ADJ
bjos-8666637	62	17	,	,	PUNCT
bjos-8666637	62	18	and	and	CCONJ
bjos-8666637	62	19	contraindicated	contraindicated	ADJ
bjos-8666637	62	20	use	use	NOUN
bjos-8666637	62	21	.	.	PUNCT
bjos-8666637	63	1	statistical	statistical	ADJ
bjos-8666637	63	2	analysis	analysis	NOUN
bjos-8666637	63	3	general	general	ADJ
bjos-8666637	63	4	and	and	CCONJ
bjos-8666637	63	5	sociodemographic	sociodemographic	ADJ
bjos-8666637	63	6	data	datum	NOUN
bjos-8666637	63	7	were	be	AUX
bjos-8666637	63	8	provided	provide	VERB
bjos-8666637	63	9	in	in	ADP
bjos-8666637	63	10	the	the	DET
bjos-8666637	63	11	form	form	NOUN
bjos-8666637	63	12	of	of	ADP
bjos-8666637	63	13	descriptive	descriptive	ADJ
bjos-8666637	63	14	statistics	statistic	NOUN
bjos-8666637	63	15	.	.	PUNCT
bjos-8666637	64	1	the	the	DET
bjos-8666637	64	2	chi	chi	ADJ
bjos-8666637	64	3	-	-	PUNCT
bjos-8666637	64	4	square	square	ADJ
bjos-8666637	64	5	test	test	NOUN
bjos-8666637	64	6	with	with	ADP
bjos-8666637	64	7	the	the	DET
bjos-8666637	64	8	calculation	calculation	NOUN
bjos-8666637	64	9	of	of	ADP
bjos-8666637	64	10	the	the	DET
bjos-8666637	64	11	prevalence	prevalence	NOUN
bjos-8666637	64	12	ratio	ratio	NOUN
bjos-8666637	64	13	(	(	PUNCT
bjos-8666637	64	14	pr	pr	NOUN
bjos-8666637	64	15	)	)	PUNCT
bjos-8666637	64	16	was	be	AUX
bjos-8666637	64	17	performed	perform	VERB
bjos-8666637	64	18	to	to	PART
bjos-8666637	64	19	assess	assess	VERB
bjos-8666637	64	20	an	an	DET
bjos-8666637	64	21	association	association	NOUN
bjos-8666637	64	22	between	between	ADP
bjos-8666637	64	23	xerostomia	xerostomia	PROPN
bjos-8666637	64	24	and	and	CCONJ
bjos-8666637	64	25	dysgeusia	dysgeusia	PROPN
bjos-8666637	64	26	(	(	PUNCT
bjos-8666637	64	27	dependent	dependent	ADJ
bjos-8666637	64	28	variables	variable	NOUN
bjos-8666637	64	29	)	)	PUNCT
bjos-8666637	64	30	with	with	ADP
bjos-8666637	64	31	polypharmacy	polypharmacy	NOUN
bjos-8666637	64	32	(	(	PUNCT
bjos-8666637	64	33	independent	independent	ADJ
bjos-8666637	64	34	variable	variable	NOUN
bjos-8666637	64	35	)	)	PUNCT
bjos-8666637	64	36	,	,	PUNCT
bjos-8666637	64	37	defined	define	VERB
bjos-8666637	64	38	as	as	ADP
bjos-8666637	64	39	the	the	DET
bjos-8666637	64	40	use	use	NOUN
bjos-8666637	64	41	of	of	ADP
bjos-8666637	64	42	3	3	NUM
bjos-8666637	64	43	or	or	CCONJ
bjos-8666637	64	44	more	more	ADJ
bjos-8666637	64	45	medications17	medications17	ADJ
bjos-8666637	64	46	.	.	PUNCT
bjos-8666637	65	1	the	the	DET
bjos-8666637	65	2	binomial	binomial	ADJ
bjos-8666637	65	3	logistic	logistic	ADJ
bjos-8666637	65	4	regression	regression	NOUN
bjos-8666637	65	5	was	be	AUX
bjos-8666637	65	6	performed	perform	VERB
bjos-8666637	65	7	to	to	PART
bjos-8666637	65	8	verify	verify	VERB
bjos-8666637	65	9	the	the	DET
bjos-8666637	65	10	association	association	NOUN
bjos-8666637	65	11	between	between	ADP
bjos-8666637	65	12	the	the	DET
bjos-8666637	65	13	medications	medication	NOUN
bjos-8666637	65	14	most	most	ADV
bjos-8666637	65	15	used	use	VERB
bjos-8666637	65	16	by	by	ADP
bjos-8666637	65	17	the	the	DET
bjos-8666637	65	18	participants	participant	NOUN
bjos-8666637	65	19	and	and	CCONJ
bjos-8666637	65	20	the	the	DET
bjos-8666637	65	21	presence	presence	NOUN
bjos-8666637	65	22	of	of	ADP
bjos-8666637	65	23	xerostomia	xerostomia	PROPN
bjos-8666637	65	24	and	and	CCONJ
bjos-8666637	65	25	dysgeusia	dysgeusia	PROPN
bjos-8666637	65	26	.	.	PUNCT
bjos-8666637	66	1	the	the	DET
bjos-8666637	66	2	level	level	NOUN
bjos-8666637	66	3	of	of	ADP
bjos-8666637	66	4	significance	significance	NOUN
bjos-8666637	66	5	adopted	adopt	VERB
bjos-8666637	66	6	was	be	AUX
bjos-8666637	66	7	for	for	ADP
bjos-8666637	66	8	p	p	NOUN
bjos-8666637	66	9	<	<	NOUN
bjos-8666637	66	10	0.05	0.05	NUM
bjos-8666637	66	11	4	4	NUM
bjos-8666637	66	12	guimarães	guimarães	NOUN
bjos-8666637	66	13	et	et	PROPN
bjos-8666637	66	14	al	al	PROPN
bjos-8666637	66	15	.	.	PROPN
bjos-8666637	67	1	braz	braz	PROPN
bjos-8666637	67	2	j	j	PROPN
bjos-8666637	67	3	oral	oral	PROPN
bjos-8666637	67	4	sci	sci	PROPN
bjos-8666637	67	5	.	.	PUNCT
bjos-8666637	68	1	2023;22	2023;22	NUM
bjos-8666637	68	2	:	:	PUNCT
bjos-8666637	68	3	e236637	e236637	ADJ
bjos-8666637	68	4	results	result	VERB
bjos-8666637	68	5	a	a	DET
bjos-8666637	68	6	total	total	NOUN
bjos-8666637	68	7	of	of	ADP
bjos-8666637	68	8	96	96	NUM
bjos-8666637	68	9	older	old	ADJ
bjos-8666637	68	10	people	people	NOUN
bjos-8666637	68	11	were	be	AUX
bjos-8666637	68	12	interviewed	interview	VERB
bjos-8666637	68	13	,	,	PUNCT
bjos-8666637	68	14	all	all	PRON
bjos-8666637	68	15	of	of	ADP
bjos-8666637	68	16	whom	whom	PRON
bjos-8666637	68	17	were	be	AUX
bjos-8666637	68	18	being	be	AUX
bjos-8666637	68	19	monitored	monitor	VERB
bjos-8666637	68	20	at	at	ADP
bjos-8666637	68	21	the	the	DET
bjos-8666637	68	22	multidisciplinary	multidisciplinary	ADJ
bjos-8666637	68	23	center	center	NOUN
bjos-8666637	68	24	of	of	ADP
bjos-8666637	68	25	the	the	DET
bjos-8666637	68	26	university	university	NOUN
bjos-8666637	68	27	hospital	hospital	NOUN
bjos-8666637	68	28	of	of	ADP
bjos-8666637	68	29	brasília	brasília	PROPN
bjos-8666637	68	30	(	(	PUNCT
bjos-8666637	68	31	hub	hub	NOUN
bjos-8666637	68	32	)	)	PUNCT
bjos-8666637	68	33	,	,	PUNCT
bjos-8666637	68	34	between	between	ADP
bjos-8666637	68	35	july	july	PROPN
bjos-8666637	68	36	and	and	CCONJ
bjos-8666637	68	37	august	august	PROPN
bjos-8666637	68	38	2018	2018	NUM
bjos-8666637	68	39	.	.	PUNCT
bjos-8666637	69	1	the	the	DET
bjos-8666637	69	2	characteristics	characteristic	NOUN
bjos-8666637	69	3	of	of	ADP
bjos-8666637	69	4	the	the	DET
bjos-8666637	69	5	research	research	NOUN
bjos-8666637	69	6	participants	participant	NOUN
bjos-8666637	69	7	are	be	AUX
bjos-8666637	69	8	shown	show	VERB
bjos-8666637	69	9	in	in	ADP
bjos-8666637	69	10	table	table	NOUN
bjos-8666637	69	11	1	1	NUM
bjos-8666637	69	12	.	.	PUNCT
bjos-8666637	69	13	table	table	NOUN
bjos-8666637	69	14	1	1	NUM
bjos-8666637	69	15	.	.	PUNCT
bjos-8666637	69	16	general	general	ADJ
bjos-8666637	69	17	characteristics	characteristic	NOUN
bjos-8666637	69	18	and	and	CCONJ
bjos-8666637	69	19	oral	oral	ADJ
bjos-8666637	69	20	health	health	NOUN
bjos-8666637	69	21	conditions	condition	NOUN
bjos-8666637	69	22	,	,	PUNCT
bjos-8666637	69	23	and	and	CCONJ
bjos-8666637	69	24	several	several	ADJ
bjos-8666637	69	25	medications	medication	NOUN
bjos-8666637	69	26	used	use	VERB
bjos-8666637	69	27	by	by	ADP
bjos-8666637	69	28	elderly	elderly	ADJ
bjos-8666637	69	29	people	people	NOUN
bjos-8666637	69	30	followed	follow	VERB
bjos-8666637	69	31	-	-	PUNCT
bjos-8666637	69	32	up	up	NOUN
bjos-8666637	69	33	at	at	ADP
bjos-8666637	69	34	the	the	DET
bjos-8666637	69	35	geriatric	geriatric	ADJ
bjos-8666637	69	36	outpatient	outpatient	NOUN
bjos-8666637	69	37	clinic	clinic	NOUN
bjos-8666637	69	38	(	(	PUNCT
bjos-8666637	69	39	university	university	NOUN
bjos-8666637	69	40	hospital	hospital	NOUN
bjos-8666637	69	41	of	of	ADP
bjos-8666637	69	42	brasília	brasília	PROPN
bjos-8666637	69	43	)	)	PUNCT
bjos-8666637	69	44	between	between	ADP
bjos-8666637	69	45	july	july	PROPN
bjos-8666637	69	46	and	and	CCONJ
bjos-8666637	69	47	august	august	PROPN
bjos-8666637	69	48	2018	2018	NUM
bjos-8666637	69	49	.	.	PUNCT
bjos-8666637	70	1	data	datum	NOUN
bjos-8666637	70	2	expressed	express	VERB
bjos-8666637	70	3	in	in	ADP
bjos-8666637	70	4	the	the	DET
bjos-8666637	70	5	form	form	NOUN
bjos-8666637	70	6	of	of	ADP
bjos-8666637	70	7	mean	mean	ADJ
bjos-8666637	70	8	and	and	CCONJ
bjos-8666637	70	9	standard	standard	ADJ
bjos-8666637	70	10	deviation	deviation	NOUN
bjos-8666637	70	11	or	or	CCONJ
bjos-8666637	70	12	absolute	absolute	ADJ
bjos-8666637	70	13	number	number	NOUN
bjos-8666637	70	14	and	and	CCONJ
bjos-8666637	70	15	percentage	percentage	NOUN
bjos-8666637	70	16	(	(	PUNCT
bjos-8666637	70	17	n	n	NOUN
bjos-8666637	70	18	=	=	SYM
bjos-8666637	70	19	96	96	NUM
bjos-8666637	70	20	)	)	PUNCT
bjos-8666637	70	21	age	age	NOUN
bjos-8666637	70	22	(	(	PUNCT
bjos-8666637	70	23	years	year	NOUN
bjos-8666637	70	24	)	)	PUNCT
bjos-8666637	70	25	74	74	NUM
bjos-8666637	70	26	±	±	NUM
bjos-8666637	70	27	8	8	NUM
bjos-8666637	70	28	gender	gender	NOUN
bjos-8666637	70	29	m	m	NOUN
bjos-8666637	70	30	17(17.7	17(17.7	ADJ
bjos-8666637	70	31	%	%	NOUN
bjos-8666637	70	32	)	)	PUNCT
bjos-8666637	70	33	f	f	PROPN
bjos-8666637	70	34	79	79	NUM
bjos-8666637	70	35	(	(	PUNCT
bjos-8666637	70	36	82.3	82.3	NUM
bjos-8666637	70	37	%	%	NOUN
bjos-8666637	70	38	)	)	PUNCT
bjos-8666637	70	39	number	number	NOUN
bjos-8666637	70	40	of	of	ADP
bjos-8666637	70	41	drugs	drug	NOUN
bjos-8666637	70	42	used	use	VERB
bjos-8666637	70	43	by	by	ADP
bjos-8666637	70	44	participants	participant	NOUN
bjos-8666637	70	45	4.4	4.4	NUM
bjos-8666637	70	46	±	±	NUM
bjos-8666637	70	47	3.1	3.1	NUM
bjos-8666637	70	48	xerostomia	xerostomia	NOUN
bjos-8666637	70	49	60	60	NUM
bjos-8666637	71	1	(	(	PUNCT
bjos-8666637	71	2	62.5	62.5	NUM
bjos-8666637	71	3	%	%	NOUN
bjos-8666637	71	4	)	)	PUNCT
bjos-8666637	71	5	dysgeusia	dysgeusia	NOUN
bjos-8666637	71	6	50	50	NUM
bjos-8666637	71	7	(	(	PUNCT
bjos-8666637	71	8	21.1	21.1	NUM
bjos-8666637	71	9	%	%	NOUN
bjos-8666637	71	10	)	)	PUNCT
bjos-8666637	71	11	total	total	NOUN
bjos-8666637	71	12	96	96	NUM
bjos-8666637	71	13	(	(	PUNCT
bjos-8666637	71	14	100	100	NUM
bjos-8666637	71	15	%	%	NOUN
bjos-8666637	71	16	)	)	PUNCT
bjos-8666637	71	17	among	among	ADP
bjos-8666637	71	18	the	the	DET
bjos-8666637	71	19	drug	drug	NOUN
bjos-8666637	71	20	classes	class	NOUN
bjos-8666637	71	21	most	most	ADV
bjos-8666637	71	22	used	use	VERB
bjos-8666637	71	23	by	by	ADP
bjos-8666637	71	24	the	the	DET
bjos-8666637	71	25	participants	participant	NOUN
bjos-8666637	71	26	,	,	PUNCT
bjos-8666637	71	27	antihypertensives	antihypertensive	NOUN
bjos-8666637	71	28	(	(	PUNCT
bjos-8666637	71	29	72.9	72.9	NUM
bjos-8666637	71	30	%	%	NOUN
bjos-8666637	71	31	)	)	PUNCT
bjos-8666637	71	32	and	and	CCONJ
bjos-8666637	71	33	antidepressants	antidepressant	NOUN
bjos-8666637	71	34	(	(	PUNCT
bjos-8666637	71	35	33	33	NUM
bjos-8666637	71	36	%	%	NOUN
bjos-8666637	71	37	)	)	PUNCT
bjos-8666637	71	38	were	be	AUX
bjos-8666637	71	39	outstanding	outstanding	ADJ
bjos-8666637	71	40	(	(	PUNCT
bjos-8666637	71	41	graph	graph	NOUN
bjos-8666637	71	42	1	1	NUM
bjos-8666637	71	43	)	)	PUNCT
bjos-8666637	71	44	.	.	PUNCT
bjos-8666637	72	1	medicines	medicine	NOUN
bjos-8666637	72	2	included	include	VERB
bjos-8666637	72	3	in	in	ADP
bjos-8666637	72	4	“	"	PUNCT
bjos-8666637	72	5	others	other	NOUN
bjos-8666637	72	6	”	"	PUNCT
bjos-8666637	72	7	are	be	AUX
bjos-8666637	72	8	food	food	NOUN
bjos-8666637	72	9	supplements	supplement	NOUN
bjos-8666637	72	10	like	like	ADP
bjos-8666637	72	11	calcium	calcium	NOUN
bjos-8666637	72	12	,	,	PUNCT
bjos-8666637	72	13	glucosamine	glucosamine	NOUN
bjos-8666637	72	14	,	,	PUNCT
bjos-8666637	72	15	omega	omega	NOUN
bjos-8666637	72	16	3	3	NUM
bjos-8666637	72	17	,	,	PUNCT
bjos-8666637	72	18	cholecalciferol	cholecalciferol	NOUN
bjos-8666637	72	19	,	,	PUNCT
bjos-8666637	72	20	melatonin	melatonin	NOUN
bjos-8666637	72	21	,	,	PUNCT
bjos-8666637	72	22	lactulose	lactulose	NOUN
bjos-8666637	72	23	,	,	PUNCT
bjos-8666637	72	24	lithium	lithium	NOUN
bjos-8666637	72	25	carbonate	carbonate	NOUN
bjos-8666637	72	26	,	,	PUNCT
bjos-8666637	72	27	and	and	CCONJ
bjos-8666637	72	28	folic	folic	ADJ
bjos-8666637	72	29	acid	acid	NOUN
bjos-8666637	72	30	;	;	PUNCT
bjos-8666637	72	31	thyroid	thyroid	NOUN
bjos-8666637	72	32	treatment	treatment	NOUN
bjos-8666637	72	33	agents	agent	NOUN
bjos-8666637	72	34	such	such	ADJ
bjos-8666637	72	35	as	as	ADP
bjos-8666637	72	36	levothyroxine	levothyroxine	NOUN
bjos-8666637	72	37	;	;	PUNCT
bjos-8666637	72	38	hormone	hormone	NOUN
bjos-8666637	72	39	therapy	therapy	NOUN
bjos-8666637	72	40	medications	medication	NOUN
bjos-8666637	72	41	such	such	ADJ
bjos-8666637	72	42	as	as	ADP
bjos-8666637	72	43	tibolone	tibolone	NOUN
bjos-8666637	72	44	;	;	PUNCT
bjos-8666637	72	45	parkinson	parkinson	NOUN
bjos-8666637	72	46	’s	’s	PART
bjos-8666637	72	47	treatment	treatment	NOUN
bjos-8666637	72	48	agents	agent	NOUN
bjos-8666637	72	49	such	such	ADJ
bjos-8666637	72	50	as	as	ADP
bjos-8666637	72	51	levodopa	levodopa	NOUN
bjos-8666637	72	52	and	and	CCONJ
bjos-8666637	72	53	benserazide	benserazide	ADJ
bjos-8666637	72	54	hydrochloride	hydrochloride	NOUN
bjos-8666637	72	55	;	;	PUNCT
bjos-8666637	72	56	gastric	gastric	ADJ
bjos-8666637	72	57	protectors	protector	NOUN
bjos-8666637	72	58	such	such	ADJ
bjos-8666637	72	59	as	as	ADP
bjos-8666637	72	60	omeprazole	omeprazole	NOUN
bjos-8666637	72	61	and	and	CCONJ
bjos-8666637	72	62	pantoprazole	pantoprazole	NOUN
bjos-8666637	72	63	;	;	PUNCT
bjos-8666637	72	64	medications	medication	NOUN
bjos-8666637	72	65	for	for	ADP
bjos-8666637	72	66	cardiac	cardiac	ADJ
bjos-8666637	72	67	arrhythmias	arrhythmia	NOUN
bjos-8666637	72	68	such	such	ADJ
bjos-8666637	72	69	as	as	ADP
bjos-8666637	72	70	propafenone	propafenone	NOUN
bjos-8666637	72	71	,	,	PUNCT
bjos-8666637	72	72	amiodarone	amiodarone	NOUN
bjos-8666637	72	73	;	;	PUNCT
bjos-8666637	72	74	for	for	ADP
bjos-8666637	72	75	treatment	treatment	NOUN
bjos-8666637	72	76	of	of	ADP
bjos-8666637	72	77	benign	benign	ADJ
bjos-8666637	72	78	prostatic	prostatic	ADJ
bjos-8666637	72	79	hyperplasias	hyperplasia	NOUN
bjos-8666637	72	80	such	such	ADJ
bjos-8666637	72	81	as	as	ADP
bjos-8666637	72	82	tamsulosin	tamsulosin	NOUN
bjos-8666637	72	83	and	and	CCONJ
bjos-8666637	72	84	dutasteride	dutasteride	NOUN
bjos-8666637	72	85	;	;	PUNCT
bjos-8666637	72	86	for	for	ADP
bjos-8666637	72	87	treating	treat	VERB
bjos-8666637	72	88	glaucomas	glaucomas	NOUN
bjos-8666637	72	89	such	such	ADJ
bjos-8666637	72	90	as	as	ADP
bjos-8666637	72	91	latanoprost	latanoprost	ADJ
bjos-8666637	72	92	and	and	CCONJ
bjos-8666637	72	93	timolol	timolol	NOUN
bjos-8666637	72	94	maleate	maleate	NOUN
bjos-8666637	72	95	;	;	PUNCT
bjos-8666637	72	96	nasal	nasal	ADJ
bjos-8666637	72	97	decongestant	decongestant	NOUN
bjos-8666637	72	98	such	such	ADJ
bjos-8666637	72	99	as	as	ADP
bjos-8666637	72	100	sodium	sodium	NOUN
bjos-8666637	72	101	chloride	chloride	NOUN
bjos-8666637	72	102	;	;	PUNCT
bjos-8666637	72	103	and	and	CCONJ
bjos-8666637	72	104	anti	anti	ADJ
bjos-8666637	72	105	-	-	ADJ
bjos-8666637	72	106	vertigo	vertigo	ADJ
bjos-8666637	72	107	drugs	drug	NOUN
bjos-8666637	72	108	such	such	ADJ
bjos-8666637	72	109	as	as	ADP
bjos-8666637	72	110	bestatin	bestatin	NOUN
bjos-8666637	72	111	.	.	PUNCT
bjos-8666637	73	1	graph	graph	NOUN
bjos-8666637	73	2	1	1	NUM
bjos-8666637	73	3	.	.	PUNCT
bjos-8666637	73	4	percentage	percentage	NOUN
bjos-8666637	73	5	distribution	distribution	NOUN
bjos-8666637	73	6	of	of	ADP
bjos-8666637	73	7	drug	drug	NOUN
bjos-8666637	73	8	classes	class	NOUN
bjos-8666637	73	9	used	use	VERB
bjos-8666637	73	10	by	by	ADP
bjos-8666637	73	11	older	old	ADJ
bjos-8666637	73	12	people	people	NOUN
bjos-8666637	73	13	followed	follow	VERB
bjos-8666637	73	14	-	-	PUNCT
bjos-8666637	73	15	up	up	NOUN
bjos-8666637	73	16	at	at	ADP
bjos-8666637	73	17	the	the	DET
bjos-8666637	73	18	geriatric	geriatric	ADJ
bjos-8666637	73	19	outpatient	outpatient	NOUN
bjos-8666637	73	20	clinic	clinic	NOUN
bjos-8666637	73	21	(	(	PUNCT
bjos-8666637	73	22	university	university	NOUN
bjos-8666637	73	23	hospital	hospital	NOUN
bjos-8666637	73	24	of	of	ADP
bjos-8666637	73	25	brasília	brasília	PROPN
bjos-8666637	73	26	)	)	PUNCT
bjos-8666637	73	27	between	between	ADP
bjos-8666637	73	28	july	july	PROPN
bjos-8666637	73	29	and	and	CCONJ
bjos-8666637	73	30	august	august	PROPN
bjos-8666637	73	31	2018	2018	NUM
bjos-8666637	73	32	100.00	100.00	NUM
bjos-8666637	73	33	%	%	NOUN
bjos-8666637	73	34	75.00	75.00	NUM
bjos-8666637	73	35	%	%	NOUN
bjos-8666637	73	36	50.00	50.00	NUM
bjos-8666637	73	37	%	%	NOUN
bjos-8666637	73	38	25.00	25.00	NUM
bjos-8666637	73	39	%	%	NOUN
bjos-8666637	73	40	0.00	0.00	NUM
bjos-8666637	73	41	%	%	NOUN
bjos-8666637	73	42	hypoglycemic	hypoglycemic	ADJ
bjos-8666637	73	43	antihypertensive	antihypertensive	ADJ
bjos-8666637	73	44	anti	anti	ADJ
bjos-8666637	73	45	-	-	ADJ
bjos-8666637	73	46	platelet	platelet	ADJ
bjos-8666637	73	47	and	and	CCONJ
bjos-8666637	73	48	anticoagulant	anticoagulant	ADJ
bjos-8666637	73	49	agents	agent	NOUN
bjos-8666637	73	50	antidepressants	antidepressant	VERB
bjos-8666637	73	51	antilipidemics	antilipidemics	NOUN
bjos-8666637	73	52	analgesics	analgesic	NOUN
bjos-8666637	73	53	and	and	CCONJ
bjos-8666637	73	54	nsaids	nsaid	NOUN
bjos-8666637	73	55	muscle	muscle	NOUN
bjos-8666637	73	56	relaxants	relaxant	NOUN
bjos-8666637	73	57	benzodiazepines	benzodiazepine	VERB
bjos-8666637	73	58	others	other	NOUN
bjos-8666637	73	59	5	5	NUM
bjos-8666637	73	60	guimarães	guimarães	NOUN
bjos-8666637	74	1	et	et	PROPN
bjos-8666637	74	2	al	al	PROPN
bjos-8666637	74	3	.	.	PROPN
bjos-8666637	74	4	braz	braz	PROPN
bjos-8666637	74	5	j	j	PROPN
bjos-8666637	74	6	oral	oral	PROPN
bjos-8666637	74	7	sci	sci	PROPN
bjos-8666637	74	8	.	.	PUNCT
bjos-8666637	75	1	2023;22	2023;22	NUM
bjos-8666637	75	2	:	:	PUNCT
bjos-8666637	75	3	e236637	e236637	ADJ
bjos-8666637	75	4	the	the	DET
bjos-8666637	75	5	medications	medication	NOUN
bjos-8666637	75	6	most	most	ADV
bjos-8666637	75	7	used	use	VERB
bjos-8666637	75	8	by	by	ADP
bjos-8666637	75	9	research	research	NOUN
bjos-8666637	75	10	participants	participant	NOUN
bjos-8666637	75	11	are	be	AUX
bjos-8666637	75	12	listed	list	VERB
bjos-8666637	75	13	in	in	ADP
bjos-8666637	75	14	table	table	NOUN
bjos-8666637	75	15	2	2	NUM
bjos-8666637	75	16	.	.	PUNCT
bjos-8666637	76	1	the	the	DET
bjos-8666637	76	2	use	use	NOUN
bjos-8666637	76	3	of	of	ADP
bjos-8666637	76	4	losartan	losartan	ADJ
bjos-8666637	76	5	(	(	PUNCT
bjos-8666637	76	6	51	51	NUM
bjos-8666637	76	7	%	%	NOUN
bjos-8666637	76	8	)	)	PUNCT
bjos-8666637	76	9	,	,	PUNCT
bjos-8666637	76	10	amlodipine	amlodipine	NOUN
bjos-8666637	76	11	(	(	PUNCT
bjos-8666637	76	12	22.9	22.9	NUM
bjos-8666637	76	13	%	%	NOUN
bjos-8666637	76	14	)	)	PUNCT
bjos-8666637	76	15	,	,	PUNCT
bjos-8666637	76	16	and	and	CCONJ
bjos-8666637	76	17	metformin	metformin	NOUN
bjos-8666637	76	18	(	(	PUNCT
bjos-8666637	76	19	16.6	16.6	NUM
bjos-8666637	76	20	%	%	NOUN
bjos-8666637	76	21	)	)	PUNCT
bjos-8666637	76	22	were	be	AUX
bjos-8666637	76	23	outstanding	outstanding	ADJ
bjos-8666637	76	24	.	.	PUNCT
bjos-8666637	77	1	medicines	medicine	NOUN
bjos-8666637	77	2	mentioned	mention	VERB
bjos-8666637	77	3	five	five	NUM
bjos-8666637	77	4	times	time	NOUN
bjos-8666637	77	5	or	or	CCONJ
bjos-8666637	77	6	more	more	ADJ
bjos-8666637	77	7	by	by	ADP
bjos-8666637	77	8	the	the	DET
bjos-8666637	77	9	elderly	elderly	ADJ
bjos-8666637	77	10	were	be	AUX
bjos-8666637	77	11	considered	consider	VERB
bjos-8666637	77	12	.	.	PUNCT
bjos-8666637	78	1	table	table	NOUN
bjos-8666637	78	2	2	2	NUM
bjos-8666637	78	3	.	.	PUNCT
bjos-8666637	79	1	prevalence	prevalence	NOUN
bjos-8666637	79	2	of	of	ADP
bjos-8666637	79	3	medication	medication	NOUN
bjos-8666637	79	4	use	use	NOUN
bjos-8666637	79	5	by	by	ADP
bjos-8666637	79	6	older	old	ADJ
bjos-8666637	79	7	people	people	NOUN
bjos-8666637	79	8	monitored	monitor	VERB
bjos-8666637	79	9	at	at	ADP
bjos-8666637	79	10	the	the	DET
bjos-8666637	79	11	geriatric	geriatric	PROPN
bjos-8666637	79	12	clinic	clinic	NOUN
bjos-8666637	79	13	between	between	ADP
bjos-8666637	79	14	july	july	PROPN
bjos-8666637	79	15	and	and	CCONJ
bjos-8666637	79	16	august	august	PROPN
bjos-8666637	79	17	2018	2018	NUM
bjos-8666637	79	18	medication	medication	NOUN
bjos-8666637	79	19	prevalence	prevalence	NOUN
bjos-8666637	79	20	of	of	ADP
bjos-8666637	79	21	use	use	NOUN
bjos-8666637	79	22	among	among	ADP
bjos-8666637	79	23	participants	participant	NOUN
bjos-8666637	79	24	losartan	losartan	ADJ
bjos-8666637	79	25	51	51	NUM
bjos-8666637	79	26	%	%	NOUN
bjos-8666637	79	27	amlodipine	amlodipine	NOUN
bjos-8666637	79	28	22.9	22.9	NUM
bjos-8666637	79	29	%	%	NOUN
bjos-8666637	79	30	metformin	metformin	NOUN
bjos-8666637	79	31	16.6	16.6	NUM
bjos-8666637	79	32	%	%	NOUN
bjos-8666637	79	33	hydrochlorothiazide	hydrochlorothiazide	NOUN
bjos-8666637	79	34	(	(	PUNCT
bjos-8666637	79	35	hctz	hctz	PROPN
bjos-8666637	79	36	)	)	PUNCT
bjos-8666637	79	37	15.6	15.6	NUM
bjos-8666637	79	38	%	%	NOUN
bjos-8666637	79	39	simvastatin	simvastatin	NOUN
bjos-8666637	79	40	13.5	13.5	NUM
bjos-8666637	79	41	%	%	NOUN
bjos-8666637	79	42	acetylsalicylic	acetylsalicylic	PROPN
bjos-8666637	79	43	acid(asa	acid(asa	PROPN
bjos-8666637	79	44	)	)	PUNCT
bjos-8666637	79	45	12.5	12.5	NUM
bjos-8666637	79	46	%	%	NOUN
bjos-8666637	79	47	calcium	calcium	NOUN
bjos-8666637	79	48	12.5	12.5	NUM
bjos-8666637	79	49	%	%	NOUN
bjos-8666637	79	50	levothyroxine	levothyroxine	NOUN
bjos-8666637	79	51	11.4	11.4	NUM
bjos-8666637	79	52	%	%	NOUN
bjos-8666637	79	53	dipyrone	dipyrone	NOUN
bjos-8666637	79	54	11.4	11.4	NUM
bjos-8666637	79	55	%	%	NOUN
bjos-8666637	79	56	atenolol	atenolol	NOUN
bjos-8666637	79	57	10.4	10.4	NUM
bjos-8666637	79	58	%	%	NOUN
bjos-8666637	79	59	indapamide	indapamide	ADV
bjos-8666637	79	60	10.4	10.4	NUM
bjos-8666637	79	61	%	%	NOUN
bjos-8666637	79	62	omeprazole	omeprazole	NOUN
bjos-8666637	79	63	10.4	10.4	NUM
bjos-8666637	79	64	%	%	NOUN
bjos-8666637	79	65	acetaminophen	acetaminophen	NOUN
bjos-8666637	79	66	7.2	7.2	NUM
bjos-8666637	79	67	%	%	NOUN
bjos-8666637	79	68	rosuvastatin	rosuvastatin	NOUN
bjos-8666637	79	69	7.2	7.2	NUM
bjos-8666637	79	70	%	%	NOUN
bjos-8666637	79	71	mirtazapine	mirtazapine	NOUN
bjos-8666637	79	72	6.2	6.2	NUM
bjos-8666637	79	73	%	%	NOUN
bjos-8666637	79	74	gliclazide	gliclazide	NOUN
bjos-8666637	79	75	5.2	5.2	NUM
bjos-8666637	79	76	%	%	NOUN
bjos-8666637	79	77	duloxetine	duloxetine	NOUN
bjos-8666637	79	78	5.2	5.2	NUM
bjos-8666637	79	79	%	%	NOUN
bjos-8666637	79	80	the	the	DET
bjos-8666637	79	81	interactions	interaction	NOUN
bjos-8666637	79	82	between	between	ADP
bjos-8666637	79	83	the	the	DET
bjos-8666637	79	84	drugs	drug	NOUN
bjos-8666637	79	85	used	use	VERB
bjos-8666637	79	86	with	with	ADP
bjos-8666637	79	87	those	those	PRON
bjos-8666637	79	88	most	most	ADV
bjos-8666637	79	89	prescribed	prescribe	VERB
bjos-8666637	79	90	in	in	ADP
bjos-8666637	79	91	dentistry16	dentistry16	NOUN
bjos-8666637	79	92	were	be	AUX
bjos-8666637	79	93	described	describe	VERB
bjos-8666637	79	94	in	in	ADP
bjos-8666637	79	95	chart	chart	NOUN
bjos-8666637	79	96	1	1	NUM
bjos-8666637	79	97	.	.	PUNCT
bjos-8666637	80	1	no	no	DET
bjos-8666637	80	2	relevant	relevant	ADJ
bjos-8666637	80	3	drug	drug	NOUN
bjos-8666637	80	4	interactions	interaction	NOUN
bjos-8666637	80	5	with	with	ADP
bjos-8666637	80	6	local	local	ADJ
bjos-8666637	80	7	anesthetics	anesthetic	NOUN
bjos-8666637	80	8	used	use	VERB
bjos-8666637	80	9	in	in	ADP
bjos-8666637	80	10	dental	dental	ADJ
bjos-8666637	80	11	practice	practice	NOUN
bjos-8666637	80	12	were	be	AUX
bjos-8666637	80	13	found	find	VERB
bjos-8666637	80	14	.	.	PUNCT
bjos-8666637	81	1	there	there	PRON
bjos-8666637	81	2	was	be	VERB
bjos-8666637	81	3	an	an	DET
bjos-8666637	81	4	association	association	NOUN
bjos-8666637	81	5	between	between	ADP
bjos-8666637	81	6	polypharmacy	polypharmacy	NOUN
bjos-8666637	81	7	and	and	CCONJ
bjos-8666637	81	8	xerostomia	xerostomia	NOUN
bjos-8666637	81	9	(	(	PUNCT
bjos-8666637	81	10	pr	pr	X
bjos-8666637	81	11	=	=	NOUN
bjos-8666637	81	12	1.57	1.57	NUM
bjos-8666637	81	13	,	,	PUNCT
bjos-8666637	81	14	95%ci	95%ci	NUM
bjos-8666637	81	15	,	,	PUNCT
bjos-8666637	81	16	1.10	1.10	NUM
bjos-8666637	81	17	-	-	SYM
bjos-8666637	81	18	2.23	2.23	NUM
bjos-8666637	81	19	,	,	PUNCT
bjos-8666637	81	20	p	p	NOUN
bjos-8666637	81	21	=	=	NOUN
bjos-8666637	81	22	0.004	0.004	NUM
bjos-8666637	81	23	)	)	PUNCT
bjos-8666637	81	24	,	,	PUNCT
bjos-8666637	81	25	but	but	CCONJ
bjos-8666637	81	26	there	there	PRON
bjos-8666637	81	27	was	be	VERB
bjos-8666637	81	28	no	no	DET
bjos-8666637	81	29	association	association	NOUN
bjos-8666637	81	30	between	between	ADP
bjos-8666637	81	31	polypharmacy	polypharmacy	NOUN
bjos-8666637	81	32	and	and	CCONJ
bjos-8666637	81	33	dysgeusia	dysgeusia	NOUN
bjos-8666637	81	34	(	(	PUNCT
bjos-8666637	81	35	pr	pr	X
bjos-8666637	81	36	=	=	SYM
bjos-8666637	81	37	1.14	1.14	NUM
bjos-8666637	81	38	,	,	PUNCT
bjos-8666637	81	39	95%ci	95%ci	NUM
bjos-8666637	81	40	,	,	PUNCT
bjos-8666637	81	41	0.862	0.862	NUM
bjos-8666637	81	42	-	-	SYM
bjos-8666637	81	43	1	1	NUM
bjos-8666637	81	44	.51	.51	NUM
bjos-8666637	81	45	,	,	PUNCT
bjos-8666637	81	46	p=0.348	p=0.348	NOUN
bjos-8666637	81	47	)	)	PUNCT
bjos-8666637	81	48	.	.	PUNCT
bjos-8666637	82	1	table	table	NOUN
bjos-8666637	82	2	3	3	NUM
bjos-8666637	82	3	shows	show	VERB
bjos-8666637	82	4	the	the	DET
bjos-8666637	82	5	result	result	NOUN
bjos-8666637	82	6	of	of	ADP
bjos-8666637	82	7	the	the	DET
bjos-8666637	82	8	binomial	binomial	ADJ
bjos-8666637	82	9	logistic	logistic	ADJ
bjos-8666637	82	10	regression	regression	NOUN
bjos-8666637	82	11	.	.	PUNCT
bjos-8666637	83	1	the	the	DET
bjos-8666637	83	2	use	use	NOUN
bjos-8666637	83	3	of	of	ADP
bjos-8666637	83	4	antihypertensive	antihypertensive	ADJ
bjos-8666637	83	5	drugs	drug	NOUN
bjos-8666637	83	6	was	be	AUX
bjos-8666637	83	7	associated	associate	VERB
bjos-8666637	83	8	with	with	ADP
bjos-8666637	83	9	the	the	DET
bjos-8666637	83	10	occurrence	occurrence	NOUN
bjos-8666637	83	11	of	of	ADP
bjos-8666637	83	12	xerostomia	xerostomia	PROPN
bjos-8666637	83	13	.	.	PUNCT
bjos-8666637	84	1	there	there	PRON
bjos-8666637	84	2	was	be	VERB
bjos-8666637	84	3	no	no	DET
bjos-8666637	84	4	association	association	NOUN
bjos-8666637	84	5	between	between	ADP
bjos-8666637	84	6	the	the	DET
bjos-8666637	84	7	use	use	NOUN
bjos-8666637	84	8	of	of	ADP
bjos-8666637	84	9	the	the	DET
bjos-8666637	84	10	drugs	drug	NOUN
bjos-8666637	84	11	listed	list	VERB
bjos-8666637	84	12	and	and	CCONJ
bjos-8666637	84	13	the	the	DET
bjos-8666637	84	14	presence	presence	NOUN
bjos-8666637	84	15	of	of	ADP
bjos-8666637	84	16	dysgeusia	dysgeusia	PROPN
bjos-8666637	84	17	.	.	PROPN
bjos-8666637	85	1	6	6	NUM
bjos-8666637	85	2	guimarães	guimarães	NOUN
bjos-8666637	85	3	et	et	PROPN
bjos-8666637	85	4	al	al	PROPN
bjos-8666637	85	5	.	.	PROPN
bjos-8666637	85	6	braz	braz	PROPN
bjos-8666637	85	7	j	j	PROPN
bjos-8666637	85	8	oral	oral	PROPN
bjos-8666637	85	9	sci	sci	PROPN
bjos-8666637	85	10	.	.	PUNCT
bjos-8666637	86	1	2023;22	2023;22	NUM
bjos-8666637	86	2	:	:	PUNCT
bjos-8666637	86	3	e236637	e236637	ADJ
bjos-8666637	86	4	ch	ch	PROPN
bjos-8666637	86	5	ar	ar	PROPN
bjos-8666637	86	6	t	t	PROPN
bjos-8666637	86	7	1	1	NUM
bjos-8666637	86	8	.	.	PUNCT
bjos-8666637	87	1	i	i	PRON
bjos-8666637	87	2	nt	not	PART
bjos-8666637	87	3	er	er	INTJ
bjos-8666637	87	4	ac	ac	INTJ
bjos-8666637	87	5	tio	tio	PROPN
bjos-8666637	87	6	ns	ns	NUM
bjos-8666637	87	7	b	b	PROPN
bjos-8666637	87	8	et	et	PROPN
bjos-8666637	87	9	w	w	PROPN
bjos-8666637	87	10	ee	ee	PROPN
bjos-8666637	87	11	n	n	PROPN
bjos-8666637	87	12	th	th	X
bjos-8666637	87	13	e	e	X
bjos-8666637	87	14	dr	dr	PROPN
bjos-8666637	87	15	ug	ug	ADP
bjos-8666637	87	16	s	s	PROPN
bjos-8666637	87	17	m	m	VERB
bjos-8666637	87	18	os	os	PROPN
bjos-8666637	87	19	t	t	PROPN
bjos-8666637	87	20	u	u	PROPN
bjos-8666637	87	21	se	se	PROPN
bjos-8666637	87	22	d	d	PROPN
bjos-8666637	87	23	by	by	ADP
bjos-8666637	87	24	s	s	PROPN
bjos-8666637	87	25	tu	tu	PROPN
bjos-8666637	87	26	dy	dy	X
bjos-8666637	87	27	p	p	PROPN
bjos-8666637	87	28	ar	ar	PROPN
bjos-8666637	87	29	tic	tic	PROPN
bjos-8666637	87	30	ip	ip	VERB
bjos-8666637	88	1	an	an	DET
bjos-8666637	88	2	ts	ts	ADP
bjos-8666637	88	3	a	a	DET
bjos-8666637	88	4	nd	nd	INTJ
bjos-8666637	88	5	th	th	X
bjos-8666637	88	6	os	os	NOUN
bjos-8666637	88	7	e	e	NOUN
bjos-8666637	88	8	fr	fr	PROPN
bjos-8666637	88	9	eq	eq	PROPN
bjos-8666637	88	10	ue	ue	INTJ
bjos-8666637	89	1	nt	not	PART
bjos-8666637	89	2	ly	ly	X
bjos-8666637	89	3	p	p	X
bjos-8666637	89	4	re	re	X
bjos-8666637	89	5	sc	sc	PROPN
bjos-8666637	89	6	rib	rib	PROPN
bjos-8666637	89	7	ed	ed	NOUN
bjos-8666637	89	8	in	in	ADP
bjos-8666637	89	9	d	d	PROPN
bjos-8666637	89	10	en	en	X
bjos-8666637	89	11	tis	tis	PROPN
bjos-8666637	89	12	tr	tr	PROPN
bjos-8666637	89	13	y	y	PROPN
bjos-8666637	89	14	,	,	PUNCT
bjos-8666637	89	15	ac	ac	PROPN
bjos-8666637	89	16	co	co	PROPN
bjos-8666637	89	17	rd	rd	PROPN
bjos-8666637	89	18	in	in	ADP
bjos-8666637	89	19	g	g	PROPN
bjos-8666637	89	20	to	to	ADP
bjos-8666637	89	21	th	th	X
bjos-8666637	89	22	e	e	X
bjos-8666637	89	23	se	se	X
bjos-8666637	89	24	ve	ve	VERB
bjos-8666637	89	25	rit	rit	PROPN
bjos-8666637	89	26	y	y	PROPN
bjos-8666637	89	27	of	of	ADP
bjos-8666637	89	28	th	th	X
bjos-8666637	89	29	e	e	NOUN
bjos-8666637	89	30	in	in	ADP
bjos-8666637	89	31	te	te	ADP
bjos-8666637	89	32	ra	ra	PROPN
bjos-8666637	89	33	ct	ct	PROPN
bjos-8666637	89	34	io	io	PROPN
bjos-8666637	89	35	n	n	PROPN
bjos-8666637	89	36	de	de	PROPN
bjos-8666637	89	37	sc	sc	PROPN
bjos-8666637	89	38	rib	rib	NOUN
bjos-8666637	89	39	ed	ed	NOUN
bjos-8666637	89	40	by	by	ADP
bjos-8666637	89	41	m	m	PROPN
bjos-8666637	89	42	ic	ic	PROPN
bjos-8666637	89	43	ro	ro	PROPN
bjos-8666637	89	44	m	m	PROPN
bjos-8666637	89	45	ed	ed	NOUN
bjos-8666637	89	46	ex	ex	X
bjos-8666637	90	1	d	d	NOUN
bjos-8666637	90	2	ru	ru	NOUN
bjos-8666637	90	3	g	g	NOUN
bjos-8666637	90	4	in	in	ADP
bjos-8666637	90	5	te	te	ADP
bjos-8666637	90	6	ra	ra	PROPN
bjos-8666637	90	7	ct	ct	PROPN
bjos-8666637	90	8	io	io	PROPN
bjos-8666637	90	9	ns	ns	PROPN
bjos-8666637	90	10	®	®	PROPN
bjos-8666637	90	11	a	a	DET
bjos-8666637	90	12	nd	nd	NOUN
bjos-8666637	90	13	d	d	X
bjos-8666637	90	14	yn	yn	PROPN
bjos-8666637	90	15	am	be	AUX
bjos-8666637	90	16	ed	ed	NOUN
bjos-8666637	90	17	®	®	NOUN
bjos-8666637	90	18	dr	dr	PROPN
bjos-8666637	90	19	ug	ug	ADP
bjos-8666637	90	20	c	c	PROPN
bjos-8666637	90	21	la	la	INTJ
bjos-8666637	90	22	ss	ss	PROPN
bjos-8666637	91	1	es	es	NOUN
bjos-8666637	91	2	m	m	PROPN
bjos-8666637	91	3	ed	ed	NOUN
bjos-8666637	91	4	ic	ic	PROPN
bjos-8666637	91	5	in	in	ADP
bjos-8666637	91	6	es	es	X
bjos-8666637	91	7	o	o	NOUN
bjos-8666637	91	8	fte	fte	NOUN
bjos-8666637	91	9	n	n	ADP
bjos-8666637	91	10	pr	pr	NOUN
bjos-8666637	91	11	es	es	X
bjos-8666637	91	12	cr	cr	PROPN
bjos-8666637	91	13	ib	ib	PROPN
bjos-8666637	91	14	ed	ed	PROPN
bjos-8666637	91	15	in	in	ADP
bjos-8666637	91	16	de	de	X
bjos-8666637	91	17	nt	not	PART
bjos-8666637	91	18	is	be	AUX
bjos-8666637	91	19	try	try	VERB
bjos-8666637	91	20	m	m	PROPN
bjos-8666637	91	21	ed	ed	NOUN
bjos-8666637	91	22	ic	ic	PROPN
bjos-8666637	91	23	in	in	ADP
bjos-8666637	91	24	es	es	X
bjos-8666637	91	25	m	m	PROPN
bjos-8666637	91	26	os	os	PROPN
bjos-8666637	91	27	t	t	PROPN
bjos-8666637	91	28	u	u	PROPN
bjos-8666637	91	29	se	se	PROPN
bjos-8666637	91	30	d	d	X
bjos-8666637	91	31	by	by	ADP
bjos-8666637	91	32	th	th	X
bjos-8666637	91	33	e	e	X
bjos-8666637	91	34	ol	ol	PROPN
bjos-8666637	91	35	de	de	PROPN
bjos-8666637	91	36	r	r	PROPN
bjos-8666637	91	37	p	p	X
bjos-8666637	91	38	eo	eo	PROPN
bjos-8666637	91	39	pl	pl	PROPN
bjos-8666637	91	40	e	e	PROPN
bjos-8666637	91	41	a	a	DET
bjos-8666637	91	42	sa	sa	NOUN
bjos-8666637	91	43	at	at	ADP
bjos-8666637	91	44	en	en	X
bjos-8666637	91	45	ol	ol	PROPN
bjos-8666637	91	46	ol	ol	PROPN
bjos-8666637	91	47	du	du	PROPN
bjos-8666637	91	48	lo	lo	PROPN
bjos-8666637	91	49	xe	xe	PROPN
bjos-8666637	91	50	tin	tin	PROPN
bjos-8666637	91	51	e	e	PROPN
bjos-8666637	91	52	di	di	X
bjos-8666637	92	1	py	py	PROPN
bjos-8666637	92	2	ro	ro	PROPN
bjos-8666637	92	3	ne	ne	PROPN
bjos-8666637	92	4	h	h	PROPN
bjos-8666637	93	1	ct	ct	PROPN
bjos-8666637	93	2	z	z	PROPN
bjos-8666637	93	3	in	in	ADP
bjos-8666637	93	4	da	da	PROPN
bjos-8666637	93	5	pa	pa	PROPN
bjos-8666637	93	6	m	m	PROPN
bjos-8666637	93	7	i	i	PROPN
bjos-8666637	93	8	d	d	PROPN
bjos-8666637	93	9	e	e	PROPN
bjos-8666637	93	10	lo	lo	PROPN
bjos-8666637	93	11	sa	sa	PROPN
bjos-8666637	93	12	rt	rt	PROPN
bjos-8666637	94	1	an	an	DET
bjos-8666637	94	2	m	m	PROPN
bjos-8666637	94	3	irt	irt	PROPN
bjos-8666637	94	4	az	az	PROPN
bjos-8666637	94	5	ap	ap	PROPN
bjos-8666637	94	6	in	in	ADP
bjos-8666637	94	7	e	e	PROPN
bjos-8666637	94	8	om	om	PROPN
bjos-8666637	94	9	ep	ep	PROPN
bjos-8666637	94	10	ra	ra	PROPN
bjos-8666637	94	11	zo	zo	PROPN
bjos-8666637	94	12	le	le	X
bjos-8666637	94	13	ac	ac	PROPN
bjos-8666637	94	14	et	et	PROPN
bjos-8666637	94	15	am	be	AUX
bjos-8666637	94	16	in	in	ADP
bjos-8666637	94	17	op	op	NOUN
bjos-8666637	94	18	he	he	PRON
bjos-8666637	95	1	n	n	ADV
bjos-8666637	95	2	pr	pr	VERB
bjos-8666637	95	3	ed	ed	PROPN
bjos-8666637	95	4	ni	ni	PROPN
bjos-8666637	95	5	so	so	PROPN
bjos-8666637	95	6	ne	ne	PROPN
bjos-8666637	95	7	ro	ro	PROPN
bjos-8666637	95	8	su	su	PROPN
bjos-8666637	95	9	va	va	PROPN
bjos-8666637	95	10	st	st	PROPN
bjos-8666637	95	11	at	at	ADP
bjos-8666637	95	12	in	in	ADP
bjos-8666637	95	13	si	si	PROPN
bjos-8666637	95	14	m	m	PROPN
bjos-8666637	95	15	va	va	PROPN
bjos-8666637	95	16	st	st	PROPN
bjos-8666637	95	17	at	at	ADP
bjos-8666637	95	18	in	in	ADP
bjos-8666637	95	19	n	n	CCONJ
bjos-8666637	95	20	on	on	ADV
bjos-8666637	95	21	-o	-o	INTJ
bjos-8666637	95	22	pi	pi	NOUN
bjos-8666637	96	1	oi	oi	PROPN
bjos-8666637	96	2	d	d	X
bjos-8666637	96	3	an	an	PROPN
bjos-8666637	96	4	al	al	PROPN
bjos-8666637	96	5	ge	ge	PROPN
bjos-8666637	96	6	si	si	PROPN
bjos-8666637	96	7	cs	cs	PROPN
bjos-8666637	96	8	/	/	SYM
bjos-8666637	96	9	n	n	PROPN
bjos-8666637	96	10	sa	sa	PROPN
bjos-8666637	97	1	i	i	PROPN
bjos-8666637	97	2	d	d	PROPN
bjos-8666637	97	3	s/	s/	VERB
bjos-8666637	98	1	o	o	INTJ
bjos-8666637	99	1	pi	pi	NOUN
bjos-8666637	99	2	oi	oi	INTJ
bjos-8666637	100	1	d	d	X
bjos-8666637	100	2	an	an	PROPN
bjos-8666637	100	3	al	al	PROPN
bjos-8666637	100	4	ge	ge	PROPN
bjos-8666637	100	5	si	si	PROPN
bjos-8666637	100	6	cs	cs	PROPN
bjos-8666637	100	7	di	di	X
bjos-8666637	100	8	py	py	PROPN
bjos-8666637	100	9	ro	ro	X
bjos-8666637	100	10	ne	ne	PROPN
bjos-8666637	101	1	+	+	PROPN
bjos-8666637	101	2	+	+	X
bjos-8666637	101	3	+	+	ADJ
bjos-8666637	101	4	+	+	ADJ
bjos-8666637	101	5	+	+	ADJ
bjos-8666637	101	6	+	+	ADJ
bjos-8666637	101	7	+	+	ADJ
bjos-8666637	101	8	+	+	ADJ
bjos-8666637	101	9	+	+	ADJ
bjos-8666637	101	10	+	+	ADJ
bjos-8666637	101	11	+	+	PROPN
bjos-8666637	101	12	as	as	ADP
bjos-8666637	101	13	a	a	DET
bjos-8666637	101	14	+	+	NOUN
bjos-8666637	101	15	+	+	ADJ
bjos-8666637	101	16	+	+	ADJ
bjos-8666637	101	17	+	+	ADJ
bjos-8666637	101	18	+	+	ADJ
bjos-8666637	101	19	+	+	ADJ
bjos-8666637	101	20	+	+	ADJ
bjos-8666637	101	21	+	+	ADJ
bjos-8666637	101	22	+	+	ADJ
bjos-8666637	101	23	+	+	ADJ
bjos-8666637	101	24	di	di	X
bjos-8666637	101	25	cl	cl	NOUN
bjos-8666637	101	26	of	of	ADP
bjos-8666637	101	27	en	en	X
bjos-8666637	101	28	ac	ac	PROPN
bjos-8666637	102	1	so	so	ADV
bjos-8666637	102	2	di	di	INTJ
bjos-8666637	102	3	um	um	INTJ
bjos-8666637	103	1	+	+	PROPN
bjos-8666637	103	2	+	+	ADJ
bjos-8666637	103	3	+	+	ADJ
bjos-8666637	103	4	+	+	ADJ
bjos-8666637	103	5	+	+	ADJ
bjos-8666637	103	6	+	+	ADJ
bjos-8666637	103	7	+	+	ADJ
bjos-8666637	103	8	+	+	ADJ
bjos-8666637	103	9	+	+	ADJ
bjos-8666637	103	10	+	+	ADJ
bjos-8666637	103	11	+	+	ADJ
bjos-8666637	103	12	+	+	ADJ
bjos-8666637	103	13	+	+	ADJ
bjos-8666637	103	14	+	+	ADJ
bjos-8666637	103	15	+	+	ADJ
bjos-8666637	103	16	+	+	ADJ
bjos-8666637	103	17	+	+	ADJ
bjos-8666637	103	18	+	+	ADJ
bjos-8666637	103	19	+	+	CCONJ
bjos-8666637	103	20	ib	ib	X
bjos-8666637	103	21	up	up	ADP
bjos-8666637	103	22	ro	ro	X
bjos-8666637	103	23	fe	fe	X
bjos-8666637	103	24	n	n	X
bjos-8666637	103	25	+	+	PROPN
bjos-8666637	103	26	+	+	PROPN
bjos-8666637	103	27	+	+	ADJ
bjos-8666637	103	28	+	+	ADJ
bjos-8666637	103	29	+	+	ADJ
bjos-8666637	103	30	+	+	ADJ
bjos-8666637	103	31	+	+	ADJ
bjos-8666637	103	32	+	+	ADJ
bjos-8666637	103	33	+	+	ADJ
bjos-8666637	103	34	+	+	ADJ
bjos-8666637	103	35	+	+	ADJ
bjos-8666637	103	36	+	+	ADJ
bjos-8666637	103	37	+	+	ADJ
bjos-8666637	103	38	+	+	ADJ
bjos-8666637	103	39	+	+	ADJ
bjos-8666637	103	40	+	+	ADJ
bjos-8666637	103	41	+	+	ADJ
bjos-8666637	103	42	+	+	VERB
bjos-8666637	103	43	+	+	NUM
bjos-8666637	103	44	co	co	X
bjos-8666637	103	45	de	de	X
bjos-8666637	103	46	in	in	ADP
bjos-8666637	103	47	e	e	X
bjos-8666637	103	48	+	+	PROPN
bjos-8666637	103	49	+	+	PROPN
bjos-8666637	103	50	+	+	X
bjos-8666637	103	51	+	+	ADJ
bjos-8666637	103	52	+	+	ADJ
bjos-8666637	103	53	+	+	CCONJ
bjos-8666637	103	54	an	an	DET
bjos-8666637	103	55	tib	tib	X
bjos-8666637	103	56	io	io	X
bjos-8666637	103	57	tic	tic	PROPN
bjos-8666637	103	58	s	s	PART
bjos-8666637	103	59	er	er	INTJ
bjos-8666637	103	60	yt	yt	X
bjos-8666637	103	61	hr	hr	NOUN
bjos-8666637	103	62	om	om	INTJ
bjos-8666637	103	63	yc	yc	INTJ
bjos-8666637	103	64	in	in	ADP
bjos-8666637	103	65	x	x	PROPN
bjos-8666637	103	66	az	az	PROPN
bjos-8666637	103	67	ith	ith	PROPN
bjos-8666637	104	1	ro	ro	PROPN
bjos-8666637	104	2	m	m	VERB
bjos-8666637	104	3	yc	yc	VERB
bjos-8666637	104	4	in	in	ADP
bjos-8666637	104	5	+	+	PROPN
bjos-8666637	104	6	+	+	PROPN
bjos-8666637	104	7	+	+	CCONJ
bjos-8666637	104	8	ei	ei	X
bjos-8666637	104	9	a	a	PRON
bjos-8666637	104	10	de	de	X
bjos-8666637	104	11	xa	xa	PROPN
bjos-8666637	104	12	m	m	PROPN
bjos-8666637	104	13	et	et	NOUN
bjos-8666637	104	14	ha	ha	INTJ
bjos-8666637	104	15	so	so	ADV
bjos-8666637	104	16	ne	ne	PROPN
bjos-8666637	105	1	+	+	PROPN
bjos-8666637	105	2	+	+	X
bjos-8666637	105	3	+	+	ADJ
bjos-8666637	105	4	+	+	ADJ
bjos-8666637	105	5	+	+	CCONJ
bjos-8666637	105	6	an	an	DET
bjos-8666637	105	7	xi	xi	X
bjos-8666637	105	8	ol	ol	PROPN
bjos-8666637	105	9	yt	yt	PROPN
bjos-8666637	105	10	ic	ic	PROPN
bjos-8666637	105	11	s	s	PROPN
bjos-8666637	105	12	(	(	PUNCT
bjos-8666637	105	13	b	b	PROPN
bjos-8666637	105	14	en	en	ADP
bjos-8666637	105	15	zo	zo	PROPN
bjos-8666637	105	16	di	di	PROPN
bjos-8666637	105	17	az	az	PROPN
bjos-8666637	105	18	ep	ep	PROPN
bjos-8666637	105	19	in	in	ADP
bjos-8666637	105	20	es	es	X
bjos-8666637	105	21	)	)	PUNCT
bjos-8666637	105	22	di	di	PROPN
bjos-8666637	105	23	az	az	PROPN
bjos-8666637	105	24	ep	ep	PROPN
bjos-8666637	105	25	am	be	AUX
bjos-8666637	105	26	+	+	PROPN
bjos-8666637	105	27	+	+	ADJ
bjos-8666637	105	28	+	+	ADJ
bjos-8666637	105	29	+	+	CCONJ
bjos-8666637	106	1	an	an	DET
bjos-8666637	106	2	tif	tif	PROPN
bjos-8666637	106	3	un	un	PROPN
bjos-8666637	106	4	ga	ga	PROPN
bjos-8666637	106	5	ls	ls	PROPN
bjos-8666637	107	1	fl	fl	INTJ
bjos-8666637	107	2	uc	uc	INTJ
bjos-8666637	107	3	on	on	ADP
bjos-8666637	107	4	az	az	PROPN
bjos-8666637	107	5	ol	ol	PROPN
bjos-8666637	107	6	e	e	PROPN
bjos-8666637	107	7	x	x	PUNCT
bjos-8666637	108	1	+	+	PUNCT
bjos-8666637	108	2	+	+	ADJ
bjos-8666637	108	3	+	+	ADJ
bjos-8666637	108	4	+	+	ADJ
bjos-8666637	108	5	+	+	ADJ
bjos-8666637	108	6	+	+	X
bjos-8666637	108	7	se	se	X
bjos-8666637	108	8	ve	ve	VERB
bjos-8666637	108	9	rit	rit	PROPN
bjos-8666637	108	10	y	y	PROPN
bjos-8666637	108	11	of	of	ADP
bjos-8666637	108	12	d	d	PROPN
bjos-8666637	108	13	ru	ru	PROPN
bjos-8666637	108	14	g	g	NOUN
bjos-8666637	108	15	in	in	ADP
bjos-8666637	108	16	te	te	ADP
bjos-8666637	108	17	ra	ra	PROPN
bjos-8666637	108	18	ct	ct	PROPN
bjos-8666637	108	19	io	io	PROPN
bjos-8666637	108	20	n	n	CCONJ
bjos-8666637	108	21	:	:	PUNCT
bjos-8666637	108	22	x	x	X
bjos-8666637	108	23	:	:	PUNCT
bjos-8666637	108	24	c	c	X
bjos-8666637	108	25	on	on	ADP
bjos-8666637	108	26	tra	tra	PROPN
bjos-8666637	108	27	in	in	ADP
bjos-8666637	108	28	di	di	X
bjos-8666637	108	29	ca	can	AUX
bjos-8666637	108	30	te	te	PROPN
bjos-8666637	108	31	d	d	NOUN
bjos-8666637	108	32	;	;	PUNCT
bjos-8666637	108	33	+	+	CCONJ
bjos-8666637	109	1	+	+	PUNCT
bjos-8666637	109	2	+	+	NUM
bjos-8666637	109	3	:	:	PUNCT
bjos-8666637	109	4	m	m	VERB
bjos-8666637	109	5	aj	aj	ADJ
bjos-8666637	109	6	or	or	CCONJ
bjos-8666637	109	7	;	;	PUNCT
bjos-8666637	109	8	+	+	CCONJ
bjos-8666637	109	9	+	+	ADV
bjos-8666637	109	10	:	:	PUNCT
bjos-8666637	109	11	m	m	VERB
bjos-8666637	109	12	od	od	INTJ
bjos-8666637	109	13	er	er	INTJ
bjos-8666637	109	14	at	at	ADP
bjos-8666637	109	15	e	e	NOUN
bjos-8666637	109	16	;	;	PUNCT
bjos-8666637	109	17	+	+	CCONJ
bjos-8666637	109	18	:	:	PUNCT
bjos-8666637	109	19	m	m	VERB
bjos-8666637	109	20	in	in	ADP
bjos-8666637	109	21	or	or	CCONJ
bjos-8666637	109	22	.	.	PUNCT
bjos-8666637	109	23	7	7	NUM
bjos-8666637	109	24	guimarães	guimarães	NOUN
bjos-8666637	109	25	et	et	PROPN
bjos-8666637	109	26	al	al	PROPN
bjos-8666637	109	27	.	.	PROPN
bjos-8666637	110	1	braz	braz	PROPN
bjos-8666637	110	2	j	j	PROPN
bjos-8666637	110	3	oral	oral	PROPN
bjos-8666637	110	4	sci	sci	PROPN
bjos-8666637	110	5	.	.	PUNCT
bjos-8666637	111	1	2023;22	2023;22	NUM
bjos-8666637	111	2	:	:	PUNCT
bjos-8666637	111	3	e236637	e236637	ADJ
bjos-8666637	111	4	chart	chart	NOUN
bjos-8666637	111	5	2	2	NUM
bjos-8666637	111	6	.	.	PUNCT
bjos-8666637	112	1	details	detail	NOUN
bjos-8666637	112	2	about	about	ADP
bjos-8666637	112	3	the	the	DET
bjos-8666637	112	4	interactions	interaction	NOUN
bjos-8666637	112	5	between	between	ADP
bjos-8666637	112	6	the	the	DET
bjos-8666637	112	7	drugs	drug	NOUN
bjos-8666637	112	8	most	most	ADV
bjos-8666637	112	9	used	use	VERB
bjos-8666637	112	10	by	by	ADP
bjos-8666637	112	11	study	study	NOUN
bjos-8666637	112	12	participants	participant	NOUN
bjos-8666637	112	13	and	and	CCONJ
bjos-8666637	112	14	those	those	PRON
bjos-8666637	112	15	frequently	frequently	ADV
bjos-8666637	112	16	prescribed	prescribe	VERB
bjos-8666637	112	17	in	in	ADP
bjos-8666637	112	18	dentistry	dentistry	NOUN
bjos-8666637	112	19	described	describe	VERB
bjos-8666637	112	20	by	by	ADP
bjos-8666637	112	21	micromedex	micromedex	NOUN
bjos-8666637	112	22	drug	drug	NOUN
bjos-8666637	112	23	interactions	interaction	NOUN
bjos-8666637	112	24	®	®	NOUN
bjos-8666637	112	25	and	and	CCONJ
bjos-8666637	112	26	dynamed	dyname	VERB
bjos-8666637	112	27	®	®	NOUN
bjos-8666637	112	28	medicines	medicine	NOUN
bjos-8666637	112	29	most	most	ADV
bjos-8666637	112	30	used	use	VERB
bjos-8666637	112	31	by	by	ADP
bjos-8666637	112	32	the	the	DET
bjos-8666637	112	33	older	old	ADJ
bjos-8666637	112	34	people	people	NOUN
bjos-8666637	112	35	medicines	medicine	NOUN
bjos-8666637	112	36	often	often	ADV
bjos-8666637	112	37	prescribed	prescribe	VERB
bjos-8666637	112	38	in	in	ADP
bjos-8666637	112	39	dentistry	dentistry	NOUN
bjos-8666637	112	40	interactions	interaction	NOUN
bjos-8666637	112	41	asa	asa	PROPN
bjos-8666637	112	42	1	1	NUM
bjos-8666637	112	43	.	.	PUNCT
bjos-8666637	112	44	diclofenac	diclofenac	ADJ
bjos-8666637	112	45	sodium	sodium	NOUN
bjos-8666637	112	46	1	1	NUM
bjos-8666637	112	47	.	.	PUNCT
bjos-8666637	112	48	may	may	AUX
bjos-8666637	112	49	result	result	VERB
bjos-8666637	112	50	in	in	ADP
bjos-8666637	112	51	an	an	DET
bjos-8666637	112	52	increased	increase	VERB
bjos-8666637	112	53	risk	risk	NOUN
bjos-8666637	112	54	of	of	ADP
bjos-8666637	112	55	bleeding	bleeding	NOUN
bjos-8666637	112	56	and	and	CCONJ
bjos-8666637	112	57	cardiovascular	cardiovascular	ADJ
bjos-8666637	112	58	events	event	NOUN
bjos-8666637	112	59	2	2	NUM
bjos-8666637	112	60	.	.	PUNCT
bjos-8666637	113	1	ibuprofen	ibuprofen	PROPN
bjos-8666637	113	2	2	2	PROPN
bjos-8666637	113	3	.	.	PUNCT
bjos-8666637	113	4	may	may	AUX
bjos-8666637	113	5	result	result	VERB
bjos-8666637	113	6	in	in	ADP
bjos-8666637	113	7	decreased	decrease	VERB
bjos-8666637	113	8	antiplatelet	antiplatelet	ADJ
bjos-8666637	113	9	effect	effect	NOUN
bjos-8666637	113	10	of	of	ADP
bjos-8666637	113	11	acetylsalicylic	acetylsalicylic	PROPN
bjos-8666637	113	12	acid	acid	PROPN
bjos-8666637	113	13	,	,	PUNCT
bjos-8666637	113	14	an	an	DET
bjos-8666637	113	15	additive	additive	ADJ
bjos-8666637	113	16	risk	risk	NOUN
bjos-8666637	113	17	of	of	ADP
bjos-8666637	113	18	bleeding	bleeding	NOUN
bjos-8666637	113	19	,	,	PUNCT
bjos-8666637	113	20	and	and	CCONJ
bjos-8666637	113	21	risk	risk	NOUN
bjos-8666637	113	22	of	of	ADP
bjos-8666637	113	23	cardiovascular	cardiovascular	ADJ
bjos-8666637	113	24	events	event	NOUN
bjos-8666637	113	25	3	3	X
bjos-8666637	113	26	.	.	PUNCT
bjos-8666637	113	27	dexamethasone	dexamethasone	NOUN
bjos-8666637	113	28	3	3	X
bjos-8666637	113	29	.	.	PUNCT
bjos-8666637	113	30	may	may	AUX
bjos-8666637	113	31	result	result	VERB
bjos-8666637	113	32	in	in	ADP
bjos-8666637	113	33	an	an	DET
bjos-8666637	113	34	increased	increase	VERB
bjos-8666637	113	35	risk	risk	NOUN
bjos-8666637	113	36	of	of	ADP
bjos-8666637	113	37	gastrointestinal	gastrointestinal	ADJ
bjos-8666637	113	38	ulceration	ulceration	NOUN
bjos-8666637	113	39	and	and	CCONJ
bjos-8666637	113	40	lower	low	ADJ
bjos-8666637	113	41	aspirin	aspirin	NOUN
bjos-8666637	113	42	serum	serum	NOUN
bjos-8666637	113	43	concentrations	concentration	NOUN
bjos-8666637	113	44	atenolol	atenolol	PROPN
bjos-8666637	113	45	1	1	X
bjos-8666637	113	46	.	.	PUNCT
bjos-8666637	114	1	dipyrone	dipyrone	NOUN
bjos-8666637	114	2	1	1	NUM
bjos-8666637	114	3	.	.	PUNCT
bjos-8666637	114	4	may	may	AUX
bjos-8666637	114	5	result	result	VERB
bjos-8666637	114	6	in	in	ADP
bjos-8666637	114	7	decreased	decrease	VERB
bjos-8666637	114	8	antihypertensive	antihypertensive	ADJ
bjos-8666637	114	9	activities	activity	NOUN
bjos-8666637	114	10	2	2	NUM
bjos-8666637	114	11	.	.	X
bjos-8666637	114	12	asa	asa	PROPN
bjos-8666637	114	13	2	2	NUM
bjos-8666637	114	14	-	-	SYM
bjos-8666637	114	15	4	4	NUM
bjos-8666637	114	16	.	.	PUNCT
bjos-8666637	114	17	concurrent	concurrent	ADJ
bjos-8666637	114	18	use	use	NOUN
bjos-8666637	114	19	of	of	ADP
bjos-8666637	114	20	them	they	PRON
bjos-8666637	114	21	may	may	AUX
bjos-8666637	114	22	result	result	VERB
bjos-8666637	114	23	in	in	ADP
bjos-8666637	114	24	an	an	DET
bjos-8666637	114	25	increased	increase	VERB
bjos-8666637	114	26	blood	blood	NOUN
bjos-8666637	114	27	pressure3	pressure3	NOUN
bjos-8666637	114	28	.	.	PUNCT
bjos-8666637	115	1	diclofenac	diclofenac	ADJ
bjos-8666637	115	2	sodium	sodium	NOUN
bjos-8666637	115	3	4	4	NUM
bjos-8666637	115	4	.	.	PUNCT
bjos-8666637	116	1	ibuprofen	ibuprofen	NOUN
bjos-8666637	116	2	duloxetine	duloxetine	NOUN
bjos-8666637	116	3	1	1	NUM
bjos-8666637	116	4	.	.	PUNCT
bjos-8666637	117	1	dipyrone	dipyrone	NOUN
bjos-8666637	117	2	1	1	NUM
bjos-8666637	117	3	.	.	PUNCT
bjos-8666637	117	4	may	may	AUX
bjos-8666637	117	5	result	result	VERB
bjos-8666637	117	6	in	in	ADP
bjos-8666637	117	7	increased	increase	VERB
bjos-8666637	117	8	risk	risk	NOUN
bjos-8666637	117	9	or	or	CCONJ
bjos-8666637	117	10	severity	severity	NOUN
bjos-8666637	117	11	of	of	ADP
bjos-8666637	117	12	gastrointestinal	gastrointestinal	ADJ
bjos-8666637	117	13	bleeding	bleed	VERB
bjos-8666637	117	14	2	2	NUM
bjos-8666637	117	15	.	.	PUNCT
bjos-8666637	117	16	asa	asa	PROPN
bjos-8666637	117	17	2	2	NUM
bjos-8666637	117	18	-	-	SYM
bjos-8666637	117	19	4	4	NUM
bjos-8666637	117	20	.	.	PUNCT
bjos-8666637	117	21	may	may	AUX
bjos-8666637	117	22	result	result	VERB
bjos-8666637	117	23	in	in	ADP
bjos-8666637	117	24	an	an	DET
bjos-8666637	117	25	increased	increase	VERB
bjos-8666637	117	26	risk	risk	NOUN
bjos-8666637	117	27	of	of	ADP
bjos-8666637	117	28	bleeding3	bleeding3	PROPN
bjos-8666637	117	29	.	.	PUNCT
bjos-8666637	118	1	diclofenac	diclofenac	ADJ
bjos-8666637	118	2	sodium	sodium	NOUN
bjos-8666637	118	3	4	4	NUM
bjos-8666637	118	4	.	.	PUNCT
bjos-8666637	119	1	ibuprofen	ibuprofen	PROPN
bjos-8666637	119	2	5	5	NUM
bjos-8666637	119	3	.	.	PUNCT
bjos-8666637	119	4	codeine	codeine	PROPN
bjos-8666637	119	5	5	5	NUM
bjos-8666637	119	6	.	.	PUNCT
bjos-8666637	120	1	may	may	AUX
bjos-8666637	120	2	result	result	VERB
bjos-8666637	120	3	in	in	ADP
bjos-8666637	120	4	an	an	DET
bjos-8666637	120	5	increased	increase	VERB
bjos-8666637	120	6	risk	risk	NOUN
bjos-8666637	120	7	of	of	ADP
bjos-8666637	120	8	serotonin	serotonin	NOUN
bjos-8666637	120	9	syndrome	syndrome	NOUN
bjos-8666637	120	10	increased	increase	VERB
bjos-8666637	120	11	codeine	codeine	NOUN
bjos-8666637	120	12	plasma	plasma	NOUN
bjos-8666637	120	13	concentrations	concentration	NOUN
bjos-8666637	120	14	and	and	CCONJ
bjos-8666637	120	15	reduces	reduce	VERB
bjos-8666637	120	16	plasma	plasma	NOUN
bjos-8666637	120	17	concentrations	concentration	NOUN
bjos-8666637	120	18	of	of	ADP
bjos-8666637	120	19	the	the	DET
bjos-8666637	120	20	active	active	ADJ
bjos-8666637	120	21	metabolite	metabolite	NOUN
bjos-8666637	120	22	dipyrone	dipyrone	NOUN
bjos-8666637	120	23	1	1	X
bjos-8666637	120	24	.	.	PUNCT
bjos-8666637	121	1	dexamethasone	dexamethasone	NOUN
bjos-8666637	121	2	1	1	NUM
bjos-8666637	121	3	.	.	PUNCT
bjos-8666637	121	4	may	may	AUX
bjos-8666637	121	5	result	result	VERB
bjos-8666637	121	6	in	in	ADP
bjos-8666637	121	7	increased	increase	VERB
bjos-8666637	121	8	risk	risk	NOUN
bjos-8666637	121	9	or	or	CCONJ
bjos-8666637	121	10	severity	severity	NOUN
bjos-8666637	121	11	of	of	ADP
bjos-8666637	121	12	gastrointestinal	gastrointestinal	ADJ
bjos-8666637	121	13	irritation	irritation	NOUN
bjos-8666637	121	14	hctz	hctz	NOUN
bjos-8666637	121	15	1	1	NUM
bjos-8666637	121	16	.	.	PUNCT
bjos-8666637	122	1	dipyrone	dipyrone	NOUN
bjos-8666637	122	2	1	1	NUM
bjos-8666637	122	3	.	.	PUNCT
bjos-8666637	122	4	may	may	AUX
bjos-8666637	122	5	result	result	VERB
bjos-8666637	122	6	in	in	ADP
bjos-8666637	122	7	decreased	decrease	VERB
bjos-8666637	122	8	hydrochlorothiazide	hydrochlorothiazide	PROPN
bjos-8666637	122	9	therapeutic	therapeutic	ADJ
bjos-8666637	122	10	efficacy	efficacy	NOUN
bjos-8666637	122	11	2	2	NUM
bjos-8666637	122	12	.	.	PUNCT
bjos-8666637	122	13	asa	asa	PROPN
bjos-8666637	122	14	2	2	NUM
bjos-8666637	122	15	-	-	SYM
bjos-8666637	122	16	4	4	NUM
bjos-8666637	122	17	.	.	PUNCT
bjos-8666637	123	1	may	may	AUX
bjos-8666637	123	2	result	result	VERB
bjos-8666637	123	3	in	in	ADP
bjos-8666637	123	4	reduced	reduced	ADJ
bjos-8666637	123	5	diuretic	diuretic	ADJ
bjos-8666637	123	6	effectiveness	effectiveness	NOUN
bjos-8666637	123	7	and	and	CCONJ
bjos-8666637	123	8	possible	possible	ADJ
bjos-8666637	123	9	nephrotoxicity3	nephrotoxicity3	PROPN
bjos-8666637	123	10	.	.	PUNCT
bjos-8666637	124	1	diclofenac	diclofenac	ADJ
bjos-8666637	124	2	sodium	sodium	NOUN
bjos-8666637	124	3	4	4	NUM
bjos-8666637	124	4	.	.	PUNCT
bjos-8666637	125	1	ibuprofen	ibuprofen	NOUN
bjos-8666637	125	2	indapamide	indapamide	PROPN
bjos-8666637	125	3	1	1	NUM
bjos-8666637	125	4	.	.	PUNCT
bjos-8666637	125	5	dipyrone	dipyrone	NOUN
bjos-8666637	125	6	1	1	NUM
bjos-8666637	125	7	.	.	PUNCT
bjos-8666637	125	8	may	may	AUX
bjos-8666637	125	9	result	result	VERB
bjos-8666637	125	10	in	in	ADP
bjos-8666637	125	11	decreased	decrease	VERB
bjos-8666637	125	12	indapamide	indapamide	ADP
bjos-8666637	125	13	therapeutic	therapeutic	ADJ
bjos-8666637	125	14	efficacy	efficacy	NOUN
bjos-8666637	125	15	2	2	NUM
bjos-8666637	125	16	.	.	PUNCT
bjos-8666637	125	17	asa	asa	PROPN
bjos-8666637	125	18	2	2	NUM
bjos-8666637	125	19	-	-	SYM
bjos-8666637	125	20	4	4	NUM
bjos-8666637	125	21	.	.	PUNCT
bjos-8666637	125	22	may	may	AUX
bjos-8666637	125	23	result	result	VERB
bjos-8666637	125	24	in	in	ADP
bjos-8666637	125	25	reduced	reduced	ADJ
bjos-8666637	125	26	diuretic	diuretic	ADJ
bjos-8666637	125	27	effectiveness	effectiveness	NOUN
bjos-8666637	125	28	and	and	CCONJ
bjos-8666637	125	29	possible	possible	ADJ
bjos-8666637	125	30	nephrotoxicity3	nephrotoxicity3	PROPN
bjos-8666637	125	31	.	.	PUNCT
bjos-8666637	126	1	diclofenac	diclofenac	ADJ
bjos-8666637	126	2	sodium	sodium	NOUN
bjos-8666637	126	3	4	4	NUM
bjos-8666637	126	4	.	.	PUNCT
bjos-8666637	127	1	ibuprofen	ibuprofen	PROPN
bjos-8666637	127	2	losartan	losartan	PROPN
bjos-8666637	127	3	1	1	NUM
bjos-8666637	127	4	.	.	PUNCT
bjos-8666637	127	5	asa	asa	PROPN
bjos-8666637	127	6	1	1	NUM
bjos-8666637	127	7	-	-	SYM
bjos-8666637	127	8	3	3	NUM
bjos-8666637	127	9	.	.	PUNCT
bjos-8666637	127	10	may	may	AUX
bjos-8666637	127	11	result	result	VERB
bjos-8666637	127	12	in	in	ADP
bjos-8666637	127	13	renal	renal	ADJ
bjos-8666637	127	14	dysfunction	dysfunction	NOUN
bjos-8666637	127	15	and/or	and/or	CCONJ
bjos-8666637	127	16	increased	increase	VERB
bjos-8666637	127	17	blood	blood	NOUN
bjos-8666637	127	18	pressure2	pressure2	PROPN
bjos-8666637	127	19	.	.	PUNCT
bjos-8666637	128	1	diclofenac	diclofenac	ADJ
bjos-8666637	128	2	sodium	sodium	NOUN
bjos-8666637	128	3	3	3	X
bjos-8666637	128	4	.	.	PUNCT
bjos-8666637	129	1	ibuprofen	ibuprofen	PROPN
bjos-8666637	129	2	mirtazapine	mirtazapine	PROPN
bjos-8666637	129	3	1	1	NUM
bjos-8666637	129	4	.	.	PUNCT
bjos-8666637	129	5	diazepam	diazepam	VERB
bjos-8666637	129	6	1	1	NUM
bjos-8666637	129	7	.	.	PUNCT
bjos-8666637	130	1	may	may	AUX
bjos-8666637	130	2	result	result	VERB
bjos-8666637	130	3	in	in	ADP
bjos-8666637	130	4	an	an	DET
bjos-8666637	130	5	increased	increase	VERB
bjos-8666637	130	6	risk	risk	NOUN
bjos-8666637	130	7	of	of	ADP
bjos-8666637	130	8	somnolence	somnolence	NOUN
bjos-8666637	130	9	2	2	NUM
bjos-8666637	130	10	.	.	PUNCT
bjos-8666637	130	11	fluconazole	fluconazole	NOUN
bjos-8666637	130	12	2	2	NUM
bjos-8666637	130	13	.	.	PUNCT
bjos-8666637	130	14	may	may	AUX
bjos-8666637	130	15	result	result	VERB
bjos-8666637	130	16	in	in	ADP
bjos-8666637	130	17	increased	increase	VERB
bjos-8666637	130	18	mirtazapine	mirtazapine	NOUN
bjos-8666637	130	19	plasma	plasma	NOUN
bjos-8666637	130	20	concentrations	concentration	NOUN
bjos-8666637	130	21	and	and	CCONJ
bjos-8666637	130	22	increased	increase	VERB
bjos-8666637	130	23	risk	risk	NOUN
bjos-8666637	130	24	of	of	ADP
bjos-8666637	130	25	qt	qt	NOUN
bjos-8666637	130	26	-	-	PUNCT
bjos-8666637	130	27	interval	interval	NOUN
bjos-8666637	130	28	prolongation	prolongation	NOUN
bjos-8666637	130	29	and	and	CCONJ
bjos-8666637	130	30	ventricular	ventricular	ADJ
bjos-8666637	130	31	arrhythmias	arrhythmia	NOUN
bjos-8666637	130	32	omeprazole	omeprazole	ADJ
bjos-8666637	130	33	1	1	NUM
bjos-8666637	130	34	.	.	PUNCT
bjos-8666637	131	1	diazepam	diazepam	VERB
bjos-8666637	131	2	1	1	NUM
bjos-8666637	131	3	.	.	PUNCT
bjos-8666637	132	1	may	may	AUX
bjos-8666637	132	2	result	result	VERB
bjos-8666637	132	3	in	in	ADP
bjos-8666637	132	4	enhanced	enhanced	ADJ
bjos-8666637	132	5	and	and	CCONJ
bjos-8666637	132	6	prolonged	prolonged	ADJ
bjos-8666637	132	7	diazepam	diazepam	NOUN
bjos-8666637	132	8	effects	effect	NOUN
bjos-8666637	132	9	2	2	NUM
bjos-8666637	132	10	.	.	PUNCT
bjos-8666637	132	11	fluconazole	fluconazole	NOUN
bjos-8666637	132	12	2	2	NUM
bjos-8666637	132	13	.	.	PUNCT
bjos-8666637	132	14	may	may	AUX
bjos-8666637	132	15	result	result	VERB
bjos-8666637	132	16	in	in	ADP
bjos-8666637	132	17	increased	increase	VERB
bjos-8666637	132	18	plasma	plasma	NOUN
bjos-8666637	132	19	concentrations	concentration	NOUN
bjos-8666637	132	20	of	of	ADP
bjos-8666637	132	21	omeprazole	omeprazole	ADJ
bjos-8666637	132	22	acetaminophen	acetaminophen	NOUN
bjos-8666637	132	23	1	1	X
bjos-8666637	132	24	.	.	X
bjos-8666637	132	25	asa	asa	PROPN
bjos-8666637	132	26	1	1	NUM
bjos-8666637	132	27	.	.	PUNCT
bjos-8666637	132	28	may	may	AUX
bjos-8666637	132	29	result	result	VERB
bjos-8666637	132	30	in	in	ADP
bjos-8666637	132	31	an	an	DET
bjos-8666637	132	32	increased	increase	VERB
bjos-8666637	132	33	risk	risk	NOUN
bjos-8666637	132	34	of	of	ADP
bjos-8666637	132	35	bleeding	bleed	VERB
bjos-8666637	132	36	continue	continue	VERB
bjos-8666637	132	37	8	8	NUM
bjos-8666637	132	38	guimarães	guimarães	NOUN
bjos-8666637	132	39	et	et	PROPN
bjos-8666637	133	1	al	al	PROPN
bjos-8666637	133	2	.	.	PROPN
bjos-8666637	133	3	braz	braz	PROPN
bjos-8666637	133	4	j	j	PROPN
bjos-8666637	133	5	oral	oral	PROPN
bjos-8666637	133	6	sci	sci	PROPN
bjos-8666637	133	7	.	.	PUNCT
bjos-8666637	134	1	2023;22	2023;22	NUM
bjos-8666637	134	2	:	:	PUNCT
bjos-8666637	134	3	e236637	e236637	ADJ
bjos-8666637	134	4	continuation	continuation	NOUN
bjos-8666637	134	5	prednisone	prednisone	NOUN
bjos-8666637	134	6	1	1	NUM
bjos-8666637	134	7	.	.	PUNCT
bjos-8666637	134	8	asa	asa	PROPN
bjos-8666637	134	9	1	1	NUM
bjos-8666637	134	10	.	.	PUNCT
bjos-8666637	134	11	may	may	AUX
bjos-8666637	134	12	result	result	VERB
bjos-8666637	134	13	in	in	ADP
bjos-8666637	134	14	an	an	DET
bjos-8666637	134	15	increased	increase	VERB
bjos-8666637	134	16	risk	risk	NOUN
bjos-8666637	134	17	of	of	ADP
bjos-8666637	134	18	gastrointestinal	gastrointestinal	ADJ
bjos-8666637	134	19	ulceration	ulceration	NOUN
bjos-8666637	134	20	and	and	CCONJ
bjos-8666637	134	21	lower	low	ADJ
bjos-8666637	134	22	aspirin	aspirin	NOUN
bjos-8666637	134	23	serum	serum	NOUN
bjos-8666637	134	24	concentrations	concentration	NOUN
bjos-8666637	134	25	2	2	NUM
bjos-8666637	134	26	.	.	PUNCT
bjos-8666637	134	27	diclofenac	diclofenac	NOUN
bjos-8666637	134	28	sodium	sodium	NOUN
bjos-8666637	134	29	2	2	NUM
bjos-8666637	134	30	-	-	SYM
bjos-8666637	134	31	3	3	NUM
bjos-8666637	134	32	.	.	PUNCT
bjos-8666637	134	33	may	may	AUX
bjos-8666637	134	34	result	result	VERB
bjos-8666637	134	35	in	in	ADP
bjos-8666637	134	36	an	an	DET
bjos-8666637	134	37	increased	increase	VERB
bjos-8666637	134	38	risk	risk	NOUN
bjos-8666637	134	39	of	of	ADP
bjos-8666637	134	40	a	a	DET
bjos-8666637	134	41	gastrointestinal	gastrointestinal	ADJ
bjos-8666637	134	42	ulcer	ulcer	NOUN
bjos-8666637	134	43	or	or	CCONJ
bjos-8666637	134	44	bleeding3	bleeding3	NOUN
bjos-8666637	134	45	.	.	PUNCT
bjos-8666637	135	1	ibuprofen	ibuprofen	PROPN
bjos-8666637	135	2	4	4	NUM
bjos-8666637	135	3	.	.	PUNCT
bjos-8666637	135	4	fluconazole	fluconazole	NOUN
bjos-8666637	135	5	4	4	NUM
bjos-8666637	135	6	.	.	PUNCT
bjos-8666637	135	7	may	may	AUX
bjos-8666637	135	8	result	result	VERB
bjos-8666637	135	9	in	in	ADP
bjos-8666637	135	10	a	a	DET
bjos-8666637	135	11	decrease	decrease	NOUN
bjos-8666637	135	12	in	in	ADP
bjos-8666637	135	13	the	the	DET
bjos-8666637	135	14	metabolic	metabolic	NOUN
bjos-8666637	135	15	degradation	degradation	NOUN
bjos-8666637	135	16	of	of	ADP
bjos-8666637	135	17	prednisone	prednisone	NOUN
bjos-8666637	135	18	and	and	CCONJ
bjos-8666637	135	19	an	an	DET
bjos-8666637	135	20	increase	increase	NOUN
bjos-8666637	135	21	in	in	ADP
bjos-8666637	135	22	prednisone	prednisone	PROPN
bjos-8666637	135	23	efficacy	efficacy	NOUN
bjos-8666637	135	24	rosuvastatin	rosuvastatin	NOUN
bjos-8666637	135	25	1	1	NUM
bjos-8666637	135	26	.	.	PUNCT
bjos-8666637	135	27	fluconazole	fluconazole	NOUN
bjos-8666637	135	28	1	1	NUM
bjos-8666637	135	29	.	.	PUNCT
bjos-8666637	135	30	may	may	AUX
bjos-8666637	135	31	result	result	VERB
bjos-8666637	135	32	in	in	ADP
bjos-8666637	135	33	increased	increase	VERB
bjos-8666637	135	34	rosuvastatin	rosuvastatin	ADJ
bjos-8666637	135	35	exposure	exposure	NOUN
bjos-8666637	135	36	and	and	CCONJ
bjos-8666637	135	37	an	an	DET
bjos-8666637	135	38	increased	increase	VERB
bjos-8666637	135	39	risk	risk	NOUN
bjos-8666637	135	40	of	of	ADP
bjos-8666637	135	41	myopathy	myopathy	ADJ
bjos-8666637	135	42	or	or	CCONJ
bjos-8666637	135	43	rhabdomyolysis	rhabdomyolysis	NOUN
bjos-8666637	136	1	simvastatin	simvastatin	NOUN
bjos-8666637	136	2	1	1	NUM
bjos-8666637	136	3	.	.	PUNCT
bjos-8666637	136	4	codeine	codeine	PROPN
bjos-8666637	136	5	1	1	NUM
bjos-8666637	136	6	.	.	PUNCT
bjos-8666637	136	7	may	may	AUX
bjos-8666637	136	8	result	result	VERB
bjos-8666637	136	9	in	in	ADP
bjos-8666637	136	10	decreased	decrease	VERB
bjos-8666637	136	11	simvastatin	simvastatin	ADJ
bjos-8666637	136	12	metabolism	metabolism	NOUN
bjos-8666637	136	13	2	2	NUM
bjos-8666637	136	14	.	.	X
bjos-8666637	136	15	erythromycin	erythromycin	NOUN
bjos-8666637	136	16	2	2	NUM
bjos-8666637	136	17	.	.	PUNCT
bjos-8666637	136	18	may	may	AUX
bjos-8666637	136	19	result	result	VERB
bjos-8666637	136	20	in	in	ADP
bjos-8666637	136	21	an	an	DET
bjos-8666637	136	22	increased	increase	VERB
bjos-8666637	136	23	risk	risk	NOUN
bjos-8666637	136	24	of	of	ADP
bjos-8666637	136	25	myopathy	myopathy	ADJ
bjos-8666637	136	26	or	or	CCONJ
bjos-8666637	136	27	rhabdomyolysis	rhabdomyolysis	NOUN
bjos-8666637	136	28	3	3	NUM
bjos-8666637	136	29	.	.	X
bjos-8666637	136	30	azithromycin	azithromycin	PROPN
bjos-8666637	136	31	3	3	NUM
bjos-8666637	136	32	.	.	PUNCT
bjos-8666637	136	33	may	may	AUX
bjos-8666637	136	34	result	result	VERB
bjos-8666637	136	35	in	in	ADP
bjos-8666637	136	36	an	an	DET
bjos-8666637	136	37	increased	increase	VERB
bjos-8666637	136	38	risk	risk	NOUN
bjos-8666637	136	39	of	of	ADP
bjos-8666637	136	40	rhabdomyolysis	rhabdomyolysis	NOUN
bjos-8666637	136	41	table	table	NOUN
bjos-8666637	136	42	3	3	NUM
bjos-8666637	136	43	.	.	PUNCT
bjos-8666637	136	44	binomial	binomial	ADJ
bjos-8666637	136	45	logistic	logistic	ADJ
bjos-8666637	136	46	regression	regression	NOUN
bjos-8666637	136	47	model	model	NOUN
bjos-8666637	136	48	between	between	ADP
bjos-8666637	136	49	xerostomia	xerostomia	PROPN
bjos-8666637	136	50	and	and	CCONJ
bjos-8666637	136	51	the	the	DET
bjos-8666637	136	52	drugs	drug	NOUN
bjos-8666637	136	53	most	most	ADV
bjos-8666637	136	54	used	use	VERB
bjos-8666637	136	55	by	by	ADP
bjos-8666637	136	56	the	the	DET
bjos-8666637	136	57	participants	participant	NOUN
bjos-8666637	136	58	.	.	PUNCT
bjos-8666637	137	1	drugs	drug	NOUN
bjos-8666637	137	2	classes	class	NOUN
bjos-8666637	137	3	estimate	estimate	VERB
bjos-8666637	137	4	standard	standard	ADJ
bjos-8666637	137	5	error	error	NOUN
bjos-8666637	137	6	z1	z1	NOUN
bjos-8666637	137	7	p	p	NOUN
bjos-8666637	137	8	value	value	NOUN
bjos-8666637	137	9	hypoglycemic	hypoglycemic	ADJ
bjos-8666637	137	10	0.188	0.188	NUM
bjos-8666637	137	11	0.597	0.597	NUM
bjos-8666637	137	12	0.31484	0.31484	NUM
bjos-8666637	137	13	0.753	0.753	NUM
bjos-8666637	137	14	antihypertensives	antihypertensive	VERB
bjos-8666637	137	15	1.397	1.397	NUM
bjos-8666637	137	16	0.536	0.536	NUM
bjos-8666637	137	17	2.60448	2.60448	NUM
bjos-8666637	137	18	0.009	0.009	NUM
bjos-8666637	137	19	platelet	platelet	NOUN
bjos-8666637	137	20	antiaggregants	antiaggregant	NOUN
bjos-8666637	137	21	and	and	CCONJ
bjos-8666637	137	22	anticoagulants	anticoagulant	NOUN
bjos-8666637	137	23	-1.414	-1.414	PUNCT
bjos-8666637	137	24	0.777	0.777	NUM
bjos-8666637	137	25	-1.82012	-1.82012	NOUN
bjos-8666637	137	26	0.069	0.069	NUM
bjos-8666637	137	27	antidepressants	antidepressant	NOUN
bjos-8666637	137	28	0.600	0.600	NUM
bjos-8666637	137	29	0.597	0.597	NUM
bjos-8666637	137	30	1.00482	1.00482	NUM
bjos-8666637	137	31	0.315	0.315	NUM
bjos-8666637	137	32	antilipidemics	antilipidemic	NOUN
bjos-8666637	137	33	-0.177	-0.177	PUNCT
bjos-8666637	137	34	0.676	0.676	NUM
bjos-8666637	137	35	-0.26170	-0.26170	NOUN
bjos-8666637	137	36	0.794	0.794	NUM
bjos-8666637	137	37	analgesics	analgesic	NOUN
bjos-8666637	137	38	and	and	CCONJ
bjos-8666637	137	39	nsaids	nsaid	VERB
bjos-8666637	137	40	0.517	0.517	NUM
bjos-8666637	137	41	0.608	0.608	NUM
bjos-8666637	137	42	0.85171	0.85171	NUM
bjos-8666637	137	43	0.394	0.394	NUM
bjos-8666637	137	44	benzodiazepines	benzodiazepine	NOUN
bjos-8666637	137	45	-18.991	-18.991	PUNCT
bjos-8666637	137	46	2452.989	2452.989	NUM
bjos-8666637	137	47	-0.00774	-0.00774	NOUN
bjos-8666637	137	48	0.994	0.994	NUM
bjos-8666637	137	49	others	other	NOUN
bjos-8666637	137	50	0.919	0.919	NUM
bjos-8666637	137	51	0.588	0.588	NUM
bjos-8666637	137	52	1.56239	1.56239	NUM
bjos-8666637	137	53	0.118	0.118	NUM
bjos-8666637	137	54	1z	1z	NOUN
bjos-8666637	137	55	-	-	PUNCT
bjos-8666637	137	56	score	score	NOUN
bjos-8666637	137	57	discussion	discussion	NOUN
bjos-8666637	137	58	the	the	DET
bjos-8666637	137	59	majority	majority	NOUN
bjos-8666637	137	60	of	of	ADP
bjos-8666637	137	61	study	study	NOUN
bjos-8666637	137	62	participants	participant	NOUN
bjos-8666637	137	63	reported	report	VERB
bjos-8666637	137	64	having	have	VERB
bjos-8666637	137	65	xerostomia	xerostomia	NOUN
bjos-8666637	137	66	,	,	PUNCT
bjos-8666637	137	67	which	which	PRON
bjos-8666637	137	68	was	be	AUX
bjos-8666637	137	69	statistically	statistically	ADV
bjos-8666637	137	70	associated	associate	VERB
bjos-8666637	137	71	with	with	ADP
bjos-8666637	137	72	polypharmacy	polypharmacy	NOUN
bjos-8666637	137	73	.	.	PUNCT
bjos-8666637	138	1	therefore	therefore	ADV
bjos-8666637	138	2	,	,	PUNCT
bjos-8666637	138	3	the	the	DET
bjos-8666637	138	4	prevalence	prevalence	NOUN
bjos-8666637	138	5	of	of	ADP
bjos-8666637	138	6	xerostomia	xerostomia	NOUN
bjos-8666637	138	7	was	be	AUX
bjos-8666637	138	8	high	high	ADJ
bjos-8666637	138	9	(	(	PUNCT
bjos-8666637	138	10	62.5	62.5	NUM
bjos-8666637	138	11	%	%	NOUN
bjos-8666637	138	12	)	)	PUNCT
bjos-8666637	138	13	compared	compare	VERB
bjos-8666637	138	14	with	with	ADP
bjos-8666637	138	15	that	that	PRON
bjos-8666637	138	16	of	of	ADP
bjos-8666637	138	17	another	another	DET
bjos-8666637	138	18	study	study	NOUN
bjos-8666637	138	19	,	,	PUNCT
bjos-8666637	138	20	also	also	ADV
bjos-8666637	138	21	conducted	conduct	VERB
bjos-8666637	138	22	in	in	ADP
bjos-8666637	138	23	brazil	brazil	PROPN
bjos-8666637	138	24	,	,	PUNCT
bjos-8666637	138	25	in	in	ADP
bjos-8666637	138	26	which	which	PRON
bjos-8666637	138	27	it	it	PRON
bjos-8666637	138	28	was	be	AUX
bjos-8666637	138	29	prevalent	prevalent	ADJ
bjos-8666637	138	30	in	in	ADP
bjos-8666637	138	31	49	49	NUM
bjos-8666637	138	32	%	%	NOUN
bjos-8666637	138	33	of	of	ADP
bjos-8666637	138	34	non	non	ADJ
bjos-8666637	138	35	-	-	ADJ
bjos-8666637	138	36	institutionalized	institutionalized	ADJ
bjos-8666637	138	37	elderly18	elderly18	NOUN
bjos-8666637	138	38	.	.	PUNCT
bjos-8666637	139	1	a	a	DET
bjos-8666637	139	2	systematic	systematic	ADJ
bjos-8666637	139	3	review	review	NOUN
bjos-8666637	139	4	with	with	ADP
bjos-8666637	139	5	meta	meta	ADJ
bjos-8666637	139	6	-	-	PUNCT
bjos-8666637	139	7	analysis	analysis	NOUN
bjos-8666637	139	8	showed	show	VERB
bjos-8666637	139	9	a	a	DET
bjos-8666637	139	10	prevalence	prevalence	NOUN
bjos-8666637	139	11	of	of	ADP
bjos-8666637	139	12	xerostomia	xerostomia	NOUN
bjos-8666637	139	13	of	of	ADP
bjos-8666637	139	14	22	22	NUM
bjos-8666637	139	15	%	%	NOUN
bjos-8666637	139	16	in	in	ADP
bjos-8666637	139	17	adults	adult	NOUN
bjos-8666637	139	18	,	,	PUNCT
bjos-8666637	139	19	and	and	CCONJ
bjos-8666637	139	20	that	that	SCONJ
bjos-8666637	139	21	this	this	DET
bjos-8666637	139	22	percentage	percentage	NOUN
bjos-8666637	139	23	was	be	AUX
bjos-8666637	139	24	higher	high	ADJ
bjos-8666637	139	25	in	in	ADP
bjos-8666637	139	26	the	the	DET
bjos-8666637	139	27	elderly19	elderly19	NOUN
bjos-8666637	139	28	due	due	ADP
bjos-8666637	139	29	to	to	ADP
bjos-8666637	139	30	the	the	DET
bjos-8666637	139	31	aging	age	VERB
bjos-8666637	139	32	process	process	NOUN
bjos-8666637	139	33	predisposed	predispose	VERB
bjos-8666637	139	34	to	to	PART
bjos-8666637	139	35	salivary	salivary	VERB
bjos-8666637	139	36	gland	gland	NOUN
bjos-8666637	139	37	agenesis	agenesis	NOUN
bjos-8666637	139	38	,	,	PUNCT
bjos-8666637	139	39	immunological	immunological	ADJ
bjos-8666637	139	40	disorders	disorder	NOUN
bjos-8666637	139	41	such	such	ADJ
bjos-8666637	139	42	as	as	ADP
bjos-8666637	139	43	sjogren	sjogren	PROPN
bjos-8666637	139	44	’s	’s	PART
bjos-8666637	139	45	syndrome	syndrome	NOUN
bjos-8666637	139	46	,	,	PUNCT
bjos-8666637	139	47	metabolic	metabolic	NOUN
bjos-8666637	139	48	disorders	disorder	NOUN
bjos-8666637	139	49	such	such	ADJ
bjos-8666637	139	50	as	as	ADP
bjos-8666637	139	51	diabetes	diabetes	NOUN
bjos-8666637	139	52	mellitus	mellitus	NOUN
bjos-8666637	139	53	and	and	CCONJ
bjos-8666637	139	54	rheumatoid	rheumatoid	VERB
bjos-8666637	139	55	arthritis	arthritis	NOUN
bjos-8666637	139	56	,	,	PUNCT
bjos-8666637	139	57	and	and	CCONJ
bjos-8666637	139	58	use	use	VERB
bjos-8666637	139	59	a	a	DET
bjos-8666637	139	60	lot	lot	NOUN
bjos-8666637	139	61	of	of	ADP
bjos-8666637	139	62	medications	medication	NOUN
bjos-8666637	139	63	7	7	NUM
bjos-8666637	139	64	.	.	X
bjos-8666637	139	65	xerostomia	xerostomia	PROPN
bjos-8666637	139	66	is	be	AUX
bjos-8666637	139	67	a	a	DET
bjos-8666637	139	68	subjective	subjective	ADJ
bjos-8666637	139	69	measure	measure	NOUN
bjos-8666637	139	70	,	,	PUNCT
bjos-8666637	139	71	and	and	CCONJ
bjos-8666637	139	72	its	its	PRON
bjos-8666637	139	73	diagnosis	diagnosis	NOUN
bjos-8666637	139	74	is	be	AUX
bjos-8666637	139	75	often	often	ADV
bjos-8666637	139	76	the	the	DET
bjos-8666637	139	77	patient	patient	NOUN
bjos-8666637	139	78	’s	’s	PART
bjos-8666637	139	79	report10	report10	NOUN
bjos-8666637	139	80	.	.	PUNCT
bjos-8666637	140	1	methods	method	NOUN
bjos-8666637	140	2	to	to	PART
bjos-8666637	140	3	assess	assess	VERB
bjos-8666637	140	4	the	the	DET
bjos-8666637	140	5	quantity	quantity	NOUN
bjos-8666637	140	6	and	and	CCONJ
bjos-8666637	140	7	quality	quality	NOUN
bjos-8666637	140	8	of	of	ADP
bjos-8666637	140	9	saliva	saliva	NOUN
bjos-8666637	140	10	can	can	AUX
bjos-8666637	140	11	be	be	AUX
bjos-8666637	140	12	used	use	VERB
bjos-8666637	140	13	simultaneously	simultaneously	ADV
bjos-8666637	140	14	,	,	PUNCT
bjos-8666637	141	1	9	9	NUM
bjos-8666637	141	2	guimarães	guimarães	NOUN
bjos-8666637	141	3	et	et	PROPN
bjos-8666637	141	4	al	al	PROPN
bjos-8666637	141	5	.	.	PROPN
bjos-8666637	141	6	braz	braz	PROPN
bjos-8666637	141	7	j	j	PROPN
bjos-8666637	141	8	oral	oral	PROPN
bjos-8666637	141	9	sci	sci	PROPN
bjos-8666637	141	10	.	.	PUNCT
bjos-8666637	142	1	2023;22	2023;22	NUM
bjos-8666637	142	2	:	:	PUNCT
bjos-8666637	142	3	e236637	e236637	NUM
bjos-8666637	142	4	such	such	ADJ
bjos-8666637	142	5	as	as	ADP
bjos-8666637	142	6	chewing	chew	VERB
bjos-8666637	142	7	gum	gum	NOUN
bjos-8666637	142	8	test	test	NOUN
bjos-8666637	142	9	,	,	PUNCT
bjos-8666637	142	10	paraffin	paraffin	NOUN
bjos-8666637	142	11	,	,	PUNCT
bjos-8666637	142	12	or	or	CCONJ
bjos-8666637	142	13	saxon	saxon	PROPN
bjos-8666637	142	14	test7	test7	NOUN
bjos-8666637	142	15	.	.	PUNCT
bjos-8666637	143	1	in	in	ADP
bjos-8666637	143	2	addition	addition	NOUN
bjos-8666637	143	3	,	,	PUNCT
bjos-8666637	143	4	scintigraphy	scintigraphy	NOUN
bjos-8666637	143	5	,	,	PUNCT
bjos-8666637	143	6	sialography	sialography	NOUN
bjos-8666637	143	7	,	,	PUNCT
bjos-8666637	143	8	and	and	CCONJ
bjos-8666637	143	9	minor	minor	ADJ
bjos-8666637	143	10	salivary	salivary	ADJ
bjos-8666637	143	11	gland	gland	NOUN
bjos-8666637	143	12	biopsy	biopsy	NOUN
bjos-8666637	143	13	can	can	AUX
bjos-8666637	143	14	help	help	VERB
bjos-8666637	143	15	gland	gland	VERB
bjos-8666637	143	16	dysfunctions	dysfunction	NOUN
bjos-8666637	143	17	diagnosis7,8	diagnosis7,8	PROPN
bjos-8666637	143	18	.	.	PUNCT
bjos-8666637	144	1	it	it	PRON
bjos-8666637	144	2	is	be	AUX
bjos-8666637	144	3	essential	essential	ADJ
bjos-8666637	144	4	to	to	PART
bjos-8666637	144	5	emphasize	emphasize	VERB
bjos-8666637	144	6	the	the	DET
bjos-8666637	144	7	importance	importance	NOUN
bjos-8666637	144	8	of	of	ADP
bjos-8666637	144	9	a	a	DET
bjos-8666637	144	10	multidisciplinary	multidisciplinary	ADJ
bjos-8666637	144	11	approach	approach	NOUN
bjos-8666637	144	12	to	to	ADP
bjos-8666637	144	13	the	the	DET
bjos-8666637	144	14	elderly	elderly	ADJ
bjos-8666637	144	15	with	with	ADP
bjos-8666637	144	16	xerostomia	xerostomia	PROPN
bjos-8666637	144	17	with	with	ADP
bjos-8666637	144	18	the	the	DET
bjos-8666637	144	19	purpose	purpose	NOUN
bjos-8666637	144	20	of	of	ADP
bjos-8666637	144	21	verifying	verify	VERB
bjos-8666637	144	22	the	the	DET
bjos-8666637	144	23	etiology	etiology	NOUN
bjos-8666637	144	24	and	and	CCONJ
bjos-8666637	144	25	implementing	implement	VERB
bjos-8666637	144	26	the	the	DET
bjos-8666637	144	27	most	most	ADV
bjos-8666637	144	28	appropriate	appropriate	ADJ
bjos-8666637	144	29	treatment	treatment	NOUN
bjos-8666637	144	30	for	for	ADP
bjos-8666637	144	31	this	this	DET
bjos-8666637	144	32	situation10,11	situation10,11	PROPN
bjos-8666637	144	33	.	.	PUNCT
bjos-8666637	145	1	the	the	DET
bjos-8666637	145	2	doctor	doctor	NOUN
bjos-8666637	145	3	and	and	CCONJ
bjos-8666637	145	4	the	the	DET
bjos-8666637	145	5	pharmaceutical	pharmaceutical	NOUN
bjos-8666637	145	6	responsible	responsible	ADJ
bjos-8666637	145	7	can	can	AUX
bjos-8666637	145	8	help	help	VERB
bjos-8666637	145	9	in	in	ADP
bjos-8666637	145	10	the	the	DET
bjos-8666637	145	11	alternative	alternative	ADJ
bjos-8666637	145	12	medications	medication	NOUN
bjos-8666637	145	13	to	to	PART
bjos-8666637	145	14	improve	improve	VERB
bjos-8666637	145	15	the	the	DET
bjos-8666637	145	16	dry	dry	ADJ
bjos-8666637	145	17	mouth	mouth	NOUN
bjos-8666637	145	18	sensation	sensation	NOUN
bjos-8666637	145	19	;	;	PUNCT
bjos-8666637	145	20	use	use	NOUN
bjos-8666637	145	21	of	of	ADP
bjos-8666637	145	22	chewing	chew	VERB
bjos-8666637	145	23	gums	gum	NOUN
bjos-8666637	145	24	and	and	CCONJ
bjos-8666637	145	25	substitutes	substitute	NOUN
bjos-8666637	145	26	of	of	ADP
bjos-8666637	145	27	saliva	saliva	NOUN
bjos-8666637	145	28	are	be	AUX
bjos-8666637	145	29	non	non	ADJ
bjos-8666637	145	30	-	-	ADJ
bjos-8666637	145	31	pharmacological	pharmacological	ADJ
bjos-8666637	145	32	alternatives	alternative	NOUN
bjos-8666637	145	33	that	that	PRON
bjos-8666637	145	34	can	can	AUX
bjos-8666637	145	35	relieve	relieve	VERB
bjos-8666637	145	36	the	the	DET
bjos-8666637	145	37	xerostomia8	xerostomia8	PROPN
bjos-8666637	145	38	.	.	PUNCT
bjos-8666637	146	1	our	our	PRON
bjos-8666637	146	2	study	study	NOUN
bjos-8666637	146	3	showed	show	VERB
bjos-8666637	146	4	a	a	DET
bjos-8666637	146	5	low	low	ADJ
bjos-8666637	146	6	prevalence	prevalence	NOUN
bjos-8666637	146	7	of	of	ADP
bjos-8666637	146	8	dysgeusia	dysgeusia	PROPN
bjos-8666637	146	9	(	(	PUNCT
bjos-8666637	146	10	21.1	21.1	NUM
bjos-8666637	146	11	%	%	NOUN
bjos-8666637	146	12	)	)	PUNCT
bjos-8666637	146	13	,	,	PUNCT
bjos-8666637	146	14	similar	similar	ADJ
bjos-8666637	146	15	to	to	ADP
bjos-8666637	146	16	rates	rate	NOUN
bjos-8666637	146	17	in	in	ADP
bjos-8666637	146	18	another	another	DET
bjos-8666637	146	19	brazilian	brazilian	ADJ
bjos-8666637	146	20	study	study	NOUN
bjos-8666637	146	21	,	,	PUNCT
bjos-8666637	146	22	which	which	PRON
bjos-8666637	146	23	found	find	VERB
bjos-8666637	146	24	a	a	DET
bjos-8666637	146	25	prevalence	prevalence	NOUN
bjos-8666637	146	26	of	of	ADP
bjos-8666637	146	27	19.4	19.4	NUM
bjos-8666637	146	28	%	%	NOUN
bjos-8666637	146	29	in	in	ADP
bjos-8666637	146	30	the	the	DET
bjos-8666637	146	31	elderly20	elderly20	NOUN
bjos-8666637	146	32	.	.	PUNCT
bjos-8666637	147	1	dysgeusia	dysgeusia	PROPN
bjos-8666637	147	2	has	have	VERB
bjos-8666637	147	3	a	a	DET
bjos-8666637	147	4	multifactorial	multifactorial	ADJ
bjos-8666637	147	5	etiology	etiology	NOUN
bjos-8666637	147	6	and	and	CCONJ
bjos-8666637	147	7	may	may	AUX
bjos-8666637	147	8	result	result	VERB
bjos-8666637	147	9	from	from	ADP
bjos-8666637	147	10	sensory	sensory	ADJ
bjos-8666637	147	11	and	and	CCONJ
bjos-8666637	147	12	nutritional	nutritional	ADJ
bjos-8666637	147	13	disorders	disorder	NOUN
bjos-8666637	147	14	,	,	PUNCT
bjos-8666637	147	15	medications	medication	NOUN
bjos-8666637	147	16	,	,	PUNCT
bjos-8666637	147	17	and	and	CCONJ
bjos-8666637	147	18	polypharmacy	polypharmacy	NOUN
bjos-8666637	147	19	.	.	PUNCT
bjos-8666637	148	1	furthermore	furthermore	ADV
bjos-8666637	148	2	,	,	PUNCT
bjos-8666637	148	3	it	it	PRON
bjos-8666637	148	4	may	may	AUX
bjos-8666637	148	5	be	be	AUX
bjos-8666637	148	6	related	relate	VERB
bjos-8666637	148	7	to	to	ADP
bjos-8666637	148	8	infections	infection	NOUN
bjos-8666637	148	9	since	since	SCONJ
bjos-8666637	148	10	half	half	NOUN
bjos-8666637	148	11	of	of	ADP
bjos-8666637	148	12	those	those	PRON
bjos-8666637	148	13	infected	infect	VERB
bjos-8666637	148	14	with	with	ADP
bjos-8666637	148	15	sars	sar	NOUN
bjos-8666637	148	16	-	-	PUNCT
bjos-8666637	148	17	cov-2	cov-2	PART
bjos-8666637	148	18	have	have	AUX
bjos-8666637	148	19	experienced	experience	VERB
bjos-8666637	148	20	a	a	DET
bjos-8666637	148	21	loss	loss	NOUN
bjos-8666637	148	22	of	of	ADP
bjos-8666637	148	23	taste21	taste21	NOUN
bjos-8666637	148	24	.	.	PUNCT
bjos-8666637	149	1	dysgeusia	dysgeusia	PROPN
bjos-8666637	149	2	interferes	interfere	VERB
bjos-8666637	149	3	with	with	ADP
bjos-8666637	149	4	the	the	DET
bjos-8666637	149	5	quality	quality	NOUN
bjos-8666637	149	6	of	of	ADP
bjos-8666637	149	7	life	life	NOUN
bjos-8666637	149	8	of	of	ADP
bjos-8666637	149	9	the	the	DET
bjos-8666637	149	10	elderly	elderly	ADJ
bjos-8666637	149	11	,	,	PUNCT
bjos-8666637	149	12	as	as	SCONJ
bjos-8666637	149	13	it	it	PRON
bjos-8666637	149	14	can	can	AUX
bjos-8666637	149	15	cause	cause	VERB
bjos-8666637	149	16	feeding	feeding	NOUN
bjos-8666637	149	17	difficulties	difficulty	NOUN
bjos-8666637	149	18	related	relate	VERB
bjos-8666637	149	19	to	to	ADP
bjos-8666637	149	20	the	the	DET
bjos-8666637	149	21	lack	lack	NOUN
bjos-8666637	149	22	of	of	ADP
bjos-8666637	149	23	perception	perception	NOUN
bjos-8666637	149	24	and	and	CCONJ
bjos-8666637	149	25	taste	taste	VERB
bjos-8666637	149	26	distinction	distinction	NOUN
bjos-8666637	149	27	and	and	CCONJ
bjos-8666637	149	28	consequently	consequently	ADV
bjos-8666637	149	29	lead	lead	VERB
bjos-8666637	149	30	to	to	ADP
bjos-8666637	149	31	weight	weight	NOUN
bjos-8666637	149	32	loss12	loss12	NOUN
bjos-8666637	149	33	.	.	PUNCT
bjos-8666637	150	1	in	in	ADP
bjos-8666637	150	2	both	both	DET
bjos-8666637	150	3	xerostomia	xerostomia	PROPN
bjos-8666637	150	4	and	and	CCONJ
bjos-8666637	150	5	dysgeusia	dysgeusia	PROPN
bjos-8666637	150	6	,	,	PUNCT
bjos-8666637	150	7	polypharmacy	polypharmacy	NOUN
bjos-8666637	150	8	and	and	CCONJ
bjos-8666637	150	9	drug	drug	NOUN
bjos-8666637	150	10	use	use	NOUN
bjos-8666637	150	11	are	be	AUX
bjos-8666637	150	12	common	common	ADJ
bjos-8666637	150	13	causes4,6	causes4,6	PROPN
bjos-8666637	150	14	.	.	PUNCT
bjos-8666637	151	1	in	in	ADP
bjos-8666637	151	2	the	the	DET
bjos-8666637	151	3	present	present	ADJ
bjos-8666637	151	4	study	study	NOUN
bjos-8666637	151	5	,	,	PUNCT
bjos-8666637	151	6	there	there	PRON
bjos-8666637	151	7	was	be	VERB
bjos-8666637	151	8	an	an	DET
bjos-8666637	151	9	association	association	NOUN
bjos-8666637	151	10	between	between	ADP
bjos-8666637	151	11	xerostomia	xerostomia	NOUN
bjos-8666637	151	12	and	and	CCONJ
bjos-8666637	151	13	polypharmacy	polypharmacy	NOUN
bjos-8666637	151	14	(	(	PUNCT
bjos-8666637	151	15	particularly	particularly	ADV
bjos-8666637	151	16	the	the	DET
bjos-8666637	151	17	use	use	NOUN
bjos-8666637	151	18	of	of	ADP
bjos-8666637	151	19	antihypertensive	antihypertensive	ADJ
bjos-8666637	151	20	drugs	drug	NOUN
bjos-8666637	151	21	)	)	PUNCT
bjos-8666637	151	22	,	,	PUNCT
bjos-8666637	151	23	but	but	CCONJ
bjos-8666637	151	24	not	not	PART
bjos-8666637	151	25	between	between	ADP
bjos-8666637	151	26	dysgeusia	dysgeusia	NOUN
bjos-8666637	151	27	and	and	CCONJ
bjos-8666637	151	28	polypharmacy	polypharmacy	NOUN
bjos-8666637	151	29	.	.	PUNCT
bjos-8666637	152	1	previous	previous	ADJ
bjos-8666637	152	2	studies	study	NOUN
bjos-8666637	152	3	have	have	AUX
bjos-8666637	152	4	shown	show	VERB
bjos-8666637	152	5	elevated	elevated	ADJ
bjos-8666637	152	6	rates	rate	NOUN
bjos-8666637	152	7	of	of	ADP
bjos-8666637	152	8	xerostomia	xerostomia	NOUN
bjos-8666637	152	9	associated	associate	VERB
bjos-8666637	152	10	with	with	ADP
bjos-8666637	152	11	polypharmacy	polypharmacy	NOUN
bjos-8666637	152	12	that	that	PRON
bjos-8666637	152	13	included	include	VERB
bjos-8666637	152	14	use	use	NOUN
bjos-8666637	152	15	of	of	ADP
bjos-8666637	152	16	antihypertensives	antihypertensive	NOUN
bjos-8666637	152	17	,	,	PUNCT
bjos-8666637	152	18	anticholinergic	anticholinergic	ADJ
bjos-8666637	152	19	,	,	PUNCT
bjos-8666637	152	20	adrenergic	adrenergic	ADJ
bjos-8666637	152	21	,	,	PUNCT
bjos-8666637	152	22	thyroid	thyroid	NOUN
bjos-8666637	152	23	-	-	PUNCT
bjos-8666637	152	24	stimulating	stimulate	VERB
bjos-8666637	152	25	hormones	hormone	NOUN
bjos-8666637	152	26	,	,	PUNCT
bjos-8666637	152	27	sedative	sedative	ADJ
bjos-8666637	152	28	,	,	PUNCT
bjos-8666637	152	29	hypoglycemic	hypoglycemic	ADJ
bjos-8666637	152	30	,	,	PUNCT
bjos-8666637	152	31	nonsteroidal	nonsteroidal	NOUN
bjos-8666637	152	32	anti	anti	ADJ
bjos-8666637	152	33	-	-	ADJ
bjos-8666637	152	34	inflammatory	inflammatory	ADJ
bjos-8666637	152	35	,	,	PUNCT
bjos-8666637	152	36	corticosteroid	corticosteroid	ADJ
bjos-8666637	152	37	,	,	PUNCT
bjos-8666637	152	38	and	and	CCONJ
bjos-8666637	152	39	antiulcerogenic	antiulcerogenic	ADJ
bjos-8666637	152	40	hormones18	hormones18	NOUN
bjos-8666637	152	41	.	.	PUNCT
bjos-8666637	153	1	although	although	SCONJ
bjos-8666637	153	2	the	the	DET
bjos-8666637	153	3	literature	literature	NOUN
bjos-8666637	153	4	has	have	AUX
bjos-8666637	153	5	previously	previously	ADV
bjos-8666637	153	6	included	include	VERB
bjos-8666637	153	7	the	the	DET
bjos-8666637	153	8	association	association	NOUN
bjos-8666637	153	9	of	of	ADP
bjos-8666637	153	10	dysgeusia	dysgeusia	PROPN
bjos-8666637	153	11	with	with	ADP
bjos-8666637	153	12	various	various	ADJ
bjos-8666637	153	13	medications	medication	NOUN
bjos-8666637	153	14	,	,	PUNCT
bjos-8666637	153	15	such	such	ADJ
bjos-8666637	153	16	as	as	ADP
bjos-8666637	153	17	antimicrobials	antimicrobial	NOUN
bjos-8666637	153	18	,	,	PUNCT
bjos-8666637	153	19	angiotensin	angiotensin	NOUN
bjos-8666637	153	20	-	-	PUNCT
bjos-8666637	153	21	converting	convert	VERB
bjos-8666637	153	22	enzyme	enzyme	NOUN
bjos-8666637	153	23	inhibitors	inhibitor	NOUN
bjos-8666637	153	24	,	,	PUNCT
bjos-8666637	153	25	chemotherapeutic	chemotherapeutic	ADJ
bjos-8666637	153	26	agents	agent	NOUN
bjos-8666637	153	27	,	,	PUNCT
bjos-8666637	153	28	among	among	ADP
bjos-8666637	153	29	others12	others12	NOUN
bjos-8666637	153	30	,	,	PUNCT
bjos-8666637	153	31	in	in	ADP
bjos-8666637	153	32	this	this	DET
bjos-8666637	153	33	study	study	NOUN
bjos-8666637	153	34	,	,	PUNCT
bjos-8666637	153	35	no	no	DET
bjos-8666637	153	36	drug	drug	NOUN
bjos-8666637	153	37	classes	class	NOUN
bjos-8666637	153	38	were	be	AUX
bjos-8666637	153	39	found	find	VERB
bjos-8666637	153	40	to	to	PART
bjos-8666637	153	41	be	be	AUX
bjos-8666637	153	42	associated	associate	VERB
bjos-8666637	153	43	with	with	ADP
bjos-8666637	153	44	dysgeusia	dysgeusia	PROPN
bjos-8666637	153	45	.	.	PUNCT
bjos-8666637	154	1	the	the	DET
bjos-8666637	154	2	medications	medication	NOUN
bjos-8666637	154	3	most	most	ADV
bjos-8666637	154	4	used	use	VERB
bjos-8666637	154	5	by	by	ADP
bjos-8666637	154	6	the	the	DET
bjos-8666637	154	7	participants	participant	NOUN
bjos-8666637	154	8	were	be	AUX
bjos-8666637	154	9	antihypertensives	antihypertensive	NOUN
bjos-8666637	154	10	(	(	PUNCT
bjos-8666637	154	11	losartan	losartan	ADJ
bjos-8666637	154	12	and	and	CCONJ
bjos-8666637	154	13	amlodipine	amlodipine	ADJ
bjos-8666637	154	14	)	)	PUNCT
bjos-8666637	154	15	and	and	CCONJ
bjos-8666637	154	16	hypoglycemic	hypoglycemic	ADJ
bjos-8666637	154	17	agents	agent	NOUN
bjos-8666637	154	18	(	(	PUNCT
bjos-8666637	154	19	metformin	metformin	NOUN
bjos-8666637	154	20	)	)	PUNCT
bjos-8666637	154	21	,	,	PUNCT
bjos-8666637	154	22	followed	follow	VERB
bjos-8666637	154	23	by	by	ADP
bjos-8666637	154	24	antidepressants	antidepressant	NOUN
bjos-8666637	154	25	.	.	PUNCT
bjos-8666637	155	1	a	a	DET
bjos-8666637	155	2	cohort	cohort	NOUN
bjos-8666637	155	3	conducted	conduct	VERB
bjos-8666637	155	4	in	in	ADP
bjos-8666637	155	5	the	the	DET
bjos-8666637	155	6	united	united	PROPN
bjos-8666637	155	7	states	states	PROPN
bjos-8666637	155	8	showed	show	VERB
bjos-8666637	155	9	that	that	SCONJ
bjos-8666637	155	10	the	the	DET
bjos-8666637	155	11	drug	drug	NOUN
bjos-8666637	155	12	classes	class	NOUN
bjos-8666637	155	13	most	most	ADV
bjos-8666637	155	14	used	use	VERB
bjos-8666637	155	15	among	among	ADP
bjos-8666637	155	16	the	the	DET
bjos-8666637	155	17	population	population	NOUN
bjos-8666637	155	18	were	be	AUX
bjos-8666637	155	19	antihypertensives	antihypertensive	NOUN
bjos-8666637	155	20	,	,	PUNCT
bjos-8666637	155	21	analgesics	analgesic	NOUN
bjos-8666637	155	22	,	,	PUNCT
bjos-8666637	155	23	statins	statin	NOUN
bjos-8666637	155	24	,	,	PUNCT
bjos-8666637	155	25	anticholinergics	anticholinergic	NOUN
bjos-8666637	155	26	,	,	PUNCT
bjos-8666637	155	27	psychiatric	psychiatric	ADJ
bjos-8666637	155	28	drugs	drug	NOUN
bjos-8666637	155	29	,	,	PUNCT
bjos-8666637	155	30	and	and	CCONJ
bjos-8666637	155	31	antibiotics6	antibiotics6	PROPN
bjos-8666637	155	32	.	.	PUNCT
bjos-8666637	156	1	a	a	DET
bjos-8666637	156	2	brazilian	brazilian	ADJ
bjos-8666637	156	3	study	study	NOUN
bjos-8666637	156	4	also	also	ADV
bjos-8666637	156	5	highlighted	highlight	VERB
bjos-8666637	156	6	antihypertensives	antihypertensive	NOUN
bjos-8666637	156	7	,	,	PUNCT
bjos-8666637	156	8	used	use	VERB
bjos-8666637	156	9	by	by	ADP
bjos-8666637	156	10	70.9	70.9	NUM
bjos-8666637	156	11	%	%	NOUN
bjos-8666637	156	12	of	of	ADP
bjos-8666637	156	13	the	the	DET
bjos-8666637	156	14	elderly	elderly	ADJ
bjos-8666637	156	15	,	,	PUNCT
bjos-8666637	156	16	followed	follow	VERB
bjos-8666637	156	17	by	by	ADP
bjos-8666637	156	18	antilipemic	antilipemic	ADJ
bjos-8666637	156	19	agents	agent	NOUN
bjos-8666637	156	20	,	,	PUNCT
bjos-8666637	156	21	antacids	antacid	NOUN
bjos-8666637	156	22	,	,	PUNCT
bjos-8666637	156	23	hypoglycemic	hypoglycemic	ADJ
bjos-8666637	156	24	agents	agent	NOUN
bjos-8666637	156	25	,	,	PUNCT
bjos-8666637	156	26	antiplatelet	antiplatelet	NOUN
bjos-8666637	156	27	agents	agent	NOUN
bjos-8666637	156	28	,	,	PUNCT
bjos-8666637	156	29	thyroid	thyroid	NOUN
bjos-8666637	156	30	hormone	hormone	NOUN
bjos-8666637	156	31	,	,	PUNCT
bjos-8666637	156	32	antidepressants	antidepressant	NOUN
bjos-8666637	156	33	,	,	PUNCT
bjos-8666637	156	34	and	and	CCONJ
bjos-8666637	156	35	benzodiazepines22	benzodiazepines22	NOUN
bjos-8666637	156	36	.	.	PUNCT
bjos-8666637	157	1	these	these	DET
bjos-8666637	157	2	data	datum	NOUN
bjos-8666637	157	3	reflect	reflect	VERB
bjos-8666637	157	4	the	the	DET
bjos-8666637	157	5	epidemiological	epidemiological	ADJ
bjos-8666637	157	6	transition	transition	NOUN
bjos-8666637	157	7	experienced	experience	VERB
bjos-8666637	157	8	in	in	ADP
bjos-8666637	157	9	brazil	brazil	PROPN
bjos-8666637	157	10	.	.	PUNCT
bjos-8666637	158	1	there	there	PRON
bjos-8666637	158	2	is	be	VERB
bjos-8666637	158	3	an	an	DET
bjos-8666637	158	4	increase	increase	NOUN
bjos-8666637	158	5	in	in	ADP
bjos-8666637	158	6	the	the	DET
bjos-8666637	158	7	prevalence	prevalence	NOUN
bjos-8666637	158	8	of	of	ADP
bjos-8666637	158	9	chronic	chronic	ADJ
bjos-8666637	158	10	and	and	CCONJ
bjos-8666637	158	11	mental	mental	ADJ
bjos-8666637	158	12	diseases	disease	NOUN
bjos-8666637	158	13	when	when	SCONJ
bjos-8666637	158	14	compared	compare	VERB
bjos-8666637	158	15	with	with	ADP
bjos-8666637	158	16	the	the	DET
bjos-8666637	158	17	high	high	ADJ
bjos-8666637	158	18	number	number	NOUN
bjos-8666637	158	19	of	of	ADP
bjos-8666637	158	20	infectious	infectious	ADJ
bjos-8666637	158	21	diseases	disease	NOUN
bjos-8666637	158	22	reported	report	VERB
bjos-8666637	158	23	in	in	ADP
bjos-8666637	158	24	the	the	DET
bjos-8666637	158	25	past23	past23	PROPN
bjos-8666637	158	26	.	.	PUNCT
bjos-8666637	159	1	drug	drug	NOUN
bjos-8666637	159	2	therapy	therapy	NOUN
bjos-8666637	159	3	in	in	ADP
bjos-8666637	159	4	dentistry	dentistry	NOUN
bjos-8666637	159	5	includes	include	VERB
bjos-8666637	159	6	infection	infection	NOUN
bjos-8666637	159	7	,	,	PUNCT
bjos-8666637	159	8	inflammation	inflammation	NOUN
bjos-8666637	159	9	,	,	PUNCT
bjos-8666637	159	10	pain	pain	NOUN
bjos-8666637	159	11	,	,	PUNCT
bjos-8666637	159	12	and	and	CCONJ
bjos-8666637	159	13	anxiety24	anxiety24	NOUN
bjos-8666637	159	14	.	.	PUNCT
bjos-8666637	160	1	therefore	therefore	ADV
bjos-8666637	160	2	,	,	PUNCT
bjos-8666637	160	3	it	it	PRON
bjos-8666637	160	4	is	be	AUX
bjos-8666637	160	5	necessary	necessary	ADJ
bjos-8666637	160	6	to	to	PART
bjos-8666637	160	7	use	use	VERB
bjos-8666637	160	8	non	non	ADJ
bjos-8666637	160	9	-	-	ADJ
bjos-8666637	160	10	opioid	opioid	ADJ
bjos-8666637	160	11	and	and	CCONJ
bjos-8666637	160	12	opioid	opioid	ADJ
bjos-8666637	160	13	analgesics	analgesic	NOUN
bjos-8666637	160	14	,	,	PUNCT
bjos-8666637	160	15	non	non	ADJ
bjos-8666637	160	16	-	-	ADJ
bjos-8666637	160	17	steroidal	steroidal	ADJ
bjos-8666637	160	18	anti	anti	ADJ
bjos-8666637	160	19	-	-	ADJ
bjos-8666637	160	20	inflammatory	inflammatory	ADJ
bjos-8666637	160	21	drugs	drug	NOUN
bjos-8666637	160	22	(	(	PUNCT
bjos-8666637	160	23	nsaids	nsaid	NOUN
bjos-8666637	160	24	)	)	PUNCT
bjos-8666637	160	25	,	,	PUNCT
bjos-8666637	160	26	antimicrobials	antimicrobial	NOUN
bjos-8666637	160	27	,	,	PUNCT
bjos-8666637	160	28	anxiolytics	anxiolytic	NOUN
bjos-8666637	160	29	,	,	PUNCT
bjos-8666637	160	30	in	in	ADP
bjos-8666637	160	31	addition	addition	NOUN
bjos-8666637	160	32	to	to	ADP
bjos-8666637	160	33	local	local	ADJ
bjos-8666637	160	34	anesthetics16	anesthetics16	NOUN
bjos-8666637	160	35	.	.	PUNCT
bjos-8666637	161	1	we	we	PRON
bjos-8666637	161	2	considered	consider	VERB
bjos-8666637	161	3	the	the	DET
bjos-8666637	161	4	medications	medication	NOUN
bjos-8666637	161	5	used	use	VERB
bjos-8666637	161	6	by	by	ADP
bjos-8666637	161	7	the	the	DET
bjos-8666637	161	8	participants	participant	NOUN
bjos-8666637	161	9	in	in	ADP
bjos-8666637	161	10	our	our	PRON
bjos-8666637	161	11	study	study	NOUN
bjos-8666637	161	12	,	,	PUNCT
bjos-8666637	161	13	and	and	CCONJ
bjos-8666637	161	14	drug	drug	NOUN
bjos-8666637	161	15	interactions	interaction	NOUN
bjos-8666637	161	16	relevant	relevant	ADJ
bjos-8666637	161	17	to	to	ADP
bjos-8666637	161	18	dental	dental	ADJ
bjos-8666637	161	19	practice	practice	NOUN
bjos-8666637	161	20	were	be	AUX
bjos-8666637	161	21	found	find	VERB
bjos-8666637	161	22	.	.	PUNCT
bjos-8666637	162	1	the	the	DET
bjos-8666637	162	2	concomitant	concomitant	ADJ
bjos-8666637	162	3	use	use	NOUN
bjos-8666637	162	4	of	of	ADP
bjos-8666637	162	5	simvastatin	simvastatin	NOUN
bjos-8666637	162	6	and	and	CCONJ
bjos-8666637	162	7	erythromycin	erythromycin	NOUN
bjos-8666637	162	8	is	be	AUX
bjos-8666637	162	9	contraindicated	contraindicate	VERB
bjos-8666637	162	10	,	,	PUNCT
bjos-8666637	162	11	as	as	SCONJ
bjos-8666637	162	12	it	it	PRON
bjos-8666637	162	13	can	can	AUX
bjos-8666637	162	14	reduce	reduce	VERB
bjos-8666637	162	15	the	the	DET
bjos-8666637	162	16	effect	effect	NOUN
bjos-8666637	162	17	of	of	ADP
bjos-8666637	162	18	simvastatin	simvastatin	NOUN
bjos-8666637	162	19	.	.	PUNCT
bjos-8666637	163	1	consequently	consequently	ADV
bjos-8666637	163	2	,	,	PUNCT
bjos-8666637	163	3	it	it	PRON
bjos-8666637	163	4	can	can	AUX
bjos-8666637	163	5	lead	lead	VERB
bjos-8666637	163	6	to	to	ADP
bjos-8666637	163	7	myopathy	myopathy	ADJ
bjos-8666637	163	8	,	,	PUNCT
bjos-8666637	163	9	as	as	SCONJ
bjos-8666637	163	10	erythromycin	erythromycin	NOUN
bjos-8666637	163	11	contains	contain	VERB
bjos-8666637	163	12	an	an	DET
bjos-8666637	163	13	inhibitory	inhibitory	ADJ
bjos-8666637	163	14	effect	effect	NOUN
bjos-8666637	163	15	on	on	ADP
bjos-8666637	163	16	a	a	DET
bjos-8666637	163	17	cyp3a4	cyp3a4	NOUN
bjos-8666637	163	18	enzyme	enzyme	NOUN
bjos-8666637	163	19	,	,	PUNCT
bjos-8666637	163	20	which	which	PRON
bjos-8666637	163	21	metabolizes	metabolize	VERB
bjos-8666637	163	22	simvastatin25	simvastatin25	NOUN
bjos-8666637	163	23	.	.	PUNCT
bjos-8666637	164	1	another	another	DET
bjos-8666637	164	2	10	10	NUM
bjos-8666637	164	3	guimarães	guimarães	NOUN
bjos-8666637	164	4	et	et	PROPN
bjos-8666637	164	5	al	al	PROPN
bjos-8666637	164	6	.	.	PROPN
bjos-8666637	164	7	braz	braz	PROPN
bjos-8666637	164	8	j	j	PROPN
bjos-8666637	164	9	oral	oral	PROPN
bjos-8666637	164	10	sci	sci	PROPN
bjos-8666637	164	11	.	.	PUNCT
bjos-8666637	165	1	2023;22	2023;22	NUM
bjos-8666637	165	2	:	:	PUNCT
bjos-8666637	165	3	e236637	e236637	ADJ
bjos-8666637	165	4	relevant	relevant	ADJ
bjos-8666637	165	5	contraindication	contraindication	NOUN
bjos-8666637	165	6	is	be	AUX
bjos-8666637	165	7	between	between	ADP
bjos-8666637	165	8	fluconazole	fluconazole	NOUN
bjos-8666637	165	9	and	and	CCONJ
bjos-8666637	165	10	mirtazapine	mirtazapine	NOUN
bjos-8666637	165	11	because	because	SCONJ
bjos-8666637	165	12	the	the	DET
bjos-8666637	165	13	cyp3a	cyp3a	NOUN
bjos-8666637	165	14	enzyme	enzyme	VERB
bjos-8666637	165	15	metabolizes	metabolize	NOUN
bjos-8666637	165	16	mirtazapine	mirtazapine	NOUN
bjos-8666637	165	17	,	,	PUNCT
bjos-8666637	165	18	and	and	CCONJ
bjos-8666637	165	19	fluconazole	fluconazole	NOUN
bjos-8666637	165	20	initiates	initiate	VERB
bjos-8666637	165	21	its	its	PRON
bjos-8666637	165	22	activity	activity	NOUN
bjos-8666637	165	23	.	.	PUNCT
bjos-8666637	166	1	the	the	DET
bjos-8666637	166	2	concomitant	concomitant	ADJ
bjos-8666637	166	3	use	use	NOUN
bjos-8666637	166	4	of	of	ADP
bjos-8666637	166	5	these	these	DET
bjos-8666637	166	6	two	two	NUM
bjos-8666637	166	7	drugs	drug	NOUN
bjos-8666637	166	8	increases	increase	VERB
bjos-8666637	166	9	the	the	DET
bjos-8666637	166	10	plasma	plasma	NOUN
bjos-8666637	166	11	concentration	concentration	NOUN
bjos-8666637	166	12	of	of	ADP
bjos-8666637	166	13	mirtazapine	mirtazapine	NOUN
bjos-8666637	166	14	,	,	PUNCT
bjos-8666637	166	15	therefore	therefore	ADV
bjos-8666637	166	16	,	,	PUNCT
bjos-8666637	166	17	increases	increase	VERB
bjos-8666637	166	18	the	the	DET
bjos-8666637	166	19	risk	risk	NOUN
bjos-8666637	166	20	of	of	ADP
bjos-8666637	166	21	prolongation	prolongation	NOUN
bjos-8666637	166	22	of	of	ADP
bjos-8666637	166	23	the	the	DET
bjos-8666637	166	24	qt	qt	NOUN
bjos-8666637	166	25	interval	interval	NOUN
bjos-8666637	166	26	and	and	CCONJ
bjos-8666637	166	27	episodes	episode	NOUN
bjos-8666637	166	28	of	of	ADP
bjos-8666637	166	29	ventricular	ventricular	ADJ
bjos-8666637	166	30	arrhythmia26	arrhythmia26	NOUN
bjos-8666637	166	31	.	.	PUNCT
bjos-8666637	167	1	furthermore	furthermore	ADV
bjos-8666637	167	2	,	,	PUNCT
bjos-8666637	167	3	healthcare	healthcare	NOUN
bjos-8666637	167	4	professionals	professional	NOUN
bjos-8666637	167	5	should	should	AUX
bjos-8666637	167	6	be	be	AUX
bjos-8666637	167	7	aware	aware	ADJ
bjos-8666637	167	8	of	of	ADP
bjos-8666637	167	9	the	the	DET
bjos-8666637	167	10	contraindication	contraindication	NOUN
bjos-8666637	167	11	between	between	ADP
bjos-8666637	167	12	nsaids	nsaid	NOUN
bjos-8666637	167	13	and	and	CCONJ
bjos-8666637	167	14	thiazide	thiazide	ADP
bjos-8666637	167	15	diuretics	diuretic	NOUN
bjos-8666637	167	16	since	since	SCONJ
bjos-8666637	167	17	this	this	DET
bjos-8666637	167	18	combination	combination	NOUN
bjos-8666637	167	19	is	be	AUX
bjos-8666637	167	20	associated	associate	VERB
bjos-8666637	167	21	with	with	ADP
bjos-8666637	167	22	diuretic	diuretic	ADJ
bjos-8666637	167	23	efficacy	efficacy	NOUN
bjos-8666637	167	24	and	and	CCONJ
bjos-8666637	167	25	can	can	AUX
bjos-8666637	167	26	lead	lead	VERB
bjos-8666637	167	27	to	to	ADP
bjos-8666637	167	28	nephrotoxicity26	nephrotoxicity26	NOUN
bjos-8666637	167	29	.	.	PUNCT
bjos-8666637	168	1	increased	increase	VERB
bjos-8666637	168	2	risk	risk	NOUN
bjos-8666637	168	3	of	of	ADP
bjos-8666637	168	4	gastrointestinal	gastrointestinal	ADJ
bjos-8666637	168	5	ulcers	ulcer	NOUN
bjos-8666637	168	6	can	can	AUX
bjos-8666637	168	7	occur	occur	VERB
bjos-8666637	168	8	when	when	SCONJ
bjos-8666637	168	9	there	there	PRON
bjos-8666637	168	10	is	be	VERB
bjos-8666637	168	11	concomitant	concomitant	ADJ
bjos-8666637	168	12	use	use	NOUN
bjos-8666637	168	13	of	of	ADP
bjos-8666637	168	14	nsaids	nsaid	NOUN
bjos-8666637	168	15	and	and	CCONJ
bjos-8666637	168	16	corticosteroids26	corticosteroids26	NOUN
bjos-8666637	168	17	.	.	PUNCT
bjos-8666637	169	1	the	the	DET
bjos-8666637	169	2	use	use	NOUN
bjos-8666637	169	3	of	of	ADP
bjos-8666637	169	4	duloxetine	duloxetine	NOUN
bjos-8666637	169	5	may	may	AUX
bjos-8666637	169	6	cause	cause	VERB
bjos-8666637	169	7	a	a	DET
bjos-8666637	169	8	relevant	relevant	ADJ
bjos-8666637	169	9	interaction	interaction	NOUN
bjos-8666637	169	10	with	with	ADP
bjos-8666637	169	11	nsaids	nsaid	NOUN
bjos-8666637	169	12	,	,	PUNCT
bjos-8666637	169	13	which	which	PRON
bjos-8666637	169	14	may	may	AUX
bjos-8666637	169	15	increase	increase	VERB
bjos-8666637	169	16	the	the	DET
bjos-8666637	169	17	risk	risk	NOUN
bjos-8666637	169	18	of	of	ADP
bjos-8666637	169	19	bleeding26	bleeding26	ADJ
bjos-8666637	169	20	.	.	PUNCT
bjos-8666637	170	1	the	the	DET
bjos-8666637	170	2	use	use	NOUN
bjos-8666637	170	3	of	of	ADP
bjos-8666637	170	4	fluconazole	fluconazole	NOUN
bjos-8666637	170	5	is	be	AUX
bjos-8666637	170	6	also	also	ADV
bjos-8666637	170	7	considered	consider	VERB
bjos-8666637	170	8	a	a	DET
bjos-8666637	170	9	risk	risk	NOUN
bjos-8666637	170	10	for	for	ADP
bjos-8666637	170	11	simultaneous	simultaneous	ADJ
bjos-8666637	170	12	use	use	NOUN
bjos-8666637	170	13	with	with	ADP
bjos-8666637	170	14	simvastatin	simvastatin	NOUN
bjos-8666637	170	15	due	due	ADP
bjos-8666637	170	16	to	to	ADP
bjos-8666637	170	17	the	the	DET
bjos-8666637	170	18	possibility	possibility	NOUN
bjos-8666637	170	19	of	of	ADP
bjos-8666637	170	20	[	[	X
bjos-8666637	170	21	leading	lead	VERB
bjos-8666637	170	22	to	to	ADP
bjos-8666637	170	23	]	]	SYM
bjos-8666637	170	24	myopathy	myopathy	ADJ
bjos-8666637	170	25	and	and	CCONJ
bjos-8666637	170	26	rhabdomyolysis26	rhabdomyolysis26	NOUN
bjos-8666637	170	27	.	.	PUNCT
bjos-8666637	171	1	drug	drug	NOUN
bjos-8666637	171	2	interactions	interaction	NOUN
bjos-8666637	171	3	may	may	AUX
bjos-8666637	171	4	occur	occur	VERB
bjos-8666637	171	5	due	due	ADP
bjos-8666637	171	6	to	to	ADP
bjos-8666637	171	7	drugs	drug	NOUN
bjos-8666637	171	8	that	that	PRON
bjos-8666637	171	9	have	have	VERB
bjos-8666637	171	10	a	a	DET
bjos-8666637	171	11	high	high	ADJ
bjos-8666637	171	12	rate	rate	NOUN
bjos-8666637	171	13	of	of	ADP
bjos-8666637	171	14	binding	bind	VERB
bjos-8666637	171	15	to	to	ADP
bjos-8666637	171	16	plasma	plasma	NOUN
bjos-8666637	171	17	proteins	protein	NOUN
bjos-8666637	171	18	,	,	PUNCT
bjos-8666637	171	19	a	a	DET
bjos-8666637	171	20	long	long	ADJ
bjos-8666637	171	21	half	half	ADJ
bjos-8666637	171	22	-	-	PUNCT
bjos-8666637	171	23	life	life	NOUN
bjos-8666637	171	24	,	,	PUNCT
bjos-8666637	171	25	and	and	CCONJ
bjos-8666637	171	26	a	a	DET
bjos-8666637	171	27	narrow	narrow	ADJ
bjos-8666637	171	28	therapeutic	therapeutic	ADJ
bjos-8666637	171	29	window	window	NOUN
bjos-8666637	171	30	.	.	PUNCT
bjos-8666637	172	1	furthermore	furthermore	ADV
bjos-8666637	172	2	,	,	PUNCT
bjos-8666637	172	3	they	they	PRON
bjos-8666637	172	4	are	be	AUX
bjos-8666637	172	5	more	more	ADV
bjos-8666637	172	6	common	common	ADJ
bjos-8666637	172	7	in	in	ADP
bjos-8666637	172	8	patients	patient	NOUN
bjos-8666637	172	9	with	with	ADP
bjos-8666637	172	10	chronic	chronic	ADJ
bjos-8666637	172	11	diseases	disease	NOUN
bjos-8666637	172	12	,	,	PUNCT
bjos-8666637	172	13	making	make	VERB
bjos-8666637	172	14	use	use	NOUN
bjos-8666637	172	15	of	of	ADP
bjos-8666637	172	16	polypharmacy	polypharmacy	NOUN
bjos-8666637	172	17	and	and	CCONJ
bjos-8666637	172	18	self	self	NOUN
bjos-8666637	172	19	-	-	PUNCT
bjos-8666637	172	20	medication	medication	NOUN
bjos-8666637	172	21	,	,	PUNCT
bjos-8666637	172	22	including	include	VERB
bjos-8666637	172	23	herbal	herbal	ADJ
bjos-8666637	172	24	medicines16	medicines16	NOUN
bjos-8666637	172	25	.	.	PUNCT
bjos-8666637	173	1	given	give	VERB
bjos-8666637	173	2	the	the	DET
bjos-8666637	173	3	above	above	ADJ
bjos-8666637	173	4	,	,	PUNCT
bjos-8666637	173	5	health	health	NOUN
bjos-8666637	173	6	professionals	professional	NOUN
bjos-8666637	173	7	who	who	PRON
bjos-8666637	173	8	prescribe	prescribe	VERB
bjos-8666637	173	9	medications	medication	NOUN
bjos-8666637	173	10	,	,	PUNCT
bjos-8666637	173	11	such	such	ADJ
bjos-8666637	173	12	as	as	ADP
bjos-8666637	173	13	physicians	physician	NOUN
bjos-8666637	173	14	and	and	CCONJ
bjos-8666637	173	15	dentists	dentist	NOUN
bjos-8666637	173	16	,	,	PUNCT
bjos-8666637	173	17	should	should	AUX
bjos-8666637	173	18	know	know	VERB
bjos-8666637	173	19	about	about	ADP
bjos-8666637	173	20	possible	possible	ADJ
bjos-8666637	173	21	drug	drug	NOUN
bjos-8666637	173	22	interactions	interaction	NOUN
bjos-8666637	173	23	and	and	CCONJ
bjos-8666637	173	24	adverse	adverse	ADJ
bjos-8666637	173	25	reactions27	reactions27	NOUN
bjos-8666637	173	26	.	.	PUNCT
bjos-8666637	174	1	therefore	therefore	ADV
bjos-8666637	174	2	,	,	PUNCT
bjos-8666637	174	3	it	it	PRON
bjos-8666637	174	4	is	be	AUX
bjos-8666637	174	5	necessary	necessary	ADJ
bjos-8666637	174	6	to	to	PART
bjos-8666637	174	7	carry	carry	VERB
bjos-8666637	174	8	out	out	ADP
bjos-8666637	174	9	a	a	DET
bjos-8666637	174	10	detailed	detailed	ADJ
bjos-8666637	174	11	anamnesis	anamnesis	NOUN
bjos-8666637	174	12	that	that	PRON
bjos-8666637	174	13	will	will	AUX
bjos-8666637	174	14	allow	allow	VERB
bjos-8666637	174	15	the	the	DET
bjos-8666637	174	16	professional	professional	NOUN
bjos-8666637	174	17	to	to	PART
bjos-8666637	174	18	recognize	recognize	VERB
bjos-8666637	174	19	the	the	DET
bjos-8666637	174	20	possibility	possibility	NOUN
bjos-8666637	174	21	of	of	ADP
bjos-8666637	174	22	drug	drug	NOUN
bjos-8666637	174	23	interactions	interaction	NOUN
bjos-8666637	174	24	occurring	occur	VERB
bjos-8666637	174	25	,	,	PUNCT
bjos-8666637	174	26	thus	thus	ADV
bjos-8666637	174	27	preventing	prevent	VERB
bjos-8666637	174	28	adverse	adverse	ADJ
bjos-8666637	174	29	effects	effect	NOUN
bjos-8666637	174	30	and	and	CCONJ
bjos-8666637	174	31	even	even	ADV
bjos-8666637	174	32	providing	provide	VERB
bjos-8666637	174	33	treatment	treatment	NOUN
bjos-8666637	174	34	when	when	SCONJ
bjos-8666637	174	35	necessary28	necessary28	NOUN
bjos-8666637	174	36	.	.	PUNCT
bjos-8666637	175	1	among	among	ADP
bjos-8666637	175	2	the	the	DET
bjos-8666637	175	3	study	study	NOUN
bjos-8666637	175	4	limitations	limitation	NOUN
bjos-8666637	175	5	,	,	PUNCT
bjos-8666637	175	6	the	the	DET
bjos-8666637	175	7	use	use	NOUN
bjos-8666637	175	8	of	of	ADP
bjos-8666637	175	9	a	a	DET
bjos-8666637	175	10	non	non	ADJ
bjos-8666637	175	11	-	-	ADJ
bjos-8666637	175	12	probabilistic	probabilistic	ADJ
bjos-8666637	175	13	sample	sample	NOUN
bjos-8666637	175	14	,	,	PUNCT
bjos-8666637	175	15	limited	limit	VERB
bjos-8666637	175	16	to	to	ADP
bjos-8666637	175	17	a	a	DET
bjos-8666637	175	18	research	research	NOUN
bjos-8666637	175	19	center	center	NOUN
bjos-8666637	175	20	can	can	AUX
bjos-8666637	175	21	be	be	AUX
bjos-8666637	175	22	mentioned	mention	VERB
bjos-8666637	175	23	.	.	PUNCT
bjos-8666637	176	1	the	the	DET
bjos-8666637	176	2	discrepancy	discrepancy	NOUN
bjos-8666637	176	3	between	between	ADP
bjos-8666637	176	4	men	man	NOUN
bjos-8666637	176	5	and	and	CCONJ
bjos-8666637	176	6	women	woman	NOUN
bjos-8666637	176	7	is	be	AUX
bjos-8666637	176	8	due	due	ADJ
bjos-8666637	176	9	to	to	ADP
bjos-8666637	176	10	the	the	DET
bjos-8666637	176	11	study	study	NOUN
bjos-8666637	176	12	location	location	NOUN
bjos-8666637	176	13	and	and	CCONJ
bjos-8666637	176	14	the	the	DET
bjos-8666637	176	15	trend	trend	NOUN
bjos-8666637	176	16	towards	towards	ADP
bjos-8666637	176	17	greater	great	ADJ
bjos-8666637	176	18	self	self	NOUN
bjos-8666637	176	19	-	-	PUNCT
bjos-8666637	176	20	care	care	NOUN
bjos-8666637	176	21	in	in	ADP
bjos-8666637	176	22	women29	women29	NOUN
bjos-8666637	176	23	.	.	PUNCT
bjos-8666637	177	1	this	this	DET
bjos-8666637	177	2	fact	fact	NOUN
bjos-8666637	177	3	may	may	AUX
bjos-8666637	177	4	have	have	AUX
bjos-8666637	177	5	influenced	influence	VERB
bjos-8666637	177	6	the	the	DET
bjos-8666637	177	7	prevalence	prevalence	NOUN
bjos-8666637	177	8	of	of	ADP
bjos-8666637	177	9	xerostomia	xerostomia	PROPN
bjos-8666637	177	10	and	and	CCONJ
bjos-8666637	177	11	dysgeusia	dysgeusia	PROPN
bjos-8666637	177	12	,	,	PUNCT
bjos-8666637	177	13	as	as	SCONJ
bjos-8666637	177	14	hormonal	hormonal	ADJ
bjos-8666637	177	15	changes	change	NOUN
bjos-8666637	177	16	are	be	AUX
bjos-8666637	177	17	frequent	frequent	ADJ
bjos-8666637	177	18	in	in	ADP
bjos-8666637	177	19	elderly	elderly	ADJ
bjos-8666637	177	20	women	woman	NOUN
bjos-8666637	177	21	and	and	CCONJ
bjos-8666637	177	22	predispose	predispose	VERB
bjos-8666637	177	23	to	to	ADP
bjos-8666637	177	24	changes	change	NOUN
bjos-8666637	177	25	in	in	ADP
bjos-8666637	177	26	taste	taste	NOUN
bjos-8666637	177	27	and	and	CCONJ
bjos-8666637	177	28	dry	dry	ADJ
bjos-8666637	177	29	mouth4,11	mouth4,11	NOUN
bjos-8666637	177	30	.	.	PUNCT
bjos-8666637	178	1	furthermore	furthermore	ADV
bjos-8666637	178	2	,	,	PUNCT
bjos-8666637	178	3	the	the	DET
bjos-8666637	178	4	dose	dose	NOUN
bjos-8666637	178	5	and	and	CCONJ
bjos-8666637	178	6	frequency	frequency	NOUN
bjos-8666637	178	7	of	of	ADP
bjos-8666637	178	8	medications	medication	NOUN
bjos-8666637	178	9	used	use	VERB
bjos-8666637	178	10	by	by	ADP
bjos-8666637	178	11	the	the	DET
bjos-8666637	178	12	participants	participant	NOUN
bjos-8666637	178	13	were	be	AUX
bjos-8666637	178	14	not	not	PART
bjos-8666637	178	15	evaluated	evaluate	VERB
bjos-8666637	178	16	.	.	PUNCT
bjos-8666637	179	1	in	in	ADP
bjos-8666637	179	2	conclusion	conclusion	NOUN
bjos-8666637	179	3	,	,	PUNCT
bjos-8666637	179	4	xerostomia	xerostomia	PROPN
bjos-8666637	179	5	is	be	AUX
bjos-8666637	179	6	a	a	DET
bjos-8666637	179	7	frequent	frequent	ADJ
bjos-8666637	179	8	complaint	complaint	NOUN
bjos-8666637	179	9	among	among	ADP
bjos-8666637	179	10	older	old	ADJ
bjos-8666637	179	11	people	people	NOUN
bjos-8666637	179	12	using	use	VERB
bjos-8666637	179	13	polypharmacy	polypharmacy	NOUN
bjos-8666637	179	14	,	,	PUNCT
bjos-8666637	179	15	especially	especially	ADV
bjos-8666637	179	16	those	those	PRON
bjos-8666637	179	17	using	use	VERB
bjos-8666637	179	18	antihypertensives	antihypertensive	NOUN
bjos-8666637	179	19	.	.	PUNCT
bjos-8666637	180	1	antihypertensives	antihypertensive	NOUN
bjos-8666637	180	2	and	and	CCONJ
bjos-8666637	180	3	antidepressants	antidepressant	NOUN
bjos-8666637	180	4	were	be	AUX
bjos-8666637	180	5	used	use	VERB
bjos-8666637	180	6	most	most	ADJ
bjos-8666637	180	7	drugs	drug	NOUN
bjos-8666637	180	8	by	by	ADP
bjos-8666637	180	9	the	the	DET
bjos-8666637	180	10	elderly	elderly	ADJ
bjos-8666637	180	11	and	and	CCONJ
bjos-8666637	180	12	exhibited	exhibit	VERB
bjos-8666637	180	13	interactions	interaction	NOUN
bjos-8666637	180	14	with	with	ADP
bjos-8666637	180	15	drugs	drug	NOUN
bjos-8666637	180	16	most	most	ADV
bjos-8666637	180	17	prescribed	prescribe	VERB
bjos-8666637	180	18	in	in	ADP
bjos-8666637	180	19	dentistry	dentistry	NOUN
bjos-8666637	180	20	.	.	PUNCT
bjos-8666637	181	1	two	two	NUM
bjos-8666637	181	2	contraindications	contraindication	NOUN
bjos-8666637	181	3	were	be	AUX
bjos-8666637	181	4	found	find	VERB
bjos-8666637	181	5	between	between	ADP
bjos-8666637	181	6	fluconazole	fluconazole	NOUN
bjos-8666637	181	7	and	and	CCONJ
bjos-8666637	181	8	mirtazapine	mirtazapine	NOUN
bjos-8666637	181	9	;	;	PUNCT
bjos-8666637	181	10	and	and	CCONJ
bjos-8666637	181	11	between	between	ADP
bjos-8666637	181	12	erythromycin	erythromycin	NOUN
bjos-8666637	181	13	and	and	CCONJ
bjos-8666637	181	14	simvastatin	simvastatin	PROPN
bjos-8666637	181	15	.	.	PUNCT
bjos-8666637	182	1	author	author	NOUN
bjos-8666637	182	2	contribution	contribution	NOUN
bjos-8666637	182	3	danielly	danielly	ADV
bjos-8666637	182	4	de	de	ADP
bjos-8666637	182	5	mendonça	mendonça	ADJ
bjos-8666637	182	6	guimarães	guimarães	NOUN
bjos-8666637	182	7	:	:	PUNCT
bjos-8666637	182	8	assisted	assist	VERB
bjos-8666637	182	9	in	in	ADP
bjos-8666637	182	10	collecting	collect	VERB
bjos-8666637	182	11	and	and	CCONJ
bjos-8666637	182	12	tabulating	tabulate	VERB
bjos-8666637	182	13	data	datum	NOUN
bjos-8666637	182	14	,	,	PUNCT
bjos-8666637	182	15	carried	carry	VERB
bjos-8666637	182	16	out	out	ADP
bjos-8666637	182	17	the	the	DET
bjos-8666637	182	18	article	article	NOUN
bjos-8666637	182	19	’s	’s	PART
bjos-8666637	182	20	writing	writing	NOUN
bjos-8666637	182	21	,	,	PUNCT
bjos-8666637	182	22	and	and	CCONJ
bjos-8666637	182	23	carried	carry	VERB
bjos-8666637	182	24	out	out	ADP
bjos-8666637	182	25	the	the	DET
bjos-8666637	182	26	final	final	ADJ
bjos-8666637	182	27	review	review	NOUN
bjos-8666637	182	28	.	.	PUNCT
bjos-8666637	183	1	yeda	yeda	PROPN
bjos-8666637	183	2	maria	maria	PROPN
bjos-8666637	183	3	parro	parro	PROPN
bjos-8666637	183	4	:	:	PUNCT
bjos-8666637	183	5	responsible	responsible	ADJ
bjos-8666637	183	6	for	for	ADP
bjos-8666637	183	7	collecting	collect	VERB
bjos-8666637	183	8	the	the	DET
bjos-8666637	183	9	data	datum	NOUN
bjos-8666637	183	10	,	,	PUNCT
bjos-8666637	183	11	helping	help	VERB
bjos-8666637	183	12	with	with	ADP
bjos-8666637	183	13	the	the	DET
bjos-8666637	183	14	study	study	NOUN
bjos-8666637	183	15	design	design	NOUN
bjos-8666637	183	16	and	and	CCONJ
bjos-8666637	183	17	reviewing	review	VERB
bjos-8666637	183	18	the	the	DET
bjos-8666637	183	19	final	final	ADJ
bjos-8666637	183	20	version	version	NOUN
bjos-8666637	183	21	of	of	ADP
bjos-8666637	183	22	the	the	DET
bjos-8666637	183	23	article	article	NOUN
bjos-8666637	183	24	.	.	PUNCT
bjos-8666637	184	1	herick	herick	PROPN
bjos-8666637	184	2	sampaio	sampaio	PROPN
bjos-8666637	184	3	muller	muller	PROPN
bjos-8666637	184	4	:	:	PUNCT
bjos-8666637	184	5	responsible	responsible	ADJ
bjos-8666637	184	6	for	for	ADP
bjos-8666637	184	7	assisting	assist	VERB
bjos-8666637	184	8	in	in	ADP
bjos-8666637	184	9	data	datum	NOUN
bjos-8666637	184	10	interpretation	interpretation	NOUN
bjos-8666637	184	11	and	and	CCONJ
bjos-8666637	184	12	reviewing	review	VERB
bjos-8666637	184	13	the	the	DET
bjos-8666637	184	14	final	final	ADJ
bjos-8666637	184	15	version	version	NOUN
bjos-8666637	184	16	of	of	ADP
bjos-8666637	184	17	the	the	DET
bjos-8666637	184	18	article	article	NOUN
bjos-8666637	184	19	.	.	PUNCT
bjos-8666637	185	1	11	11	NUM
bjos-8666637	185	2	guimarães	guimarães	NOUN
bjos-8666637	185	3	et	et	PROPN
bjos-8666637	185	4	al	al	PROPN
bjos-8666637	185	5	.	.	PROPN
bjos-8666637	185	6	braz	braz	PROPN
bjos-8666637	185	7	j	j	PROPN
bjos-8666637	185	8	oral	oral	PROPN
bjos-8666637	185	9	sci	sci	PROPN
bjos-8666637	185	10	.	.	PUNCT
bjos-8666637	186	1	2023;22	2023;22	NUM
bjos-8666637	186	2	:	:	PUNCT
bjos-8666637	186	3	e236637	e236637	ADJ
bjos-8666637	186	4	eduardo	eduardo	PROPN
bjos-8666637	186	5	barbosa	barbosa	PROPN
bjos-8666637	186	6	coelho	coelho	PROPN
bjos-8666637	186	7	:	:	PUNCT
bjos-8666637	186	8	responsible	responsible	ADJ
bjos-8666637	186	9	for	for	ADP
bjos-8666637	186	10	assisting	assist	VERB
bjos-8666637	186	11	in	in	ADP
bjos-8666637	186	12	the	the	DET
bjos-8666637	186	13	elaboration	elaboration	NOUN
bjos-8666637	186	14	of	of	ADP
bjos-8666637	186	15	the	the	DET
bjos-8666637	186	16	work	work	NOUN
bjos-8666637	186	17	methodology	methodology	NOUN
bjos-8666637	186	18	,	,	PUNCT
bjos-8666637	186	19	statistical	statistical	ADJ
bjos-8666637	186	20	calculations	calculation	NOUN
bjos-8666637	186	21	,	,	PUNCT
bjos-8666637	186	22	and	and	CCONJ
bjos-8666637	186	23	reviewing	review	VERB
bjos-8666637	186	24	the	the	DET
bjos-8666637	186	25	final	final	ADJ
bjos-8666637	186	26	version	version	NOUN
bjos-8666637	186	27	of	of	ADP
bjos-8666637	186	28	the	the	DET
bjos-8666637	186	29	article	article	NOUN
bjos-8666637	186	30	.	.	PUNCT
bjos-8666637	187	1	vicente	vicente	PROPN
bjos-8666637	187	2	de	de	PROPN
bjos-8666637	187	3	paulo	paulo	PROPN
bjos-8666637	187	4	martins	martin	NOUN
bjos-8666637	187	5	:	:	PUNCT
bjos-8666637	187	6	responsible	responsible	ADJ
bjos-8666637	187	7	for	for	ADP
bjos-8666637	187	8	assisting	assist	VERB
bjos-8666637	187	9	in	in	ADP
bjos-8666637	187	10	data	datum	NOUN
bjos-8666637	187	11	interpretation	interpretation	NOUN
bjos-8666637	187	12	and	and	CCONJ
bjos-8666637	187	13	reviewing	review	VERB
bjos-8666637	187	14	the	the	DET
bjos-8666637	187	15	end	end	NOUN
bjos-8666637	187	16	of	of	ADP
bjos-8666637	187	17	the	the	DET
bjos-8666637	187	18	article	article	NOUN
bjos-8666637	187	19	.	.	PUNCT
bjos-8666637	188	1	rafael	rafael	PROPN
bjos-8666637	188	2	santana	santana	PROPN
bjos-8666637	188	3	:	:	PUNCT
bjos-8666637	188	4	responsible	responsible	ADJ
bjos-8666637	188	5	for	for	ADP
bjos-8666637	188	6	assisting	assist	VERB
bjos-8666637	188	7	in	in	ADP
bjos-8666637	188	8	the	the	DET
bjos-8666637	188	9	interpretation	interpretation	NOUN
bjos-8666637	188	10	and	and	CCONJ
bjos-8666637	188	11	organization	organization	NOUN
bjos-8666637	188	12	of	of	ADP
bjos-8666637	188	13	data	data	PROPN
bjos-8666637	188	14	,	,	PUNCT
bjos-8666637	188	15	guiding	guide	VERB
bjos-8666637	188	16	the	the	DET
bjos-8666637	188	17	discussion	discussion	NOUN
bjos-8666637	188	18	about	about	ADP
bjos-8666637	188	19	pharmacology	pharmacology	NOUN
bjos-8666637	188	20	,	,	PUNCT
bjos-8666637	188	21	and	and	CCONJ
bjos-8666637	188	22	reviewing	review	VERB
bjos-8666637	188	23	the	the	DET
bjos-8666637	188	24	final	final	ADJ
bjos-8666637	188	25	version	version	NOUN
bjos-8666637	188	26	of	of	ADP
bjos-8666637	188	27	the	the	DET
bjos-8666637	188	28	article	article	NOUN
bjos-8666637	188	29	.	.	PUNCT
bjos-8666637	189	1	érica	érica	PROPN
bjos-8666637	189	2	negrini	negrini	PROPN
bjos-8666637	189	3	lia	lia	PROPN
bjos-8666637	189	4	:	:	PUNCT
bjos-8666637	189	5	responsible	responsible	ADJ
bjos-8666637	189	6	for	for	ADP
bjos-8666637	189	7	outlining	outline	VERB
bjos-8666637	189	8	the	the	DET
bjos-8666637	189	9	study	study	NOUN
bjos-8666637	189	10	and	and	CCONJ
bjos-8666637	189	11	guiding	guiding	NOUN
bjos-8666637	189	12	and	and	CCONJ
bjos-8666637	189	13	reviewing	review	VERB
bjos-8666637	189	14	the	the	DET
bjos-8666637	189	15	final	final	ADJ
bjos-8666637	189	16	version	version	NOUN
bjos-8666637	189	17	of	of	ADP
bjos-8666637	189	18	the	the	DET
bjos-8666637	189	19	article	article	NOUN
bjos-8666637	189	20	.	.	PUNCT
bjos-8666637	190	1	all	all	DET
bjos-8666637	190	2	authors	author	NOUN
bjos-8666637	190	3	actively	actively	ADV
bjos-8666637	190	4	participated	participate	VERB
bjos-8666637	190	5	and	and	CCONJ
bjos-8666637	190	6	revised	revise	VERB
bjos-8666637	190	7	and	and	CCONJ
bjos-8666637	190	8	approved	approve	VERB
bjos-8666637	190	9	the	the	DET
bjos-8666637	190	10	final	final	ADJ
bjos-8666637	190	11	version	version	NOUN
bjos-8666637	190	12	of	of	ADP
bjos-8666637	190	13	the	the	DET
bjos-8666637	190	14	manuscript	manuscript	NOUN
bjos-8666637	190	15	.	.	PUNCT
bjos-8666637	191	1	references	reference	NOUN
bjos-8666637	191	2	1	1	NUM
bjos-8666637	191	3	.	.	PUNCT
bjos-8666637	191	4	brazilian	brazilian	PROPN
bjos-8666637	191	5	institute	institute	PROPN
bjos-8666637	191	6	of	of	ADP
bjos-8666637	191	7	geography	geography	NOUN
bjos-8666637	191	8	and	and	CCONJ
bjos-8666637	191	9	statistics	statistic	NOUN
bjos-8666637	191	10	(	(	PUNCT
bjos-8666637	191	11	ibge	ibge	NOUN
bjos-8666637	191	12	)	)	PUNCT
bjos-8666637	191	13	.	.	PUNCT
bjos-8666637	192	1	national	national	ADJ
bjos-8666637	192	2	household	household	NOUN
bjos-8666637	192	3	sample	sample	NOUN
bjos-8666637	192	4	survey	survey	NOUN
bjos-8666637	192	5	(	(	PUNCT
bjos-8666637	192	6	pnad	pnad	PROPN
bjos-8666637	192	7	)	)	PUNCT
bjos-8666637	192	8	2019	2019	NUM
bjos-8666637	193	1	[	[	X
bjos-8666637	193	2	cited	cite	VERB
bjos-8666637	193	3	2020	2020	NUM
bjos-8666637	193	4	oct	oct	NOUN
bjos-8666637	193	5	28	28	NUM
bjos-8666637	193	6	]	]	PUNCT
bjos-8666637	193	7	.	.	PUNCT
bjos-8666637	194	1	available	available	ADJ
bjos-8666637	194	2	from	from	ADP
bjos-8666637	194	3	:	:	PUNCT
bjos-8666637	194	4	https://www.ibge.gov.br/busca.html?searchword=pnad	https://www.ibge.gov.br/busca.html?searchword=pnad	PROPN
bjos-8666637	194	5	.	.	PUNCT
bjos-8666637	195	1	portuguese	portuguese	PROPN
bjos-8666637	195	2	.	.	PUNCT
bjos-8666637	196	1	2	2	X
bjos-8666637	196	2	.	.	X
bjos-8666637	196	3	ervatti	ervatti	PROPN
bjos-8666637	196	4	lr	lr	PROPN
bjos-8666637	196	5	,	,	PUNCT
bjos-8666637	196	6	borges	borges	PROPN
bjos-8666637	196	7	gm	gm	PROPN
bjos-8666637	196	8	,	,	PUNCT
bjos-8666637	196	9	jardim	jardim	PROPN
bjos-8666637	196	10	ap	ap	PROPN
bjos-8666637	196	11	,	,	PUNCT
bjos-8666637	196	12	organizators	organizator	NOUN
bjos-8666637	196	13	.	.	PUNCT
bjos-8666637	197	1	[	[	X
bjos-8666637	197	2	demographic	demographic	ADJ
bjos-8666637	197	3	change	change	NOUN
bjos-8666637	197	4	in	in	ADP
bjos-8666637	197	5	brazil	brazil	PROPN
bjos-8666637	197	6	at	at	ADP
bjos-8666637	197	7	the	the	DET
bjos-8666637	197	8	beginning	beginning	NOUN
bjos-8666637	197	9	of	of	ADP
bjos-8666637	197	10	the	the	DET
bjos-8666637	197	11	21st	21st	ADJ
bjos-8666637	197	12	century	century	NOUN
bjos-8666637	197	13	–	–	PUNCT
bjos-8666637	197	14	subsidies	subsidy	NOUN
bjos-8666637	197	15	for	for	ADP
bjos-8666637	197	16	population	population	NOUN
bjos-8666637	197	17	projections	projection	NOUN
bjos-8666637	197	18	]	]	PUNCT
bjos-8666637	197	19	.	.	PUNCT
bjos-8666637	198	1	rio	rio	PROPN
bjos-8666637	198	2	de	de	PROPN
bjos-8666637	198	3	janeiro	janeiro	PROPN
bjos-8666637	198	4	:	:	PUNCT
bjos-8666637	198	5	ibge	ibge	NOUN
bjos-8666637	198	6	;	;	PUNCT
bjos-8666637	198	7	2015	2015	NUM
bjos-8666637	199	1	[	[	PUNCT
bjos-8666637	199	2	cited	cite	VERB
bjos-8666637	199	3	2020	2020	NUM
bjos-8666637	199	4	oct	oct	NOUN
bjos-8666637	199	5	28	28	NUM
bjos-8666637	199	6	]	]	PUNCT
bjos-8666637	199	7	.	.	PUNCT
bjos-8666637	200	1	available	available	ADJ
bjos-8666637	200	2	from	from	ADP
bjos-8666637	200	3	:	:	PUNCT
bjos-8666637	200	4	https://biblioteca.ibge.gov.br/visualizacao/livros/liv93322.pdf	https://biblioteca.ibge.gov.br/visualizacao/livros/liv93322.pdf	PROPN
bjos-8666637	200	5	.	.	PUNCT
bjos-8666637	200	6	portuguese	portuguese	PROPN
bjos-8666637	200	7	.	.	PUNCT
bjos-8666637	201	1	3	3	X
bjos-8666637	201	2	.	.	X
bjos-8666637	201	3	roughead	roughead	PROPN
bjos-8666637	201	4	ee	ee	PROPN
bjos-8666637	201	5	,	,	PUNCT
bjos-8666637	201	6	vitry	vitry	NOUN
bjos-8666637	201	7	ai	ai	VERB
bjos-8666637	201	8	,	,	PUNCT
bjos-8666637	201	9	caughey	caughey	PROPN
bjos-8666637	201	10	ge	ge	PROPN
bjos-8666637	201	11	,	,	PUNCT
bjos-8666637	201	12	gilbert	gilbert	PROPN
bjos-8666637	201	13	al	al	PROPN
bjos-8666637	201	14	.	.	PROPN
bjos-8666637	201	15	multimorbidity	multimorbidity	PROPN
bjos-8666637	201	16	,	,	PUNCT
bjos-8666637	201	17	care	care	VERB
bjos-8666637	201	18	complexity	complexity	NOUN
bjos-8666637	201	19	and	and	CCONJ
bjos-8666637	201	20	prescribing	prescribing	NOUN
bjos-8666637	201	21	for	for	ADP
bjos-8666637	201	22	the	the	DET
bjos-8666637	201	23	elderly	elderly	ADJ
bjos-8666637	201	24	.	.	PUNCT
bjos-8666637	202	1	aging	age	VERB
bjos-8666637	202	2	health	health	NOUN
bjos-8666637	202	3	.	.	PUNCT
bjos-8666637	203	1	2011;7(5):695	2011;7(5):695	X
bjos-8666637	203	2	-	-	SYM
bjos-8666637	203	3	705	705	NUM
bjos-8666637	203	4	.	.	NOUN
bjos-8666637	204	1	4	4	NUM
bjos-8666637	204	2	.	.	X
bjos-8666637	204	3	rademacher	rademacher	ADJ
bjos-8666637	204	4	wmh	wmh	NOUN
bjos-8666637	204	5	,	,	PUNCT
bjos-8666637	204	6	aziz	aziz	PROPN
bjos-8666637	204	7	y	y	PROPN
bjos-8666637	204	8	,	,	PUNCT
bjos-8666637	204	9	hielema	hielema	VERB
bjos-8666637	204	10	a	a	PRON
bjos-8666637	204	11	,	,	PUNCT
bjos-8666637	204	12	cheung	cheung	PROPN
bjos-8666637	204	13	kc	kc	PROPN
bjos-8666637	204	14	,	,	PUNCT
bjos-8666637	204	15	de	de	PROPN
bjos-8666637	204	16	lange	lange	PROPN
bjos-8666637	204	17	j	j	PROPN
bjos-8666637	204	18	,	,	PUNCT
bjos-8666637	204	19	vissink	vissink	VERB
bjos-8666637	204	20	a	a	PRON
bjos-8666637	204	21	,	,	PUNCT
bjos-8666637	204	22	et	et	PROPN
bjos-8666637	204	23	al	al	PROPN
bjos-8666637	204	24	.	.	PROPN
bjos-8666637	205	1	oral	oral	ADJ
bjos-8666637	205	2	adverse	adverse	ADJ
bjos-8666637	205	3	effects	effect	NOUN
bjos-8666637	205	4	of	of	ADP
bjos-8666637	205	5	drugs	drug	NOUN
bjos-8666637	205	6	:	:	PUNCT
bjos-8666637	205	7	taste	taste	VERB
bjos-8666637	205	8	disorders	disorder	NOUN
bjos-8666637	205	9	.	.	PUNCT
bjos-8666637	206	1	oral	oral	ADJ
bjos-8666637	206	2	dis	dis	PROPN
bjos-8666637	206	3	.	.	PUNCT
bjos-8666637	207	1	2020	2020	NUM
bjos-8666637	207	2	jan;26(1):213	jan;26(1):213	NOUN
bjos-8666637	207	3	-	-	SYM
bjos-8666637	207	4	23	23	NUM
bjos-8666637	207	5	.	.	PUNCT
bjos-8666637	208	1	doi	doi	NOUN
bjos-8666637	208	2	:	:	PUNCT
bjos-8666637	208	3	10.1111	10.1111	NUM
bjos-8666637	208	4	/	/	SYM
bjos-8666637	208	5	odi.13199	odi.13199	NUM
bjos-8666637	208	6	.	.	PUNCT
bjos-8666637	209	1	5	5	NUM
bjos-8666637	209	2	.	.	X
bjos-8666637	209	3	masnoon	masnoon	PROPN
bjos-8666637	209	4	n	n	CCONJ
bjos-8666637	209	5	,	,	PUNCT
bjos-8666637	209	6	shakib	shakib	PROPN
bjos-8666637	209	7	s	s	PROPN
bjos-8666637	209	8	,	,	PUNCT
bjos-8666637	209	9	kalisch	kalisch	PROPN
bjos-8666637	209	10	-	-	PUNCT
bjos-8666637	209	11	ellett	ellett	PROPN
bjos-8666637	209	12	l	l	PROPN
bjos-8666637	209	13	,	,	PUNCT
bjos-8666637	209	14	caughey	caughey	PROPN
bjos-8666637	209	15	ge	ge	PROPN
bjos-8666637	209	16	.	.	PUNCT
bjos-8666637	210	1	what	what	PRON
bjos-8666637	210	2	is	be	AUX
bjos-8666637	210	3	polypharmacy	polypharmacy	ADJ
bjos-8666637	210	4	?	?	PUNCT
bjos-8666637	211	1	a	a	DET
bjos-8666637	211	2	systematic	systematic	ADJ
bjos-8666637	211	3	review	review	NOUN
bjos-8666637	211	4	of	of	ADP
bjos-8666637	211	5	definitions	definition	NOUN
bjos-8666637	211	6	.	.	PUNCT
bjos-8666637	212	1	bmc	bmc	PROPN
bjos-8666637	212	2	geriatr	geriatr	PROPN
bjos-8666637	212	3	.	.	PUNCT
bjos-8666637	213	1	2017	2017	NUM
bjos-8666637	213	2	oct;17(1):230	oct;17(1):230	X
bjos-8666637	213	3	.	.	PUNCT
bjos-8666637	214	1	doi	doi	PROPN
bjos-8666637	214	2	:	:	PUNCT
bjos-8666637	214	3	10.1186	10.1186	NUM
bjos-8666637	214	4	/	/	SYM
bjos-8666637	214	5	s12877	s12877	NOUN
bjos-8666637	214	6	-	-	PUNCT
bjos-8666637	214	7	017	017	NUM
bjos-8666637	214	8	-	-	PUNCT
bjos-8666637	214	9	0621	0621	NUM
bjos-8666637	214	10	-	-	SYM
bjos-8666637	214	11	2	2	NUM
bjos-8666637	214	12	.	.	NOUN
bjos-8666637	214	13	6	6	NUM
bjos-8666637	214	14	.	.	PUNCT
bjos-8666637	214	15	marcott	marcott	PROPN
bjos-8666637	214	16	s	s	PROPN
bjos-8666637	214	17	,	,	PUNCT
bjos-8666637	214	18	dewan	dewan	PROPN
bjos-8666637	214	19	k	k	PROPN
bjos-8666637	214	20	,	,	PUNCT
bjos-8666637	214	21	kwan	kwan	PROPN
bjos-8666637	214	22	m	m	PROPN
bjos-8666637	214	23	,	,	PUNCT
bjos-8666637	214	24	baik	baik	PROPN
bjos-8666637	214	25	f	f	PROPN
bjos-8666637	214	26	,	,	PUNCT
bjos-8666637	214	27	lee	lee	PROPN
bjos-8666637	214	28	yj	yj	PROPN
bjos-8666637	214	29	,	,	PUNCT
bjos-8666637	214	30	sirjani	sirjani	PROPN
bjos-8666637	214	31	d.	d.	PROPN
bjos-8666637	214	32	where	where	SCONJ
bjos-8666637	214	33	dysphagia	dysphagia	PROPN
bjos-8666637	214	34	begins	begin	VERB
bjos-8666637	214	35	:	:	PUNCT
bjos-8666637	214	36	polypharmacy	polypharmacy	NOUN
bjos-8666637	214	37	and	and	CCONJ
bjos-8666637	214	38	xerostomia	xerostomia	NOUN
bjos-8666637	214	39	.	.	PUNCT
bjos-8666637	215	1	fed	fed	PROPN
bjos-8666637	215	2	pract	pract	PROPN
bjos-8666637	215	3	.	.	PUNCT
bjos-8666637	216	1	2020	2020	NUM
bjos-8666637	217	1	may;37(5):234	may;37(5):234	NOUN
bjos-8666637	217	2	-	-	SYM
bjos-8666637	217	3	41	41	NUM
bjos-8666637	217	4	.	.	PUNCT
bjos-8666637	218	1	7	7	X
bjos-8666637	218	2	.	.	X
bjos-8666637	218	3	anil	anil	PROPN
bjos-8666637	218	4	s	s	PROPN
bjos-8666637	218	5	,	,	PUNCT
bjos-8666637	218	6	vellappally	vellappally	ADV
bjos-8666637	218	7	s	s	PROPN
bjos-8666637	218	8	,	,	PUNCT
bjos-8666637	218	9	hashem	hashem	PROPN
bjos-8666637	218	10	m	m	PROPN
bjos-8666637	218	11	,	,	PUNCT
bjos-8666637	218	12	preethanath	preethanath	NOUN
bjos-8666637	218	13	rs	rs	NOUN
bjos-8666637	218	14	,	,	PUNCT
bjos-8666637	218	15	patil	patil	PROPN
bjos-8666637	218	16	s	s	PROPN
bjos-8666637	218	17	,	,	PUNCT
bjos-8666637	218	18	samaranayake	samaranayake	NOUN
bjos-8666637	218	19	lp	lp	NOUN
bjos-8666637	218	20	.	.	PUNCT
bjos-8666637	219	1	xerostomia	xerostomia	PROPN
bjos-8666637	219	2	in	in	ADP
bjos-8666637	219	3	geriatric	geriatric	ADJ
bjos-8666637	219	4	patients	patient	NOUN
bjos-8666637	219	5	:	:	PUNCT
bjos-8666637	219	6	a	a	DET
bjos-8666637	219	7	burgeoning	burgeon	VERB
bjos-8666637	219	8	global	global	ADJ
bjos-8666637	219	9	concern	concern	NOUN
bjos-8666637	219	10	.	.	PUNCT
bjos-8666637	220	1	j	j	PROPN
bjos-8666637	220	2	investig	investig	PROPN
bjos-8666637	220	3	clin	clin	PROPN
bjos-8666637	220	4	dent	dent	PROPN
bjos-8666637	220	5	.	.	PUNCT
bjos-8666637	221	1	2016	2016	NUM
bjos-8666637	221	2	feb;7(1):5	feb;7(1):5	ADP
bjos-8666637	221	3	-	-	PUNCT
bjos-8666637	221	4	12	12	NUM
bjos-8666637	221	5	.	.	PUNCT
bjos-8666637	222	1	doi	doi	NOUN
bjos-8666637	222	2	:	:	PUNCT
bjos-8666637	222	3	10.1111	10.1111	NUM
bjos-8666637	222	4	/	/	SYM
bjos-8666637	222	5	jicd.12120	jicd.12120	PROPN
bjos-8666637	222	6	.	.	NOUN
bjos-8666637	222	7	8	8	NUM
bjos-8666637	222	8	.	.	X
bjos-8666637	222	9	guggenheimer	guggenheimer	PROPN
bjos-8666637	222	10	j	j	PROPN
bjos-8666637	222	11	,	,	PUNCT
bjos-8666637	222	12	moore	moore	PROPN
bjos-8666637	222	13	pa	pa	PROPN
bjos-8666637	222	14	.	.	PROPN
bjos-8666637	222	15	xerostomia	xerostomia	PROPN
bjos-8666637	222	16	.	.	PUNCT
bjos-8666637	223	1	etiology	etiology	NOUN
bjos-8666637	223	2	,	,	PUNCT
bjos-8666637	223	3	recognition	recognition	NOUN
bjos-8666637	223	4	and	and	CCONJ
bjos-8666637	223	5	treatment	treatment	NOUN
bjos-8666637	223	6	.	.	PUNCT
bjos-8666637	224	1	j	j	PROPN
bjos-8666637	224	2	am	be	AUX
bjos-8666637	224	3	dent	dent	ADJ
bjos-8666637	224	4	assoc	assoc	NOUN
bjos-8666637	224	5	.	.	PUNCT
bjos-8666637	225	1	2003	2003	NUM
bjos-8666637	225	2	jan;134(1):61	jan;134(1):61	NOUN
bjos-8666637	225	3	-	-	PUNCT
bjos-8666637	225	4	9	9	NUM
bjos-8666637	225	5	;	;	PUNCT
bjos-8666637	225	6	quiz	quiz	NOUN
bjos-8666637	225	7	118	118	NUM
bjos-8666637	225	8	-	-	SYM
bjos-8666637	225	9	9	9	NUM
bjos-8666637	225	10	.	.	PUNCT
bjos-8666637	225	11	doi	doi	NOUN
bjos-8666637	225	12	:	:	PUNCT
bjos-8666637	225	13	10.14219	10.14219	NUM
bjos-8666637	225	14	/	/	SYM
bjos-8666637	225	15	jada.archive.2003.0018	jada.archive.2003.0018	NOUN
bjos-8666637	225	16	.	.	PUNCT
bjos-8666637	226	1	9	9	X
bjos-8666637	226	2	.	.	X
bjos-8666637	226	3	rech	rech	PROPN
bjos-8666637	226	4	ca	ca	PROPN
bjos-8666637	226	5	,	,	PUNCT
bjos-8666637	226	6	medeiros	medeiros	PROPN
bjos-8666637	226	7	aw	aw	INTJ
bjos-8666637	226	8	.	.	PUNCT
bjos-8666637	227	1	[	[	X
bjos-8666637	227	2	xerostomia	xerostomia	NOUN
bjos-8666637	227	3	associated	associate	VERB
bjos-8666637	227	4	with	with	ADP
bjos-8666637	227	5	drug	drug	NOUN
bjos-8666637	227	6	use	use	NOUN
bjos-8666637	227	7	in	in	ADP
bjos-8666637	227	8	elderly	elderly	ADJ
bjos-8666637	227	9	]	]	PUNCT
bjos-8666637	227	10	.	.	PUNCT
bjos-8666637	228	1	j	j	PROPN
bjos-8666637	228	2	oral	oral	PROPN
bjos-8666637	228	3	investig	investig	NOUN
bjos-8666637	228	4	.	.	PUNCT
bjos-8666637	229	1	2016;5(1):13	2016;5(1):13	NUM
bjos-8666637	229	2	-	-	SYM
bjos-8666637	229	3	8	8	NUM
bjos-8666637	229	4	.	.	PUNCT
bjos-8666637	230	1	portuguese	portuguese	PROPN
bjos-8666637	230	2	.	.	PUNCT
bjos-8666637	231	1	doi	doi	NOUN
bjos-8666637	231	2	:	:	PUNCT
bjos-8666637	231	3	10.18256/2238	10.18256/2238	NUM
bjos-8666637	231	4	-	-	PUNCT
bjos-8666637	231	5	510x	510x	PROPN
bjos-8666637	231	6	/	/	SYM
bjos-8666637	231	7	j.oralinvestigations.v5n1p13	j.oralinvestigations.v5n1p13	PROPN
bjos-8666637	231	8	-	-	SYM
bjos-8666637	231	9	18	18	NUM
bjos-8666637	231	10	.	.	PUNCT
bjos-8666637	231	11	10	10	NUM
bjos-8666637	231	12	.	.	PUNCT
bjos-8666637	232	1	viljakainen	viljakainen	PROPN
bjos-8666637	232	2	s	s	PROPN
bjos-8666637	232	3	,	,	PUNCT
bjos-8666637	232	4	nykänen	nykänen	NOUN
bjos-8666637	232	5	i	i	NOUN
bjos-8666637	232	6	,	,	PUNCT
bjos-8666637	232	7	ahonen	ahonen	ADJ
bjos-8666637	232	8	r	r	NOUN
bjos-8666637	232	9	,	,	PUNCT
bjos-8666637	232	10	komulainen	komulainen	NOUN
bjos-8666637	232	11	k	k	PROPN
bjos-8666637	232	12	,	,	PUNCT
bjos-8666637	232	13	suominen	suominen	PROPN
bjos-8666637	232	14	al	al	PROPN
bjos-8666637	232	15	,	,	PUNCT
bjos-8666637	232	16	hartikainen	hartikainen	NOUN
bjos-8666637	232	17	s	s	PROPN
bjos-8666637	232	18	,	,	PUNCT
bjos-8666637	232	19	et	et	PROPN
bjos-8666637	232	20	al	al	PROPN
bjos-8666637	232	21	.	.	PROPN
bjos-8666637	232	22	xerostomia	xerostomia	PROPN
bjos-8666637	233	1	among	among	ADP
bjos-8666637	233	2	older	old	ADJ
bjos-8666637	233	3	home	home	NOUN
bjos-8666637	233	4	care	care	NOUN
bjos-8666637	233	5	clients	client	NOUN
bjos-8666637	233	6	.	.	PUNCT
bjos-8666637	234	1	community	community	NOUN
bjos-8666637	234	2	dent	dent	NOUN
bjos-8666637	234	3	oral	oral	ADJ
bjos-8666637	234	4	epidemiol	epidemiol	NOUN
bjos-8666637	234	5	.	.	PUNCT
bjos-8666637	235	1	2016	2016	NUM
bjos-8666637	235	2	jun;44(3):232	jun;44(3):232	NOUN
bjos-8666637	235	3	-	-	PUNCT
bjos-8666637	235	4	8	8	PROPN
bjos-8666637	235	5	.	.	PUNCT
bjos-8666637	236	1	doi	doi	NOUN
bjos-8666637	236	2	:	:	PUNCT
bjos-8666637	236	3	10.1111	10.1111	NUM
bjos-8666637	236	4	/	/	SYM
bjos-8666637	236	5	cdoe.12210	cdoe.12210	PROPN
bjos-8666637	236	6	.	.	PROPN
bjos-8666637	236	7	11	11	NUM
bjos-8666637	236	8	.	.	PUNCT
bjos-8666637	237	1	pedersen	pedersen	PROPN
bjos-8666637	237	2	aml	aml	PROPN
bjos-8666637	237	3	,	,	PUNCT
bjos-8666637	237	4	sørensen	sørensen	PROPN
bjos-8666637	237	5	ce	ce	PROPN
bjos-8666637	237	6	,	,	PUNCT
bjos-8666637	237	7	proctor	proctor	PROPN
bjos-8666637	237	8	gb	gb	PROPN
bjos-8666637	237	9	,	,	PUNCT
bjos-8666637	237	10	carpenter	carpenter	PROPN
bjos-8666637	237	11	gh	gh	PROPN
bjos-8666637	237	12	,	,	PUNCT
bjos-8666637	237	13	ekström	ekström	PROPN
bjos-8666637	237	14	j.	j.	PROPN
bjos-8666637	237	15	salivary	salivary	PROPN
bjos-8666637	237	16	secretion	secretion	NOUN
bjos-8666637	237	17	in	in	ADP
bjos-8666637	237	18	health	health	NOUN
bjos-8666637	237	19	and	and	CCONJ
bjos-8666637	237	20	disease	disease	NOUN
bjos-8666637	237	21	.	.	PUNCT
bjos-8666637	238	1	j	j	PROPN
bjos-8666637	238	2	oral	oral	ADJ
bjos-8666637	238	3	rehabil	rehabil	NOUN
bjos-8666637	238	4	.	.	PUNCT
bjos-8666637	239	1	2018	2018	NUM
bjos-8666637	239	2	sep;45(9):730	sep;45(9):730	NOUN
bjos-8666637	239	3	-	-	SYM
bjos-8666637	239	4	46	46	NUM
bjos-8666637	239	5	.	.	PUNCT
bjos-8666637	240	1	doi	doi	NOUN
bjos-8666637	240	2	:	:	PUNCT
bjos-8666637	240	3	10.1111	10.1111	NUM
bjos-8666637	240	4	/	/	SYM
bjos-8666637	240	5	joor.12664	joor.12664	PROPN
bjos-8666637	240	6	.	.	PROPN
bjos-8666637	240	7	12	12	NUM
bjos-8666637	240	8	.	.	PUNCT
bjos-8666637	241	1	syed	syed	PROPN
bjos-8666637	242	1	q	q	NOUN
bjos-8666637	242	2	,	,	PUNCT
bjos-8666637	242	3	hendler	hendler	PROPN
bjos-8666637	242	4	kt	kt	PROPN
bjos-8666637	242	5	,	,	PUNCT
bjos-8666637	242	6	koncilja	koncilja	PROPN
bjos-8666637	242	7	k.	k.	PROPN
bjos-8666637	243	1	the	the	DET
bjos-8666637	243	2	impact	impact	NOUN
bjos-8666637	243	3	of	of	ADP
bjos-8666637	243	4	aging	age	VERB
bjos-8666637	243	5	and	and	CCONJ
bjos-8666637	243	6	medical	medical	ADJ
bjos-8666637	243	7	status	status	NOUN
bjos-8666637	243	8	on	on	ADP
bjos-8666637	243	9	dysgeusia	dysgeusia	PROPN
bjos-8666637	243	10	.	.	PUNCT
bjos-8666637	244	1	am	be	AUX
bjos-8666637	244	2	j	j	PROPN
bjos-8666637	244	3	med	med	PROPN
bjos-8666637	244	4	.	.	PUNCT
bjos-8666637	245	1	2016	2016	NUM
bjos-8666637	245	2	jul;129(7):753.e1	jul;129(7):753.e1	NOUN
bjos-8666637	245	3	-	-	PUNCT
bjos-8666637	245	4	6	6	NUM
bjos-8666637	245	5	.	.	PUNCT
bjos-8666637	245	6	doi	doi	NOUN
bjos-8666637	245	7	:	:	PUNCT
bjos-8666637	245	8	10.1016	10.1016	NUM
bjos-8666637	245	9	/	/	SYM
bjos-8666637	245	10	j.amjmed.2016.02.003	j.amjmed.2016.02.003	NOUN
bjos-8666637	245	11	.	.	PROPN
bjos-8666637	245	12	12	12	NUM
bjos-8666637	245	13	guimarães	guimarães	NOUN
bjos-8666637	245	14	et	et	PROPN
bjos-8666637	245	15	al	al	PROPN
bjos-8666637	245	16	.	.	PROPN
bjos-8666637	246	1	braz	braz	PROPN
bjos-8666637	246	2	j	j	PROPN
bjos-8666637	246	3	oral	oral	PROPN
bjos-8666637	246	4	sci	sci	PROPN
bjos-8666637	246	5	.	.	PUNCT
bjos-8666637	247	1	2023;22	2023;22	NUM
bjos-8666637	247	2	:	:	PUNCT
bjos-8666637	247	3	e236637	e236637	ADJ
bjos-8666637	247	4	13	13	NUM
bjos-8666637	247	5	.	.	PUNCT
bjos-8666637	248	1	tong	tong	PROPN
bjos-8666637	248	2	jy	jy	PROPN
bjos-8666637	248	3	,	,	PUNCT
bjos-8666637	248	4	wong	wong	PROPN
bjos-8666637	248	5	a	a	PROPN
bjos-8666637	248	6	,	,	PUNCT
bjos-8666637	249	1	zhu	zhu	PROPN
bjos-8666637	249	2	d	d	NOUN
bjos-8666637	249	3	,	,	PUNCT
bjos-8666637	249	4	fastenberg	fastenberg	PROPN
bjos-8666637	249	5	jh	jh	PROPN
bjos-8666637	249	6	,	,	PUNCT
bjos-8666637	249	7	tham	tham	PROPN
bjos-8666637	249	8	t.	t.	PROPN
bjos-8666637	249	9	the	the	DET
bjos-8666637	249	10	prevalence	prevalence	NOUN
bjos-8666637	249	11	of	of	ADP
bjos-8666637	249	12	olfactory	olfactory	NOUN
bjos-8666637	249	13	and	and	CCONJ
bjos-8666637	249	14	gustatory	gustatory	ADJ
bjos-8666637	249	15	dysfunction	dysfunction	NOUN
bjos-8666637	249	16	in	in	ADP
bjos-8666637	249	17	covid-19	covid-19	PROPN
bjos-8666637	249	18	patients	patient	NOUN
bjos-8666637	249	19	:	:	PUNCT
bjos-8666637	249	20	a	a	DET
bjos-8666637	249	21	systematic	systematic	ADJ
bjos-8666637	249	22	review	review	NOUN
bjos-8666637	249	23	and	and	CCONJ
bjos-8666637	249	24	meta	meta	ADJ
bjos-8666637	249	25	-	-	PUNCT
bjos-8666637	249	26	analysis	analysis	NOUN
bjos-8666637	249	27	.	.	PUNCT
bjos-8666637	250	1	otolaryngol	otolaryngol	ADJ
bjos-8666637	250	2	head	head	NOUN
bjos-8666637	250	3	neck	neck	NOUN
bjos-8666637	250	4	surg	surg	NOUN
bjos-8666637	250	5	.	.	PUNCT
bjos-8666637	251	1	2020	2020	NUM
bjos-8666637	251	2	jul;163(1):3	jul;163(1):3	PROPN
bjos-8666637	251	3	-	-	PUNCT
bjos-8666637	251	4	11	11	NUM
bjos-8666637	251	5	.	.	PUNCT
bjos-8666637	252	1	doi	doi	NOUN
bjos-8666637	252	2	:	:	PUNCT
bjos-8666637	252	3	10.1177/0194599820926473	10.1177/0194599820926473	NUM
bjos-8666637	252	4	.	.	NOUN
bjos-8666637	252	5	14	14	NUM
bjos-8666637	252	6	.	.	PUNCT
bjos-8666637	252	7	barbe	barbe	PROPN
bjos-8666637	252	8	ag	ag	PROPN
bjos-8666637	252	9	.	.	PROPN
bjos-8666637	252	10	medication	medication	NOUN
bjos-8666637	252	11	-	-	PUNCT
bjos-8666637	252	12	induced	induce	VERB
bjos-8666637	252	13	xerostomia	xerostomia	NOUN
bjos-8666637	252	14	and	and	CCONJ
bjos-8666637	252	15	hyposalivation	hyposalivation	NOUN
bjos-8666637	252	16	in	in	ADP
bjos-8666637	252	17	the	the	DET
bjos-8666637	252	18	elderly	elderly	ADJ
bjos-8666637	252	19	:	:	PUNCT
bjos-8666637	252	20	culprits	culprit	NOUN
bjos-8666637	252	21	,	,	PUNCT
bjos-8666637	252	22	complications	complication	NOUN
bjos-8666637	252	23	,	,	PUNCT
bjos-8666637	252	24	and	and	CCONJ
bjos-8666637	252	25	management	management	NOUN
bjos-8666637	252	26	.	.	PUNCT
bjos-8666637	253	1	drugs	drug	NOUN
bjos-8666637	253	2	aging	age	VERB
bjos-8666637	253	3	.	.	PUNCT
bjos-8666637	254	1	2018	2018	NUM
bjos-8666637	254	2	oct;35(10):877	oct;35(10):877	ADP
bjos-8666637	254	3	-	-	PUNCT
bjos-8666637	254	4	85	85	NUM
bjos-8666637	254	5	.	.	PUNCT
bjos-8666637	255	1	doi	doi	NOUN
bjos-8666637	255	2	:	:	PUNCT
bjos-8666637	255	3	10.1007	10.1007	NUM
bjos-8666637	255	4	/	/	SYM
bjos-8666637	255	5	s40266	s40266	NOUN
bjos-8666637	255	6	-	-	PUNCT
bjos-8666637	255	7	018	018	NUM
bjos-8666637	255	8	-	-	PUNCT
bjos-8666637	255	9	0588	0588	NUM
bjos-8666637	255	10	-	-	SYM
bjos-8666637	255	11	5	5	NUM
bjos-8666637	255	12	.	.	NOUN
bjos-8666637	255	13	15	15	NUM
bjos-8666637	255	14	.	.	PUNCT
bjos-8666637	256	1	botelho	botelho	PROPN
bjos-8666637	256	2	j	j	PROPN
bjos-8666637	256	3	,	,	PUNCT
bjos-8666637	256	4	machado	machado	PROPN
bjos-8666637	256	5	v	v	PROPN
bjos-8666637	256	6	,	,	PUNCT
bjos-8666637	256	7	proença	proença	PROPN
bjos-8666637	256	8	l	l	PROPN
bjos-8666637	256	9	,	,	PUNCT
bjos-8666637	256	10	oliveira	oliveira	PROPN
bjos-8666637	256	11	mj	mj	PROPN
bjos-8666637	256	12	,	,	PUNCT
bjos-8666637	256	13	cavacas	cavacas	PROPN
bjos-8666637	256	14	ma	ma	PROPN
bjos-8666637	256	15	,	,	PUNCT
bjos-8666637	256	16	amaro	amaro	NOUN
bjos-8666637	256	17	l	l	PROPN
bjos-8666637	256	18	,	,	PUNCT
bjos-8666637	256	19	et	et	PROPN
bjos-8666637	256	20	al	al	PROPN
bjos-8666637	256	21	.	.	PROPN
bjos-8666637	257	1	perceived	perceive	VERB
bjos-8666637	257	2	xerostomia	xerostomia	NOUN
bjos-8666637	257	3	,	,	PUNCT
bjos-8666637	257	4	stress	stress	NOUN
bjos-8666637	257	5	and	and	CCONJ
bjos-8666637	257	6	periodontal	periodontal	ADJ
bjos-8666637	257	7	status	status	NOUN
bjos-8666637	257	8	impact	impact	NOUN
bjos-8666637	257	9	on	on	ADP
bjos-8666637	257	10	elderly	elderly	ADJ
bjos-8666637	257	11	oral	oral	ADJ
bjos-8666637	257	12	health	health	NOUN
bjos-8666637	257	13	-	-	PUNCT
bjos-8666637	257	14	related	relate	VERB
bjos-8666637	257	15	quality	quality	NOUN
bjos-8666637	257	16	of	of	ADP
bjos-8666637	257	17	life	life	NOUN
bjos-8666637	257	18	:	:	PUNCT
bjos-8666637	257	19	findings	finding	NOUN
bjos-8666637	257	20	from	from	ADP
bjos-8666637	257	21	a	a	DET
bjos-8666637	257	22	cross	cross	ADJ
bjos-8666637	257	23	-	-	ADJ
bjos-8666637	257	24	sectional	sectional	ADJ
bjos-8666637	257	25	survey	survey	NOUN
bjos-8666637	257	26	.	.	PUNCT
bjos-8666637	258	1	bmc	bmc	ADJ
bjos-8666637	258	2	oral	oral	ADJ
bjos-8666637	258	3	health	health	NOUN
bjos-8666637	258	4	.	.	PUNCT
bjos-8666637	259	1	2020	2020	NUM
bjos-8666637	260	1	jul;20(1):199	jul;20(1):199	PROPN
bjos-8666637	260	2	.	.	PUNCT
bjos-8666637	261	1	doi	doi	PROPN
bjos-8666637	261	2	:	:	PUNCT
bjos-8666637	261	3	10.1186	10.1186	NUM
bjos-8666637	261	4	/	/	SYM
bjos-8666637	261	5	s12903	s12903	NOUN
bjos-8666637	261	6	-	-	PUNCT
bjos-8666637	261	7	020	020	NUM
bjos-8666637	261	8	-	-	PUNCT
bjos-8666637	261	9	01183	01183	NUM
bjos-8666637	261	10	-	-	SYM
bjos-8666637	261	11	7	7	NUM
bjos-8666637	261	12	.	.	NOUN
bjos-8666637	261	13	16	16	NUM
bjos-8666637	261	14	.	.	PUNCT
bjos-8666637	262	1	bertollo	bertollo	PROPN
bjos-8666637	262	2	al	al	PROPN
bjos-8666637	262	3	,	,	PUNCT
bjos-8666637	262	4	demartini	demartini	NOUN
bjos-8666637	262	5	c	c	NOUN
bjos-8666637	262	6	,	,	PUNCT
bjos-8666637	262	7	piato	piato	PROPN
bjos-8666637	262	8	al	al	PROPN
bjos-8666637	262	9	.	.	PUNCT
bjos-8666637	262	10	drug	drug	NOUN
bjos-8666637	262	11	interactions	interaction	NOUN
bjos-8666637	262	12	in	in	ADP
bjos-8666637	262	13	dental	dental	ADJ
bjos-8666637	262	14	clinic	clinic	NOUN
bjos-8666637	262	15	.	.	PUNCT
bjos-8666637	263	1	rev	rev	PROPN
bjos-8666637	263	2	bras	bras	PROPN
bjos-8666637	263	3	odontol	odontol	VERB
bjos-8666637	263	4	.	.	PUNCT
bjos-8666637	264	1	2013;70(2):120	2013;70(2):120	NUM
bjos-8666637	264	2	-	-	SYM
bjos-8666637	264	3	4	4	NUM
bjos-8666637	264	4	.	.	NUM
bjos-8666637	264	5	17	17	NUM
bjos-8666637	264	6	.	.	PUNCT
bjos-8666637	264	7	alic	alic	PROPN
bjos-8666637	264	8	a	a	X
bjos-8666637	264	9	,	,	PUNCT
bjos-8666637	264	10	pranjic	pranjic	NOUN
bjos-8666637	264	11	n	n	NOUN
bjos-8666637	264	12	,	,	PUNCT
bjos-8666637	264	13	ramic	ramic	PROPN
bjos-8666637	264	14	e.	e.	PROPN
bjos-8666637	264	15	polypharmacy	polypharmacy	PROPN
bjos-8666637	264	16	and	and	CCONJ
bjos-8666637	264	17	decreased	decrease	VERB
bjos-8666637	264	18	cognitive	cognitive	ADJ
bjos-8666637	264	19	abilities	ability	NOUN
bjos-8666637	264	20	in	in	ADP
bjos-8666637	264	21	elderly	elderly	ADJ
bjos-8666637	264	22	patients	patient	NOUN
bjos-8666637	264	23	.	.	PUNCT
bjos-8666637	265	1	med	med	PROPN
bjos-8666637	265	2	arh	arh	PROPN
bjos-8666637	265	3	.	.	PUNCT
bjos-8666637	266	1	2011;65(2):102	2011;65(2):102	NUM
bjos-8666637	266	2	-	-	SYM
bjos-8666637	266	3	5	5	NUM
bjos-8666637	266	4	.	.	NOUN
bjos-8666637	266	5	18	18	NUM
bjos-8666637	266	6	.	.	PUNCT
bjos-8666637	267	1	fernandes	fernandes	PROPN
bjos-8666637	267	2	ms	ms	PROPN
bjos-8666637	267	3	,	,	PUNCT
bjos-8666637	267	4	castelo	castelo	PROPN
bjos-8666637	267	5	pm	pm	VERB
bjos-8666637	267	6	,	,	PUNCT
bjos-8666637	267	7	chaves	chaves	PROPN
bjos-8666637	267	8	gn	gn	PROPN
bjos-8666637	267	9	,	,	PUNCT
bjos-8666637	267	10	fernandes	fernandes	PROPN
bjos-8666637	267	11	jps	jps	PROPN
bjos-8666637	267	12	,	,	PUNCT
bjos-8666637	267	13	fonseca	fonseca	PROPN
bjos-8666637	267	14	fla	fla	PROPN
bjos-8666637	267	15	,	,	PUNCT
bjos-8666637	267	16	zanato	zanato	PROPN
bjos-8666637	267	17	le	le	PROPN
bjos-8666637	267	18	,	,	PUNCT
bjos-8666637	268	1	et	et	PROPN
bjos-8666637	268	2	al	al	PROPN
bjos-8666637	268	3	.	.	PROPN
bjos-8666637	268	4	relationship	relationship	NOUN
bjos-8666637	268	5	between	between	ADP
bjos-8666637	268	6	polypharmacy	polypharmacy	NOUN
bjos-8666637	268	7	,	,	PUNCT
bjos-8666637	268	8	xerostomia	xerostomia	NOUN
bjos-8666637	268	9	,	,	PUNCT
bjos-8666637	268	10	gustatory	gustatory	NOUN
bjos-8666637	268	11	sensitivity	sensitivity	NOUN
bjos-8666637	268	12	,	,	PUNCT
bjos-8666637	268	13	and	and	CCONJ
bjos-8666637	268	14	swallowing	swallow	VERB
bjos-8666637	268	15	complaints	complaint	NOUN
bjos-8666637	268	16	in	in	ADP
bjos-8666637	268	17	the	the	DET
bjos-8666637	268	18	elderly	elderly	ADJ
bjos-8666637	268	19	:	:	PUNCT
bjos-8666637	268	20	a	a	DET
bjos-8666637	268	21	multidisciplinary	multidisciplinary	ADJ
bjos-8666637	268	22	approach	approach	NOUN
bjos-8666637	268	23	.	.	PUNCT
bjos-8666637	269	1	j	j	PROPN
bjos-8666637	269	2	texture	texture	ADJ
bjos-8666637	269	3	stud	stud	NOUN
bjos-8666637	269	4	.	.	PUNCT
bjos-8666637	270	1	2021	2021	NUM
bjos-8666637	270	2	apr;52(2):187	apr;52(2):187	NOUN
bjos-8666637	270	3	-	-	PUNCT
bjos-8666637	270	4	96	96	NUM
bjos-8666637	270	5	.	.	PUNCT
bjos-8666637	270	6	doi	doi	NOUN
bjos-8666637	270	7	:	:	PUNCT
bjos-8666637	270	8	10.1111	10.1111	NUM
bjos-8666637	270	9	/	/	SYM
bjos-8666637	270	10	jtxs.12573	jtxs.12573	PROPN
bjos-8666637	270	11	.	.	PROPN
bjos-8666637	270	12	19	19	NUM
bjos-8666637	270	13	.	.	PUNCT
bjos-8666637	271	1	agostini	agostini	PROPN
bjos-8666637	271	2	ba	ba	PROPN
bjos-8666637	271	3	,	,	PUNCT
bjos-8666637	271	4	cericato	cericato	PROPN
bjos-8666637	271	5	go	go	VERB
bjos-8666637	271	6	,	,	PUNCT
bjos-8666637	271	7	da	da	PROPN
bjos-8666637	271	8	silveira	silveira	PROPN
bjos-8666637	271	9	er	er	INTJ
bjos-8666637	271	10	,	,	PUNCT
bjos-8666637	271	11	nascimento	nascimento	PROPN
bjos-8666637	271	12	gg	gg	PROPN
bjos-8666637	271	13	,	,	PUNCT
bjos-8666637	271	14	costa	costa	PROPN
bjos-8666637	271	15	fds	fds	PROPN
bjos-8666637	271	16	,	,	PUNCT
bjos-8666637	271	17	thomson	thomson	PROPN
bjos-8666637	271	18	wm	wm	PROPN
bjos-8666637	271	19	,	,	PUNCT
bjos-8666637	271	20	et	et	PROPN
bjos-8666637	271	21	al	al	PROPN
bjos-8666637	271	22	.	.	PUNCT
bjos-8666637	272	1	how	how	SCONJ
bjos-8666637	272	2	common	common	ADJ
bjos-8666637	272	3	is	be	AUX
bjos-8666637	272	4	dry	dry	ADJ
bjos-8666637	272	5	mouth	mouth	NOUN
bjos-8666637	272	6	?	?	PUNCT
bjos-8666637	273	1	systematic	systematic	ADJ
bjos-8666637	273	2	review	review	NOUN
bjos-8666637	273	3	and	and	CCONJ
bjos-8666637	273	4	meta	meta	ADJ
bjos-8666637	273	5	-	-	PUNCT
bjos-8666637	273	6	regression	regression	NOUN
bjos-8666637	273	7	analysis	analysis	NOUN
bjos-8666637	273	8	of	of	ADP
bjos-8666637	273	9	prevalence	prevalence	NOUN
bjos-8666637	273	10	estimates	estimate	NOUN
bjos-8666637	273	11	.	.	PUNCT
bjos-8666637	274	1	braz	braz	PROPN
bjos-8666637	274	2	dent	dent	PROPN
bjos-8666637	274	3	j.	j.	PROPN
bjos-8666637	274	4	2018	2018	NUM
bjos-8666637	274	5	nov	nov	PROPN
bjos-8666637	274	6	-	-	PUNCT
bjos-8666637	274	7	dec;29(6):606	dec;29(6):606	PROPN
bjos-8666637	274	8	-	-	PUNCT
bjos-8666637	274	9	18	18	NUM
bjos-8666637	274	10	.	.	PUNCT
bjos-8666637	275	1	doi	doi	NOUN
bjos-8666637	275	2	:	:	PUNCT
bjos-8666637	275	3	10.1590/0103	10.1590/0103	NUM
bjos-8666637	275	4	-	-	SYM
bjos-8666637	275	5	6440201802302	6440201802302	NUM
bjos-8666637	275	6	.	.	PUNCT
bjos-8666637	276	1	20	20	NUM
bjos-8666637	276	2	.	.	PUNCT
bjos-8666637	277	1	gomes	gomes	PROPN
bjos-8666637	277	2	drp	drp	PROPN
bjos-8666637	277	3	,	,	PUNCT
bjos-8666637	277	4	schirmer	schirmer	PROPN
bjos-8666637	277	5	cl	cl	PROPN
bjos-8666637	277	6	,	,	PUNCT
bjos-8666637	277	7	nolte	nolte	PROPN
bjos-8666637	277	8	aoa	aoa	PROPN
bjos-8666637	277	9	,	,	PUNCT
bjos-8666637	277	10	bós	bós	PROPN
bjos-8666637	277	11	ajg	ajg	PROPN
bjos-8666637	277	12	,	,	PUNCT
bjos-8666637	277	13	venzke	venzke	NOUN
bjos-8666637	277	14	jg	jg	PROPN
bjos-8666637	277	15	.	.	PUNCT
bjos-8666637	278	1	[	[	X
bjos-8666637	278	2	evaluation	evaluation	NOUN
bjos-8666637	278	3	of	of	ADP
bjos-8666637	278	4	the	the	DET
bjos-8666637	278	5	taste	taste	NOUN
bjos-8666637	278	6	of	of	ADP
bjos-8666637	278	7	older	old	ADJ
bjos-8666637	278	8	people	people	NOUN
bjos-8666637	278	9	and	and	CCONJ
bjos-8666637	278	10	their	their	PRON
bjos-8666637	278	11	relationship	relationship	NOUN
bjos-8666637	278	12	with	with	ADP
bjos-8666637	278	13	nutritional	nutritional	ADJ
bjos-8666637	278	14	state	state	NOUN
bjos-8666637	278	15	and	and	CCONJ
bjos-8666637	278	16	food	food	NOUN
bjos-8666637	278	17	habits	habit	NOUN
bjos-8666637	278	18	]	]	PUNCT
bjos-8666637	278	19	.	.	PUNCT
bjos-8666637	279	1	pajar	pajar	NOUN
bjos-8666637	279	2	.	.	PUNCT
bjos-8666637	280	1	2020;8(1):1	2020;8(1):1	NOUN
bjos-8666637	280	2	-	-	PUNCT
bjos-8666637	280	3	8	8	NUM
bjos-8666637	280	4	.	.	PUNCT
bjos-8666637	281	1	portuguese	portuguese	PROPN
bjos-8666637	281	2	.	.	PUNCT
bjos-8666637	282	1	doi	doi	NOUN
bjos-8666637	282	2	:	:	PUNCT
bjos-8666637	282	3	10.15448/2357	10.15448/2357	NUM
bjos-8666637	282	4	-	-	PUNCT
bjos-8666637	282	5	9641.2020.1.37707	9641.2020.1.37707	NOUN
bjos-8666637	282	6	.	.	PUNCT
bjos-8666637	283	1	21	21	NUM
bjos-8666637	283	2	.	.	PUNCT
bjos-8666637	284	1	aziz	aziz	PROPN
bjos-8666637	284	2	m	m	PROPN
bjos-8666637	284	3	,	,	PUNCT
bjos-8666637	284	4	perisetti	perisetti	VERB
bjos-8666637	284	5	a	a	PRON
bjos-8666637	284	6	,	,	PUNCT
bjos-8666637	284	7	lee	lee	PROPN
bjos-8666637	284	8	-	-	PUNCT
bjos-8666637	284	9	smith	smith	PROPN
bjos-8666637	284	10	wm	wm	PROPN
bjos-8666637	284	11	,	,	PUNCT
bjos-8666637	284	12	gajendran	gajendran	PROPN
bjos-8666637	284	13	m	m	PROPN
bjos-8666637	284	14	,	,	PUNCT
bjos-8666637	284	15	bansal	bansal	NOUN
bjos-8666637	284	16	p	p	NOUN
bjos-8666637	284	17	,	,	PUNCT
bjos-8666637	284	18	goyal	goyal	PROPN
bjos-8666637	284	19	h.	h.	PROPN
bjos-8666637	284	20	taste	taste	NOUN
bjos-8666637	284	21	changes	change	NOUN
bjos-8666637	284	22	(	(	PUNCT
bjos-8666637	284	23	dysgeusia	dysgeusia	NOUN
bjos-8666637	284	24	)	)	PUNCT
bjos-8666637	284	25	in	in	ADP
bjos-8666637	284	26	covid-19	covid-19	PROPN
bjos-8666637	284	27	:	:	PUNCT
bjos-8666637	284	28	a	a	DET
bjos-8666637	284	29	systematic	systematic	ADJ
bjos-8666637	284	30	review	review	NOUN
bjos-8666637	284	31	and	and	CCONJ
bjos-8666637	284	32	meta	meta	ADJ
bjos-8666637	284	33	-	-	PUNCT
bjos-8666637	284	34	analysis	analysis	NOUN
bjos-8666637	284	35	.	.	PUNCT
bjos-8666637	285	1	gastroenterology	gastroenterology	NOUN
bjos-8666637	285	2	.	.	PUNCT
bjos-8666637	286	1	2020	2020	NUM
bjos-8666637	286	2	sep;159(3):1132	sep;159(3):1132	NOUN
bjos-8666637	287	1	-	-	SYM
bjos-8666637	287	2	3	3	NUM
bjos-8666637	287	3	.	.	PUNCT
bjos-8666637	287	4	doi	doi	NOUN
bjos-8666637	287	5	:	:	PUNCT
bjos-8666637	287	6	10.1053	10.1053	NUM
bjos-8666637	287	7	/	/	SYM
bjos-8666637	287	8	j.gastro.2020.05.003	j.gastro.2020.05.003	NOUN
bjos-8666637	287	9	.	.	PUNCT
bjos-8666637	288	1	epub	epub	PROPN
bjos-8666637	288	2	2020	2020	NUM
bjos-8666637	288	3	may	may	AUX
bjos-8666637	288	4	5	5	NUM
bjos-8666637	288	5	.	.	NOUN
bjos-8666637	288	6	22	22	NUM
bjos-8666637	288	7	.	.	PUNCT
bjos-8666637	289	1	lopes	lopes	PROPN
bjos-8666637	289	2	acf	acf	PROPN
bjos-8666637	289	3	,	,	PUNCT
bjos-8666637	289	4	pereira	pereira	PROPN
bjos-8666637	289	5	css	css	PROPN
bjos-8666637	289	6	,	,	PUNCT
bjos-8666637	289	7	fernandes	fernandes	PROPN
bjos-8666637	289	8	fl	fl	PROPN
bjos-8666637	289	9	,	,	PUNCT
bjos-8666637	289	10	valente	valente	PROPN
bjos-8666637	289	11	lc	lc	PROPN
bjos-8666637	289	12	,	,	PUNCT
bjos-8666637	289	13	valadão	valadão	PROPN
bjos-8666637	289	14	af	af	PROPN
bjos-8666637	289	15	,	,	PUNCT
bjos-8666637	289	16	abreu	abreu	PROPN
bjos-8666637	289	17	mns	mns	PROPN
bjos-8666637	289	18	,	,	PUNCT
bjos-8666637	289	19	et	et	PROPN
bjos-8666637	289	20	al	al	PROPN
bjos-8666637	289	21	.	.	PUNCT
bjos-8666637	290	1	prevalence	prevalence	NOUN
bjos-8666637	290	2	of	of	ADP
bjos-8666637	290	3	gustatory	gustatory	NOUN
bjos-8666637	290	4	changes	change	NOUN
bjos-8666637	290	5	in	in	ADP
bjos-8666637	290	6	elderly	elderly	ADJ
bjos-8666637	290	7	people	people	NOUN
bjos-8666637	290	8	under	under	ADP
bjos-8666637	290	9	chronic	chronic	ADJ
bjos-8666637	290	10	medication	medication	NOUN
bjos-8666637	290	11	use	use	NOUN
bjos-8666637	290	12	.	.	PUNCT
bjos-8666637	291	1	geriatr	geriatr	ADJ
bjos-8666637	291	2	gerontol	gerontol	ADJ
bjos-8666637	291	3	aging	aging	NOUN
bjos-8666637	291	4	.	.	PUNCT
bjos-8666637	292	1	2015;9(4):132	2015;9(4):132	NUM
bjos-8666637	292	2	-	-	SYM
bjos-8666637	292	3	7	7	NUM
bjos-8666637	292	4	.	.	PUNCT
bjos-8666637	292	5	portuguese	portuguese	PROPN
bjos-8666637	292	6	.	.	PUNCT
bjos-8666637	293	1	doi	doi	NOUN
bjos-8666637	293	2	:	:	PUNCT
bjos-8666637	293	3	10.5327	10.5327	NUM
bjos-8666637	293	4	/	/	SYM
bjos-8666637	293	5	z2447	z2447	NUM
bjos-8666637	293	6	-	-	PUNCT
bjos-8666637	293	7	2115201500040002	2115201500040002	NUM
bjos-8666637	293	8	.	.	PUNCT
bjos-8666637	294	1	23	23	NUM
bjos-8666637	294	2	.	.	X
bjos-8666637	294	3	travassos	travassos	PROPN
bjos-8666637	294	4	gf	gf	PROPN
bjos-8666637	294	5	,	,	PUNCT
bjos-8666637	294	6	coelho	coelho	PROPN
bjos-8666637	294	7	ab	ab	PROPN
bjos-8666637	294	8	,	,	PUNCT
bjos-8666637	294	9	arends	arend	NOUN
bjos-8666637	294	10	-	-	PUNCT
bjos-8666637	294	11	kuenning	kuenne	VERB
bjos-8666637	294	12	mp	mp	NOUN
bjos-8666637	294	13	.	.	PUNCT
bjos-8666637	295	1	the	the	DET
bjos-8666637	295	2	elderly	elderly	ADJ
bjos-8666637	295	3	in	in	ADP
bjos-8666637	295	4	brazil	brazil	PROPN
bjos-8666637	295	5	:	:	PUNCT
bjos-8666637	295	6	demographic	demographic	ADJ
bjos-8666637	295	7	transition	transition	NOUN
bjos-8666637	295	8	,	,	PUNCT
bjos-8666637	295	9	profile	profile	NOUN
bjos-8666637	295	10	,	,	PUNCT
bjos-8666637	295	11	and	and	CCONJ
bjos-8666637	295	12	socioeconomic	socioeconomic	ADJ
bjos-8666637	295	13	condition	condition	NOUN
bjos-8666637	295	14	.	.	PUNCT
bjos-8666637	296	1	rev	rev	PROPN
bjos-8666637	296	2	bras	bras	PROPN
bjos-8666637	296	3	estud	estud	VERB
bjos-8666637	296	4	popul	popul	NOUN
bjos-8666637	296	5	.	.	PUNCT
bjos-8666637	297	1	2020;37:1	2020;37:1	NUM
bjos-8666637	297	2	-	-	PUNCT
bjos-8666637	297	3	27	27	NUM
bjos-8666637	297	4	.	.	PUNCT
bjos-8666637	298	1	doi	doi	NOUN
bjos-8666637	298	2	:	:	PUNCT
bjos-8666637	298	3	10.20947	10.20947	NUM
bjos-8666637	298	4	/	/	SYM
bjos-8666637	298	5	s0102	s0102	NOUN
bjos-8666637	298	6	-	-	PUNCT
bjos-8666637	298	7	3098a0129	3098a0129	NUM
bjos-8666637	298	8	.	.	PUNCT
bjos-8666637	299	1	24	24	NUM
bjos-8666637	299	2	.	.	PUNCT
bjos-8666637	300	1	cesar	cesar	PROPN
bjos-8666637	300	2	g	g	PROPN
bjos-8666637	300	3	,	,	PUNCT
bjos-8666637	300	4	franco	franco	PROPN
bjos-8666637	300	5	n	n	CCONJ
bjos-8666637	300	6	,	,	PUNCT
bjos-8666637	300	7	cogo	cogo	PROPN
bjos-8666637	300	8	k	k	PROPN
bjos-8666637	300	9	,	,	PUNCT
bjos-8666637	300	10	montan	montan	PROPN
bjos-8666637	300	11	mf	mf	PROPN
bjos-8666637	300	12	,	,	PUNCT
bjos-8666637	300	13	groppo	groppo	PROPN
bjos-8666637	300	14	fc	fc	PROPN
bjos-8666637	300	15	,	,	PUNCT
bjos-8666637	300	16	volpato	volpato	PROPN
bjos-8666637	300	17	mc	mc	PROPN
bjos-8666637	300	18	.	.	PUNCT
bjos-8666637	301	1	[	[	X
bjos-8666637	301	2	drug	drug	NOUN
bjos-8666637	301	3	interactions	interaction	NOUN
bjos-8666637	301	4	:	:	PUNCT
bjos-8666637	301	5	factors	factor	NOUN
bjos-8666637	301	6	related	relate	VERB
bjos-8666637	301	7	to	to	ADP
bjos-8666637	301	8	the	the	DET
bjos-8666637	301	9	patient	patient	NOUN
bjos-8666637	301	10	(	(	PUNCT
bjos-8666637	301	11	part	part	NOUN
bjos-8666637	301	12	i	i	NOUN
bjos-8666637	301	13	)	)	PUNCT
bjos-8666637	301	14	]	]	PUNCT
bjos-8666637	301	15	.	.	PUNCT
bjos-8666637	302	1	rev	rev	PROPN
bjos-8666637	302	2	cir	cir	PROPN
bjos-8666637	302	3	traumatol	traumatol	PROPN
bjos-8666637	302	4	bucomaxilo	bucomaxilo	PROPN
bjos-8666637	302	5	-	-	PUNCT
bjos-8666637	302	6	fac	fac	PROPN
bjos-8666637	302	7	.	.	PUNCT
bjos-8666637	303	1	2007;7(1):17	2007;7(1):17	NUM
bjos-8666637	303	2	-	-	SYM
bjos-8666637	303	3	27	27	NUM
bjos-8666637	303	4	.	.	PUNCT
bjos-8666637	304	1	25	25	NUM
bjos-8666637	304	2	.	.	PUNCT
bjos-8666637	305	1	simvastatin	simvastatin	NOUN
bjos-8666637	305	2	.	.	PUNCT
bjos-8666637	306	1	[	[	X
bjos-8666637	306	2	package	package	NOUN
bjos-8666637	306	3	insert	insert	NOUN
bjos-8666637	306	4	for	for	ADP
bjos-8666637	306	5	the	the	DET
bjos-8666637	306	6	drug	drug	NOUN
bjos-8666637	306	7	simvastatin	simvastatin	PROPN
bjos-8666637	306	8	®	®	PROPN
bjos-8666637	306	9	]	]	PUNCT
bjos-8666637	306	10	.	.	PUNCT
bjos-8666637	307	1	américo	américo	PROPN
bjos-8666637	307	2	brasiliense	brasiliense	NOUN
bjos-8666637	307	3	/	/	SYM
bjos-8666637	307	4	sp	sp	NOUN
bjos-8666637	307	5	.	.	NOUN
bjos-8666637	307	6	folk	folk	NOUN
bjos-8666637	307	7	remedy	remedy	PROPN
bjos-8666637	307	8	foundation	foundation	PROPN
bjos-8666637	307	9	;	;	PUNCT
bjos-8666637	307	10	2017	2017	NUM
bjos-8666637	308	1	[	[	PUNCT
bjos-8666637	308	2	cited	cite	VERB
bjos-8666637	308	3	2020	2020	NUM
bjos-8666637	308	4	oct	oct	NOUN
bjos-8666637	308	5	28	28	NUM
bjos-8666637	308	6	]	]	PUNCT
bjos-8666637	308	7	.	.	PUNCT
bjos-8666637	309	1	available	available	ADJ
bjos-8666637	309	2	from	from	ADP
bjos-8666637	309	3	:	:	PUNCT
bjos-8666637	309	4	https://consultas.anvisa.gov.br/#/bulario/deta	https://consultas.anvisa.gov.br/#/bulario/deta	NOUN
bjos-8666637	309	5	lhe/1000858?nomeproduto	lhe/1000858?nomeproduto	PROPN
bjos-8666637	309	6	=	=	NOUN
bjos-8666637	309	7	sinvastatina	sinvastatina	NOUN
bjos-8666637	309	8	.	.	PUNCT
bjos-8666637	310	1	portuguese	portuguese	PROPN
bjos-8666637	310	2	.	.	PUNCT
bjos-8666637	311	1	26	26	NUM
bjos-8666637	311	2	.	.	PUNCT
bjos-8666637	311	3	dynamed	dyname	VERB
bjos-8666637	312	1	[	[	X
bjos-8666637	312	2	database	database	NOUN
bjos-8666637	312	3	online	online	ADV
bjos-8666637	312	4	]	]	PUNCT
bjos-8666637	312	5	.	.	PUNCT
bjos-8666637	313	1	ipswich	ipswich	PROPN
bjos-8666637	313	2	(	(	PUNCT
bjos-8666637	313	3	ma	ma	PROPN
bjos-8666637	313	4	):	):	PUNCT
bjos-8666637	313	5	ebsco	ebsco	PROPN
bjos-8666637	313	6	information	information	PROPN
bjos-8666637	313	7	services	service	NOUN
bjos-8666637	314	1	[	[	X
bjos-8666637	314	2	cited	cite	VERB
bjos-8666637	314	3	2021	2021	NUM
bjos-8666637	314	4	jun	jun	PROPN
bjos-8666637	314	5	28	28	NUM
bjos-8666637	314	6	]	]	PUNCT
bjos-8666637	314	7	.	.	PUNCT
bjos-8666637	315	1	available	available	ADJ
bjos-8666637	315	2	from	from	ADP
bjos-8666637	315	3	:	:	PUNCT
bjos-8666637	315	4	http://www.dynamed.com	http://www.dynamed.com	X
bjos-8666637	315	5	.	.	PUNCT
bjos-8666637	316	1	27	27	NUM
bjos-8666637	316	2	.	.	PUNCT
bjos-8666637	316	3	sousa	sousa	PROPN
bjos-8666637	316	4	itc	itc	PROPN
bjos-8666637	316	5	,	,	PUNCT
bjos-8666637	316	6	pestana	pestana	PROPN
bjos-8666637	316	7	am	am	PROPN
bjos-8666637	316	8	,	,	PUNCT
bjos-8666637	316	9	araujo	araujo	PROPN
bjos-8666637	316	10	mar	mar	PROPN
bjos-8666637	316	11	.	.	PUNCT
bjos-8666637	317	1	[	[	X
bjos-8666637	317	2	clinical	clinical	ADJ
bjos-8666637	317	3	implications	implication	NOUN
bjos-8666637	317	4	of	of	ADP
bjos-8666637	317	5	the	the	DET
bjos-8666637	317	6	use	use	NOUN
bjos-8666637	317	7	of	of	ADP
bjos-8666637	317	8	nsaids	nsaid	NOUN
bjos-8666637	317	9	in	in	ADP
bjos-8666637	317	10	hypertensive	hypertensive	ADJ
bjos-8666637	317	11	patients	patient	NOUN
bjos-8666637	317	12	:	:	PUNCT
bjos-8666637	317	13	drug	drug	NOUN
bjos-8666637	317	14	interactions	interaction	NOUN
bjos-8666637	317	15	in	in	ADP
bjos-8666637	317	16	dentistry	dentistry	NOUN
bjos-8666637	317	17	]	]	PUNCT
bjos-8666637	317	18	.	.	PUNCT
bjos-8666637	318	1	rev	rev	PROPN
bjos-8666637	318	2	bras	bras	PROPN
bjos-8666637	318	3	hipertens	hiperten	VERB
bjos-8666637	318	4	.	.	PUNCT
bjos-8666637	319	1	2019;26(3):91	2019;26(3):91	NUM
bjos-8666637	319	2	-	-	SYM
bjos-8666637	319	3	6	6	NUM
bjos-8666637	319	4	.	.	PUNCT
bjos-8666637	320	1	portuguese	portuguese	PROPN
bjos-8666637	320	2	.	.	PUNCT
bjos-8666637	321	1	28	28	NUM
bjos-8666637	321	2	.	.	PUNCT
bjos-8666637	322	1	ouanounou	ouanounou	NOUN
bjos-8666637	322	2	a	a	PRON
bjos-8666637	322	3	,	,	PUNCT
bjos-8666637	322	4	haas	haas	PROPN
bjos-8666637	322	5	da	da	PROPN
bjos-8666637	322	6	.	.	PUNCT
bjos-8666637	323	1	pharmacotherapy	pharmacotherapy	NOUN
bjos-8666637	323	2	for	for	ADP
bjos-8666637	323	3	the	the	DET
bjos-8666637	323	4	elderly	elderly	ADJ
bjos-8666637	323	5	dental	dental	ADJ
bjos-8666637	323	6	patient	patient	NOUN
bjos-8666637	323	7	.	.	PUNCT
bjos-8666637	324	1	j	j	PROPN
bjos-8666637	324	2	can	can	AUX
bjos-8666637	324	3	dent	dent	VERB
bjos-8666637	324	4	assoc	assoc	NOUN
bjos-8666637	324	5	.	.	PUNCT
bjos-8666637	325	1	2015;80	2015;80	X
bjos-8666637	325	2	:	:	PUNCT
bjos-8666637	325	3	f18	f18	NOUN
bjos-8666637	325	4	.	.	PUNCT
bjos-8666637	326	1	29	29	NUM
bjos-8666637	326	2	.	.	PUNCT
bjos-8666637	327	1	levorato	levorato	PROPN
bjos-8666637	327	2	cd	cd	PROPN
bjos-8666637	327	3	,	,	PUNCT
bjos-8666637	327	4	de	de	PROPN
bjos-8666637	327	5	mello	mello	PROPN
bjos-8666637	327	6	lm	lm	PROPN
bjos-8666637	327	7	,	,	PUNCT
bjos-8666637	327	8	da	da	PROPN
bjos-8666637	327	9	silva	silva	PROPN
bjos-8666637	327	10	as	as	ADP
bjos-8666637	327	11	,	,	PUNCT
bjos-8666637	327	12	nunes	nune	VERB
bjos-8666637	327	13	aa	aa	NOUN
bjos-8666637	327	14	.	.	PUNCT
bjos-8666637	328	1	[	[	X
bjos-8666637	328	2	factors	factor	NOUN
bjos-8666637	328	3	associated	associate	VERB
bjos-8666637	328	4	with	with	ADP
bjos-8666637	328	5	the	the	DET
bjos-8666637	328	6	demand	demand	NOUN
bjos-8666637	328	7	for	for	ADP
bjos-8666637	328	8	health	health	NOUN
bjos-8666637	328	9	services	service	NOUN
bjos-8666637	328	10	from	from	ADP
bjos-8666637	328	11	a	a	DET
bjos-8666637	328	12	gender	gender	NOUN
bjos-8666637	328	13	-	-	PUNCT
bjos-8666637	328	14	relational	relational	ADJ
bjos-8666637	328	15	perspective	perspective	NOUN
bjos-8666637	328	16	]	]	PUNCT
bjos-8666637	328	17	.	.	PUNCT
bjos-8666637	329	1	cien	cien	VERB
bjos-8666637	329	2	saude	saude	NOUN
bjos-8666637	329	3	colet	colet	NOUN
bjos-8666637	329	4	.	.	PUNCT
bjos-8666637	330	1	2014	2014	NUM
bjos-8666637	331	1	apr;19(4):1263	apr;19(4):1263	ADJ
bjos-8666637	331	2	-	-	PUNCT
bjos-8666637	331	3	74	74	NUM
bjos-8666637	331	4	.	.	PUNCT
bjos-8666637	332	1	portuguese	portuguese	PROPN
bjos-8666637	332	2	.	.	PUNCT
bjos-8666637	333	1	doi	doi	NOUN
bjos-8666637	333	2	:	:	PUNCT
bjos-8666637	333	3	10.1590/1413	10.1590/1413	NUM
bjos-8666637	333	4	-	-	NOUN
bjos-8666637	333	5	81232014194.01242013	81232014194.01242013	NOUN
bjos-8666637	333	6	.	.	PUNCT
bjos-8666637	334	1	https://consultas.anvisa.gov.br/#/bulario/detalhe/1000858?nomeproduto=sinvastatina	https://consultas.anvisa.gov.br/#/bulario/detalhe/1000858?nomeproduto=sinvastatina	PROPN